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I.  Introduction  
A. Executive Report 
This report summarizes in an integrated format, National Antimicrobial Resistance Monitoring 
System data on Salmonella and Campylobacter isolates recovered in 2004 from food animals at
federally inspected plants, retail meats, and humans.  The report also includes susceptibility 
data on Escherichia coli isolates recovered from retail meats and chickens in 2004.  For 
comparison purposes, summary data from prior years are included.   
Suggested Citation: FDA. National Antimicrobial Resistance Monitoring System – Enteric 
Bacteria (NARMS): 2004 Executive Report. Rockville, MD: U.S. Department of Health and 
Human Services, Food and Drug Administration, 2008. 
B. NARMS Program
The National Antimicrobial Resistance Monitoring System – Enteric Bacteria (NARMS) is a 
national public health surveillance system in the United States that tracks changes in the 
susceptibility of certain enteric bacteria to antimicrobial agents of human and veterinary medical 
importance. The NARMS program was established in 1996 as a collaboration between 
three federal agencies: the U.S. Food and Drug Administration (FDA), the Centers for 
Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA).  
NARMS also collaborates with scientists involved in antimicrobial resistance monitoring in other 
countries, including Canada, Denmark, France, Germany, Greece, Italy, Mexico, the Netherlands, 
Norway, Sweden, and the United Kingdom, so that information can be shared on the global 
dimensions of antimicrobial resistance in foodborne bacteria. 
NARMS monitors antimicrobial susceptibility among enteric bacteria from humans, retail meats, 
and food animals.  Surveillance is conducted for two categories of enteric bacteria: zoonotic 
bacterial pathogens (Salmonella and Campylobacter) and other bacteria (Escherichia coli 
and Enterococcus). Salmonella was chosen as the sentinel pathogen for the NARMS program 
at its inception in 1996.  Campylobacter was later added, followed by E. coli and Enterococcus. 
Monitoring of E. coli and Enterococcus isolates was added due to their ubiquitous presence in 
animals, foods, and humans and their potential to serve as reservoirs of antimicrobial resistance 
genes for bacterial pathogens.  NARMS also examines Salmonella and Campylobacter isolates 
for genetic relatedness using pulsed-field gel electrophoresis (PFGE).  In addition, NARMS 
conducts epidemiologic and microbiologic research studies.  These studies may include isolates 
of a particular serotype or those exhibiting a particular resistance pattern or they may focus on 
improving the culture, isolation, or antimicrobial susceptibility testing methodology of target 
bacteria. Comprehensive annual NARMS reports are published by CDC, FDA, and USDA.  In 
addition, NARMS data and directed research studies are reported at scientific meetings and 
published in peer-reviewed scientific journals. 
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As a public health monitoring system, the primary objectives of NARMS are to: 
•	 Provide data on the extent and temporal trends of antimicrobial resistance in zoonotic 
foodborne bacterial pathogens and select commensal organisms to veterinarians, 
physicians, public health authorities, and other stakeholders 
•	 Provide a platform for research studies to better understand the emergence and spread 
of antimicrobial resistance and assist in the development of science-based strategies to 
contain or mitigate resistance  
•	 Assist the FDA in making decisions related to the approval of safe and effective drugs 
for humans and animals, as well as to promote judicious use of antimicrobial drugs
C. NARMS Components  
The NARMS program has three components or “arms” which are briefly described below.   
1. Human Component 
The human component of NARMS was launched in 1996 within the framework of CDC’s 
Emerging Infections Program and the Foodborne Diseases Active Surveillance Network 
(FoodNet). Antimicrobial susceptibility testing of NARMS human isolates is performed at CDC’s 
laboratories in the National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED) 
in Atlanta, Georgia. 
The program initially included non-Typhi Salmonella and E. coli O157:H7 isolates from 14 state 
and local health departments.  It later expanded to include additional bacteria and testing sites.  
In 1997, testing was expanded to include monitoring of resistance among Campylobacter
isolates from humans in five sites participating in FoodNet.  In 1999, testing of Salmonella Typhi 
and Shigella isolates was added. Since 2003, all 50 states have been forwarding to CDC a 
representative sample of non-Typhi Salmonella, Salmonella Typhi, Shigella, and E. coli O157 
isolates for antimicrobial susceptibility testing.  Testing of Campylobacter also expanded over 
time and in 2004, 10 FoodNet states participated in Campylobacter surveillance. 
An enterococci resistance study began in 2001 to monitor antimicrobial resistance among 
enterococci isolated from human stool samples.  Stool samples were collected from outpatients 
at four sites and healthy volunteers at one site.  An E. coli component was added to the study in 
2004. Stool specimens for the E. coli study were from outpatients at two sites.   
2. Retail Meat Component 
The retail meat component of NARMS was launched in 2002, following a 15-month pilot study in 
Iowa. Retail meat surveillance is conducted through an ongoing collaboration between FDA’s 
Center for Veterinary Medicine (CVM), CDC, and FoodNet laboratories.  Participating FoodNet 
sites purchased chicken breasts, ground turkey, ground beef, and pork chops at retail stores 
and cultured them for Salmonella and Campylobacter. Four sites also cultured retail meats 
for E. coli and Enterococcus. Bacterial identification and antimicrobial susceptibility 
testing of retail meat isolates was performed at CVM’s Office of Research in Laurel, Maryland. 
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3. Animal Component 
The animal component of NARMS was launched in 1997 after pilot studies were conducted in 
1995 and 1996.  Antimicrobial susceptibility testing of animal isolates is conducted at the 
USDA’s Agricultural Research Service (ARS) Bacterial Epidemiology and Antimicrobial 
Resistance Research Unit at the Russell Research Center in Athens, Georgia.   
Salmonella isolates recovered from chickens, turkeys, cattle, and swine at slaughter were 
submitted to the NARMS program through the USDA Food Safety and Inspection Service (FSIS) 
Pathogen Reduction/Hazard Analysis and Critical Control Point (PR/HACCP) verification testing 
program. Salmonella isolates from USDA baseline studies, ready-to-eat sampling programs, 
and diagnostic and on-farm sources were also tested, but data on these isolates are not 
included in this report.  The program was later expanded to include monitoring of resistance
among Campylobacter (1998), E. coli (2000), and Enterococcus (2003) isolates from chicken
carcass rinsates collected at slaughter for the PR/HACCP verification testing program.  
D. Links to Additional Information 
Additional information about NARMS, including comprehensive annual reports for each NARMS 
component, can be found on the CDC, FDA, and USDA websites listed below.  The FDA 
website also contains a link to this Executive Report and the NARMS 2003 Executive Report. 
CDC: http://www.cdc.gov/narms
FDA: http://www.fda.gov/cvm/narms_pg.html
USDA: http://ars.usda.gov/Main/docs.htm?docid=6750
Information about the Foodborne Diseases Active Surveillance Network (FoodNet) can be found 
on the following CDC website: http://www.cdc.gov/foodnet/
3
  
 
 
 
 
 
 
 
 
 
   
 
 
 
 
  
 
 
 
 
                                                 
    
II. Methods 
A. Sampling Methodology
Sample collection is an integral part of many public health surveillance systems, including 
NARMS. Sampling strategies necessarily differ among the three components of NARMS and 
are described below.    
1. Human Component 
Sampling for the human pathogens depends on public health laboratory-based surveillance and
is driven by the occurrence of laboratory-confirmed cases.  NARMS testing of non-Typhi 
Salmonella began in 1996 with isolates from 14 states.  Subsequently, additional states joined 
the program. Since 2003, Salmonella isolates have been collected from clinical laboratories by 
state and local health departments in all 50 states and sent to CDC for susceptibility testing.  
From 1996 through 2002, participating sites submitted every tenth non-Typhi Salmonella they 
received to CDC for antimicrobial susceptibility testing.  In 2003 and 2004, participating sites 
submitted every 20th isolate. Salmonella serotyping was performed by the participating state 
and local public health laboratories prior to shipping.   
Surveillance for Campylobacter began in 1997 with five FoodNet sites submitting one isolate 
each week.  This was expanded through the years, and in 2004, Campylobacter isolates were 
submitted from 10 FoodNet sites (California, Colorodo, Connecticut, Georgia, Maryland, 
Minnesota, New Mexico, New York, Oregon, and Tennessee); one isolate per week was tested 
from each site.1 
2. Retail Meat Component 
In 2002, retail meat sampling began in January with FoodNet laboratories in Connecticut, 
Georgia, Maryland, Minnesota, and Tennessee; Oregon joined in September.  FoodNet 
laboratories in California and New York joined in 2003, while FoodNet laboratories in Colorado 
and New Mexico joined in 2004.   
Each FoodNet site attempted to purchase a total of 40 meat samples per month, including 10 
samples each of chicken breasts, ground turkey, ground beef, and pork chops.  An attempt was 
made by each site to sample as many different stores as possible each month and to purchase 
as many different brands of fresh (not frozen) meat and poultry as possible.  All sites cultured 
the retail meats for Salmonella and Campylobacter. Four sites (Georgia, Maryland, Oregon, 
and Tennessee) also cultured the meats for E. coli and Enterococcus. Once identified, bacterial 
isolates were sent to CVM’s Office of Research for further characterization, including serotype 
(Salmonella) or species (Campylobacter and Enterococcus) confirmation and antimicrobial 
susceptibility testing.  
1 Further details about sampling of Campylobacter isolates can be found in the NARMS Human Isolates Final Report        
for 2004. 
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3. Animal Component
The animal component of NARMS was launched in 1997 and initially included monitoring of 
antimicrobial susceptibility among Salmonella. Data for Salmonella isolates from food animals 
at slaughter are included in this report.  The isolates were recovered from carcass rinsates 
(chicken), carcass swabs (turkey, cattle, and swine), and ground products (chicken, turkey, and 
beef) collected at federally inspected slaughter and processing plants throughout the U.S. as 
part of the FSIS PR/HACCP verification testing program and pre-implementation testing.  
Serotyping was performed by the National Veterinary Services Laboratories (NVSL). 
USDA began testing Campylobacter isolates in 1998.  From 1998 to 2000, Campylobacter
isolates from chickens were obtained from a variety of FSIS programs for inclusion in NARMS.  
In 1998, Campylobacter isolates were submitted only from the Eastern FSIS laboratory, 
whereas in 1999 and 2000, isolates were obtained from all three FSIS laboratories (Eastern, 
Midwestern, and Western laboratories).  FSIS cultured samples for Campylobacter using the 
most probable number method described in the FSIS Microbiology Laboratory Guidebook.1 
Nalidixic acid susceptibility and cephalothin resistance were initially used as identification 
criteria for Campylobacter jejuni/coli.  This likely resulted in an underreporting of quinolone 
resistant Campylobacter until 2001, when use of this method was discontinued.  From January 
through June 2001, various isolation methods were compared and a new ARS method was 
adopted in July of 2001. Since that time, Campylobacter reported in the NARMS animal 
component have been isolated by ARS from spent chicken carcass rinsates submitted by the 
Eastern FSIS laboratory. The rinsates were collected as part of the Salmonella PR/HACCP 
verification testing program.  In addition to testing the Campylobacter isolates for antimicrobial 
susceptibility, the ARS laboratory speciated the isolates.  This Executive Report contains data 
on Campylobacter recovered from chicken carcass rinsates for the period July 2001 through 
December 2004, when the new ARS isolation method was used.   
USDA began testing E. coli isolates for antimicrobial susceptibility in 2000.  ARS isolated the E. 
coli from spent chicken carcass rinsates submitted by the Eastern FSIS laboratory.  The 
rinsates were collected as part of the Salmonella PR/HACCP verification testing program. 
B. Antimicrobial Susceptibility Testing Methods 
The dilution schemes and antimicrobial content of the susceptibility testing panels have 
undergone several design iterations as the NARMS program has matured.  This has resulted in 
testing arrays that now meet international standards for quality control.  The content of the 
panels was amended, as appropriate, to accommodate new antimicrobial agents entering the 
market, to omit those no longer available or used, or to adjust dilution ranges.  The susceptibility 
testing panel formats undergo annual review for possible improvements.  Customized testing 
panels have also been designed, and are available for use in phenotypic assessment of 
extended spectrum beta-lactam and fluoroquinolone resistance.   
Antimicrobial minimum inhibitory concentrations (MICs) for Salmonella and E. coli were 
determined according to manufacturer instructions using the Sensititre® semi-automated 
antimicrobial susceptibility system (Trek Diagnostic Systems, Westlake, Ohio).  In 2004, 
Salmonella and E. coli isolates were tested using a custom plate developed for Gram negative
1 http://www.fsis.usda.gov/Science/Microbiological_Lab_Guidebook/index.asp
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bacteria (catalog # CMV1AGNF).  Clinical and Laboratory Standards Institute (CLSI)1 
recommended quality control organisms were used each time that antimicrobial susceptibility 
testing was performed.  The quality control organisms included Escherichia coli ATCC 25922, 
Enterococcus faecalis ATCC 29212, Staphylococcus aureus ATCC 29213, and Pseudomonas 
aeruginosa ATCC 27853.2,3   Two content changes were made in the Salmonella/E. coli plate 
format in 2004: cephalothin was omitted from the testing panel and sulfamethoxazole was 
replaced with sulfisoxazole.  
Methods used to determine antimicrobial MICs for Campylobacter have changed over time.  
Through 2004, the human and animal components of NARMS used Etest® (AB Biodisk, Solna, 
Sweden). The antimicrobial agents tested using Etest® included: azithromycin, 
chloramphenicol, ciprofloxacin, clindamycin, erythromycin, gentamicin, nalidixic acid, and 
tetracycline.  Based on Etest® manufacturer recommendations, MIC results that fell between the 
two-fold dilutions described in CLSI documents were rounded up to next two-fold dilution before 
interpretation.4  The retail component used the CLSI-approved agar dilution method in 2002 and 
2003. Recognizing the need for a standardized semi-automated method, CVM developed a 
broth microdilution method.  The retail component began using this method in 2004 and the 
human and food animal components adopted the method in 2005.  This standardized method 
was approved and published by CLSI in 2006.5  Testing was done using the Sensititre® semi-
automated antimicrobial susceptibility system (Trek Diagnostic Systems, Westlake, Ohio) and a 
custom plate developed for Campylobacter (catalog # CAMPY).  The antimicrobial agents 
included in the broth microdilution testing were: azithromycin, ciprofloxacin, clindamycin, 
erythromycin, florfenicol, gentamicin, nalidixic acid, telithromycin, and tetracycline.  
Campylobacter jejuni ATCC 33560 was used as the quality control organism. 
C. Breakpoints 
The breakpoints used in this report are shown in Tables 1 and 2.  CLSI-approved breakpoints 
were used when available. For Salmonella and E. coli, CLSI breakpoints were available for all 
antimicrobials tested except streptomycin.  For Campylobacter, CLSI breakpoints were available 
only for ciprofloxacin, doxycycline, erythromycin, and tetracycline.  NARMS breakpoints were 
used when CLSI breakpoints were not available.  NARMS breakpoints were established based 
on the MIC distributions of NARMS isolates.  Since the NARMS 2003 Executive Report was 
published in 2006, there were changes in the breakpoints for Campylobacter for the following 
antimicrobial agents: azithromycin, clindamycin, doxycycline, erythromycin, gentamicin, and 
nalidixic acid. Resistance data for all years were recalculated using the new breakpoints.   
1 The organization was known as the National Committee on Clinical Laboratory Standards (NCCLS) until the name      
was changed in January of 2005 to CLSI.  In this report, the name CLSI is used. 
2 NCCLS. 2002. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated
   from Animals; Approved Standard—Second Edition. NCCLS document M31-A2. NCCLS, Wayne, PA. 
3 NCCLS. 2003. Performance Standards for Antimicrobial Susceptibility Testing; Thirteenth Informational
   Supplement. NCCLS document M100-S13. NCCLS, Wayne, PA. 
4 In USDA’s NARMS annual reports, MIC values were not rounded up prior to interpretation. 
5 CLSI. 2006. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious
   Bacteria; Approved Guideline. CLSI document M45-A. CLSI, Wayne, PA. 
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Table 1. Breakpoints Used for Susceptibility Testing of Salmonella and E. coli 1
 Antimicrobial Class  Antimicrobial Agent
 Aminoglycosides  Amikacin ≤ 16 32 ≥ 64
 Gentamicin ≤ 4 8 ≥ 16
 Kanamycin ≤ 16 32 ≥ 64
 Streptomycin ≤ 32 N/A ≥ 64
 Aminopenicillins  Ampicillin ≤ 8 16 ≥ 32
β-Lactam/β-Lactamase
 Inhibitor Combinations  Amoxicillin–Clavulanic Acid ≤ 8 / 4 16 / 8 ≥ 32 / 16
 Cephalosporins  Ceftiofur ≤ 2 4 ≥ 8
 Ceftriaxone ≤ 8 16 - 32 ≥ 64
 Cephalothin2 ≤ 8 16 ≥ 32
 Cephamycins  Cefoxitin ≤ 8 16 ≥ 32
 Folate Pathway Inhibitors  Sulfamethoxazole/Sulfisoxazole3 ≤ 256 N/A ≥ 512
 Trimethoprim–Sulfamethoxazole ≤ 2 / 38 N/A ≥ 4 / 76
 Phenicols  Chloramphenicol ≤ 8 16 ≥ 32
 Quinolones  Ciprofloxacin ≤ 1 2 ≥ 4
 Nalidixic acid ≤ 16 N/A ≥ 32
 Tetracyclines  Tetracycline ≤ 4 8 ≥ 16
2 Cephalothin was tested through 2003
3 Sulfamethoxazole was tested from 1996 through 2003 and was replaced by sulfisoxazole in 2004
MIC Breakpoints (µg/ml)
ResistantIntermediateSusceptible
1 Breakpoints were adopted from CLSI (Clinical and Laboratory Standards Institute), except for streptomycin, 
  which has no CLSI breakpoints
7
Table 2. Breakpoints Used for Susceptibility Testing of Campylobacter 1
 Antimicrobial Class  Antimicrobial Agent
 Aminoglycosides  Gentamicin ≤ 2 4 ≥ 8
 Ketolides  Telithromycin ≤ 4 8 ≥ 16
 Lincosamides  Clindamycin ≤ 2 4 ≥ 8
 Macrolides  Azithromycin ≤ 2 4 ≥ 8
 Erythromycin ≤ 8 16 ≥ 32
 Phenicols  Chloramphenicol ≤ 8 16 ≥ 32
 Florfenicol2 ≤ 4 N/A N/A
 Quinolones  Ciprofloxacin ≤ 1 2 ≥ 4
 Nalidixic acid ≤ 16 32 ≥ 64
 Tetracyclines  Doxycycline ≤ 2 4 ≥ 8
 Tetracycline ≤ 4 8 ≥ 16
2 For florfenicol, only a susceptible breakpoint ( ≤ 4 µg/ml) has been established.  In this report, isolates with 
  an MIC ≥ 8 µg/ml are categorized as resistant
1 Breakpoints were adopted from CLSI (Clinical and Laboratory Standards Institute), when available.  CLSI 
  breakpoints were available for erythromycin, ciprofloxacin, doxycyline, and tetracycline
MIC Breakpoints (µg/ml)
Susceptible Intermediate Resistant
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D. Reporting Methods 
The remaining three sections of this report contain NARMS surveillance data for Salmonella, 
Campylobacter, and E. coli. Section III contains data for Salmonella isolates recovered from 
food animals at slaughter, retail meats, and humans.  Antimicrobial susceptibility data are 
presented for all non-Typhi Salmonella, as well as the following four Salmonella serotypes: 
Typhimurium, Enteritidis, Newport, and Heidelberg.  Section IV contains data for Campylobacter
isolates recovered from humans, retail meats, and chicken carcass rinsates.  Antimicrobial 
susceptibility data for C. jejuni and C. coli are presented separately.  Section V contains
susceptibility data for E. coli isolates from retail meats and chicken carcass rinsates. 
Each section begins with a table that shows the number of isolates tested by source and year.  
This is followed by a table and two figures that show the percentages of retail meats that tested 
positive. Data are also provided on the distribution of Salmonella serotypes and Campylobacter
species isolated from humans, retail meats, and food animals. 
Data on antimicrobial susceptibility follows.  MIC distribution tables include MIC distributions, the 
percentages of isolates displaying intermediate susceptibility and resistance, and 95%
confidence intervals for the percent resistant, by source for 2004.  Confidence intervals were 
calculated using the Clopper-Pearson exact method.1  The unshaded areas in the MIC tables 
indicate the range of concentrations tested for each antimicrobial.2  Single vertical bars indicate 
antimicrobial susceptibility breakpoints, while double vertical bars indicate antimicrobial 
resistance breakpoints.  
The MIC distributions are followed by tables that show the numbers and percentages of isolates
that were resistant, by year, through 2004.3  The total number of isolates tested per year for 
each source is listed at the top of each table.  An empty cell in this area indicates that 
surveillance was not conducted for that particular source, whereas a zero indicates that 
surveillance was conducted, but no isolates were available for testing.  Below the section 
containing the number of isolates tested, empty shaded boxes indicate that there are no data to 
report because surveillance was not conducted or isolates were not available for testing.   
Resistance to ceftiofur and nalidixic acid among Salmonella isolates is highlighted in several pie 
charts and graphs (Figures 6-14).4,5  Third-generation cephalosporins (such as ceftriaxone) and 
fluoroquinolones (such as ciprofloxacin) are antimicrobial agents commonly used for the treatment 
of severe Salmonella infections in humans.  Ceftiofur is the only third-generation cephalosporin 
approved for use in food animals in the U.S. and elevated MICs (≥ 8 µg/ml) correlate with 
decreased susceptibility to ceftriaxone (MIC ≥ 2 µg/ml). Similarly, resistance to the quinolone 
nalidixic acid (MIC ≥ 32 µg/ml) correlates with decreased susceptibility to ciprofloxacin (MIC ≥ 
0.125 µg/ml).  Finally, for Salmonella and E. coli isolates, data on multidrug resistance (MDR) 
phenotypes of public health importance are also presented (Tables 13-17, 21, 24, 28, 32, and 47).  
1 Newcombe RG.  Two-sided confidence intervals for the single proportion: comparison of seven methods. Statistics  
  in Medicine 1998; 17(8): 857-872. 
2 The concentration ranges are also listed in the Appendix. 
3 Data on Campylobacter recovered from chickens is presented only for the period of July 2001 through December  
  2004, as described in Section IIA. 
4 Note that the scales vary from figure to figure, based on the maximum percent resistance. 
5 Below each graph is a table that shows the number of isolates tested.  Empty grey boxes indicate that surveillance  
was not conducted, while boxes with zeros indicate that there were no isolates available for testing.
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The data contained in this report may, in a few cases, differ from those previously reported.  
These differences may be due to changes in breakpoints (Campylobacter) and/or the dynamic 
nature of the data, which are updated if new information is obtained about the bacterial isolates 
under surveillance or specific isolates are retested.  In a few cases, differences may be due to 
other reasons.  Etest® MIC results for Campylobacter that fell between the two-fold dilutions 
described in CLSI documents were rounded up to next two-fold dilution prior to interpretation in 
this report, but not in USDA’s annual reports.   
10
 III. Salmonella (non-Typhi) Data
 A. Salmonella  (non-Typhi) Isolates Tested
 Table 3. Number of Salmonella  (non-Typhi) Isolates Tested, by Source and Year, 1996-2004 
Source 
Year 
1996 1997 1998 1999 2000 2001 2002 2003 2004
 Humans 
Chicken Breasts 
Ground Turkey 
Ground Beef 
Pork Chops 
Chickens 
Turkeys 
Cattle 
Swine 
1324 1301 
214 
107 
24 
111 
1460 
561 
240 
284 
793 
1497 
1438 
713 
1610 
876 
1377 
1173 
518 
1388 
451 
1419 
1307 
550 
893 
418 
2008 
60 
74 
9 
10 
1500 
244 
1008 
379 
1864 
83 
114 
10  
5 
1158 
262 
670 
211 
1793
157
142
14
11
1280
236
607
308
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 B. Isolation of Salmonella  (non-Typhi) from Retail Meats 
Table 4. Number and Percent of Retail Meat Samples Positive for Salmonella , 2004 
Chicken 
Breasts 
Ground 
Turkey 
Ground 
Beef 
Pork 
Chops 
Number Positive for Salmonella 
Number of Meat Samples Tested
 Percent Positive for Salmonella 
1172 
157 
13.4% 
1165 
142 
12.2% 
1186 
14 
1.2% 
1176
11 
0.9% 
Figure 1. Percent of Retail Meat Samples Positive for Salmonella , 2004
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Figure 2. Percent of Retail Meat Samples Positive for Salmonella , 2002-2004
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C. Salmonella  (non-Typhi) Serotypes 
Table 5. Most Common Serotypes among Salmonella (non-Typhi) Isolates from Humans, Retail Meats, 
and Food Animals, 2004 
Humans Retail Meats Food Animals
 Source  Serotype n %
 Meat 
Type Serotype n  % 
Animal 
Source Serotype n %
 Humans
 (n=1793) 
Typhimurium 
Enteritidis 
Newport 
Javiana 
Heidelberg 
Montevideo 
I 4,[5],12:i:-
Braenderup 
Muenchen 
Oranienburg 
Saintpaul 
Paratyphi B1 
382 
271 
191 
106 
93 
50 
36 
33 
32 
32 
32 
30 
21.3
15.1 
10.7 
5.9 
5.2 
2.8 
2.0 
1.8 
1.8 
1.8 
1.8 
1.7 
Chicken 
Breasts 
(n=157) 
Typhimurium 
Kentucky 
Heidelberg 
Hadar 
Schwarzengrund 
Mbandaka 
I 4,12:i:-
Enteritidis 
Montevideo 
Berta 
Agona 
49 
42 
31 
8 
5 
4 
4 
3 
3 
2 
2 
31.2
26.8 
19.7 
5.1 
3.2 
2.5 
2.5 
1.9 
1.9 
1.3 
1.3 
Chickens 
(n=1280) 
Kentucky 
Typhimurium 
Heidelberg 
Enteritidis 
I 4,[5],12:i:-
Schwarzengrund 
Montevideo 
Thompson 
Infantis 
Mbandaka 
Hadar 
570 
171 
167 
84 
44 
36 
29 
23 
19 
19 
11 
44.5 
13.4 
13.0 
6.6 
3.4 
2.8 
2.3 
1.8 
1.5 
1.5 
0.9 
Infantis 
Thompson 
Agona 
Mississippi 
Hartford 
Anatum 
Berta 
Mbandaka 
29 
26 
24 
24 
18 
16 
14 
14 
1.6 
1.5
1.3 
1.3 
1.0 
0.9 
0.8 
0.8 
Ground
 Turkey
 (n=142) 
Heidelberg 
Saintpaul 
Reading 
Schwarzengrund 
Hadar 
Agona 
IIIa 18:z4,z32:-
Muenster 
Derby 
IIIa 18:z4,z23:-
I 4,12,:i:-
Berta 
Montevideo 
Newport 
Senftenberg 
Typhimurium 
37 
24 
16 
16 
11 
6 
6 
4 
3 
2 
2 
2 
2 
2 
2 
2 
26.1
16.9 
11.3 
11.3 
7.7 
4.2 
4.2 
2.8 
2.1 
1.4 
1.4 
1.4 
1.4 
1.4 
1.4 
1.4
 Turkeys 
(n=236) 
Heidelberg 
Hadar 
Reading 
Saintpaul 
Derby 
IIIa 18:z4,z23:-
Typhimurium 
Senftenberg 
Schwarzengrund 
Newport 
Kentucky 
Muenster 
Berta 
Muenchen 
46 
31 
18 
16 
15 
14 
14 
11 
9 
7 
6 
6 
5 
5 
19.5 
13.1 
7.6 
6.8 
6.4 
5.9 
5.9 
4.7 
3.8 
3.0 
2.5 
2.5 
2.1 
2.1 
Ground
 Beef
 (n=14) 
Braenderup 
Muenster 
Newport 
Berta 
Dublin 
5 
5 
2 
1 
1 
35.7
35.7 
14.3 
7.1 
7.1 
Cattle
 (n=607) 
Montevideo 
Anatum 
Muenster 
Typhimurium 
Newport 
Agona 
Dublin 
Kentucky 
Reading 
Mbandaka 
Infantis 
82 
66 
54 
48 
44 
41 
30 
25 
21 
19 
18 
13.5 
10.9 
8.9 
7.9 
7.2 
6.8 
4.9 
4.1 
3.5 
3.1 
3.0
 Pork 
Chops
 (n=11) 
Braenderup 
Heidelberg 
Typhimurium 
Agona 
5 
3 
2 
1 
45.5
27.3 
18.2 
9.1 
Swine
 (n=308) 
Derby 
Typhimurium 
Anatum 
Infantis 
Adelaide 
Reading 
Johannesburg 
Muenchen 
Hadar 
Brandenburg 
Mbandaka 
84 
53 
32 
22 
15 
12 
11 
10 
10 
6 
6 
27.3 
17.2 
10.4 
7.1 
4.9 
3.9 
3.6 
3.2 
3.2 
1.9 
1.9 
1 Paratyphi B var. L(+) tartrate+ 
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Table 6. Most Common Salmonella (non-Typhi) Serotypes in Humans and their Distributions among Retail Meat 
and Food Animal Isolates, by Meat Type and Animal Source, 2004 
Humans Retail Meats Food Animals
Humans 
(n=1793) 
Chicken 
Breast 
(n=157) 
Ground 
Turkey 
(n=142) 
Ground 
Beef 
(n=14) 
Pork 
Chops 
(n=11) 
Chickens 
(n=1280) 
Turkeys 
(n=236) 
Cattle 
(n=607) 
Swine 
(n=308) 
1. Typhimurium 
21.3% 
382 
31.2% 
49 
1.4% 
2 
0.0% 
0 
18.2% 
2 
13.4% 
171 
5.9% 
14 
7.9% 
48 
17.2% 
53 
2. Enteritidis 
15.1% 
271  
1.9% 
3 
0.0% 
0 
0.0% 
0 
0.0% 
0 
6.6% 
84  
0.0% 
0 
0.3% 
2 
0.3% 
1 
3. Newport
10.7% 
191  
0.0% 
0 
1.4% 
2 
14.3% 
2 
0.0% 
0 
0.0% 
0 
3.0% 
7 
7.2% 
44  
0.0% 
0 
4. Javiana
5.9% 
106  
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
5. Heidelberg
5.2% 
93 
19.7% 
31 
26.1% 
37 
0.0% 
0 
27.3% 
3 
13.0% 
167 
19.5% 
46 
0.2% 
1 
1.3% 
4 
6. Montevideo
2.8% 
50  
1.9% 
3 
1.4% 
2 
0.0% 
0 
0.0% 
0 
2.3% 
29 
1.7% 
4 
13.5% 
82  
0.0% 
0 
7. I 4,[5],12:i:-
2.0% 
36  
2.5% 
4 
0.0% 
0 
0.0% 
0 
0.0% 
0 
3.4% 
44  
0.4% 
1 
0.7% 
4 
0.0% 
0 
8. Braenderup
1.8% 
33  
0.6% 
1 
0.0% 
0 
35.7% 
5 
45.5% 
5 
0.5% 
7 
0.4% 
1 
2.1% 
13  
0.0% 
0 
9. Muenchen
1.8% 
32  
0.6% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
5 
1.3% 
8 
3.2% 
10  
10. Oranienburg
1.8% 
32  
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.5% 
7 
0.0% 
0 
0.2% 
1 
0.0% 
0 
11. Saintpaul
1.8% 
32 
0.0% 
0 
16.9% 
24 
0.0% 
0 
0.0% 
0 
0.0% 
0 
6.8% 
16 
0.7% 
4 
1.3% 
4
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Figure 3. Most Common Salmonella (non-Typhi) Serotypes from 

Humans in 2004 and their Relative Frequencies, by Year, 1996-2004 
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Figures 4a-b. Most Common Salmonella (non-Typhi) Serotypes from Retail Poultry in 2004 and their Relative Frequencies, by Year, 

2002-2004
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Figures 5a-d. Most Common Salmonella (non-Typhi) Serotypes from Food Animals in 2004 and their Relative Frequencies, by Year, 
1997-2004 
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D. Antimicrobial Susceptibility among all non-Typhi Salmonella
 MIC Distributions
Table 7a. Distribution of MICs and Occurrence of Resistance among all Salmonella (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 2004        
 Isolate Source Distribution (%) of MICs (µg/ml)4
 Antimicrobial  (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminoglycosides
   Amikacin  Humans (1793) 0.0 0.0 [0.0 - 0.2] 7.8 69.5 20.0 2.5 0.2
 Chicken Breasts (157) 0.0 0.0 [0.0 - 2.3] 7.6 46.5 40.1 5.7
 Ground Turkey (142) 0.0 0.0 [0.0 - 2.6] 2.1 50.0 44.4 3.5
 Ground Beef (14) 0.0 0.0 [0.0 - 23.2] 64.3 28.6 7.1
 Pork Chops (11) 0.0 0.0 [0.0 - 28.5] 63.6 27.3 9.1
 Chickens (1280) 0.0 0.0 [0.0 - 0.3] 16.7 67.1 14.8 1.4
 Turkeys (236) 0.0 0.0 [0.0 - 1.6] 8.9 72.0 16.5 2.5
 Cattle (607) 0.0 0.0 [0.0 - 0.6] 10.9 67.5 19.1 2.1 0.3
 Swine (308) 0.0 0.0 [0.0 - 1.2] 9.4 62.7 24.4 3.6
   Gentamicin  Humans (1793) 0.4 1.3 [0.9 - 2.0] 68.4 27.7 2.0 0.2 0.1 0.4 0.6 0.8
 Chicken Breasts (157) 0.6 3.8 [1.4 - 8.1] 46.5 45.2 3.8 0.6 1.9 1.9
 Ground Turkey (142) 2.8 20.4 [14.1 - 28.0] 33.8 37.3 4.9 0.7 2.8 9.2 11.3
 Ground Beef (14) 0.0 0.0 [0.0 - 23.2] 57.1 42.9
 Pork Chops (11) 0.0 0.0 [0.0 - 28.5] 63.6 36.4
 Chickens (1280) 0.2 4.9 [3.8 - 6.3] 70.2 23.1 1.5 0.1 0.2 2.7 2.2
 Turkeys (236) 5.9 25.4 [20.0 - 31.5] 48.7 19.1 0.8 5.9 14.8 10.6
 Cattle (607) 0.8 1.8 [0.9 - 3.2] 60.6 34.1 2.1 0.5 0.8 0.8 1.0
 Swine (308) 0.0 1.3 [0.4 - 3.3] 53.9 42.2 2.6 1.0 0.3
   Kanamycin  Humans (1793) 0.2 2.8 [2.1 - 3.7] 96.7 0.3 0.2 0.2 2.6
 Chicken Breasts (157) 0.6 11.5 [6.9 - 17.5] 84.7 3.2 0.6 11.5
 Ground Turkey (142) 1.4 18.3 [12.3 - 25.7] 78.9 1.4 1.4 7.0 11.3
 Ground Beef (14) 0.0 0.0 [0.0 - 23.2] 100.0
 Pork Chops (11) 0.0 9.1 [0.2 - 41.3] 81.8 9.1 9.1
 Chickens (1280) 0.1 2.7 [1.8 - 3.7] 96.9 0.4 0.1 0.5 2.2
 Turkeys (236) 4.2 14.4 [10.2 - 19.5] 80.9 0.4 4.2 3.0 11.4
 Cattle (607) 0.2 8.9 [6.8 - 11.4] 90.8 0.2 0.2 8.9
 Swine (308) 0.0 3.9 [2.0 - 6.7] 96.1 3.9
   Streptomycin  Humans (1793) N/A 11.8 [10.4 - 13.4] 88.2 5.7 6.1
 Chicken Breasts (157) N/A 28.0 [21.2 - 35.7] 72.0 16.6 11.5
 Ground Turkey (142) N/A 34.5 [26.7 - 42.9] 65.5 21.1 13.4
 Ground Beef (14) N/A 14.3 [1.8 - 42.8] 85.7 14.3
 Pork Chops (11) N/A 27.3 [6.0 - 61.0] 72.7 27.3
 Chickens (1280) N/A 22.2 [19.9  - 24.6] 77.8 14.9 7.3
 Turkeys (236) N/A 33.9 [27.9 -  40.3] 66.1 18.6 15.3
 Cattle (607) N/A 20.9 [17.8 - 24.4] 79.1 3.8 17.1
 Swine (308) N/A 36.4 [31.0 - 42.0] 63.6 10.4 26.0
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
17
Table 7b. Distribution of MICs and Occurrence of Resistance among all Salmonella (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 2004        
 Isolate Source Distribution (%) of MICs (µg/ml)4
 Antimicrobial  (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024
 Aminopenicillins
   Ampicillin  Humans (1793) 0.1 12.0 [10.6 - 13.6] 60.4 25.8 1.7 0.1 0.1 12.0
 Chicken Breasts (157) 0.0 30.6 [23.5 - 38.4] 60.5 8.9 30.6
 Ground Turkey (142) 0.0 20.4 [14.1 - 28.0] 64.1 14.1 1.4 20.4
 Ground Beef (14) 0.0 21.4 [4.7 - 50.8] 78.6 21.4
 Pork Chops (11) 0.0 9.1 [0.2 - 41.3] 81.8 9.1 9.1
 Chickens (1280) 0.0 14.5 [12.6 - 16.5] 72.8 11.9 0.7 0.2 0.1 14.4
 Turkeys (236) 0.0 22.0 [16.9 - 27.9] 61.9 15.3 0.4 0.4 22.0
 Cattle (607) 0.0 19.3 [16.2 - 22.6] 67.7 12.5 0.5 19.3
 Swine (308) 0.0 16.2 [12.3 - 20.8] 68.8 14.0 0.3 0.6 16.2
β-Lactam/β-Lactamase
 Inhibitor Combinations
   Amoxicillin-Clavulanic Acid  Humans (1793) 5.7 3.7 [2.9 - 4.7] 83.8 3.8 0.4 2.5 5.7 0.8 2.9
 Chicken Breasts (157) 1.3 24.8 [18.3 - 32.4] 61.8 7.6 4.5 1.3 24.8
 Ground Turkey (142) 8.5 7.7 [3.9 - 13.4] 71.8 8.5 3.5 8.5 2.8 4.9
 Ground Beef (14) 0.0 14.3 [1.8 - 42.8] 71.4 7.1 7.1 14.3
 Pork Chops (11) 18.2 0.0 [0.0 - 28.5] 72.7 9.1 18.2
 Chickens (1280) 1.2 12.4 [10.7 - 14.4] 84.2 1.2 0.2 0.8 1.2 0.4 12.0
 Turkeys (236) 12.7 4.7 [2.3 - 8.2] 73.7 4.2 0.4 4.2 12.7 0.4 4.2
 Cattle (607) 1.6 13.5 [10.9 - 16.5] 78.6 2.3 1.3 2.6 1.6 1.2 12.4
 Swine (308) 8.1 1.9 [0.7 - 4.2] 80.5 2.6 0.6 6.2 8.1 1.9
 Cephalosporins
   Ceftiofur  Humans (1793) 0.3 3.4 [2.6 - 4.3] 0.6 1.5 76.2 17.6 0.4 0.3 0.1 3.3
 Chicken Breasts (157) 0.0 24.8 [18.3 - 32.4] 0.6 47.1 27.4 24.8
 Ground Turkey (142) 0.0 4.9 [2.0 - 9.9] 43.0 47.9 4.2 4.9
 Ground Beef (14) 0.0 14.3 [1.8 - 42.8] 50.0 35.7 14.3
 Pork Chops (11) 0.0 0.0 [0.0 - 28.5] 72.7 27.3
 Chickens (1280) 0.3 12.4 [10.7 - 14.4] 0.2 2.3 76.1 8.3 0.4 0.3 0.2 12.2
 Turkeys (236) 0.0 4.7 [2.3 - 8.2] 70.8 23.3 1.3 4.7
 Cattle (607) 0.2 13.3 [10.7 - 16.3] 0.8 1.0 58.3 26.0 0.3 0.2 0.7 12.7
 Swine (308) 0.0 1.9 [0.7 - 4.2] 72.7 24.7 0.6 1.9
   Ceftriaxone  Humans (1793) 2.6 0.6 [0.3 - 1.0] 96.4 0.2 0.1 0.2 1.4 1.2 0.5 0.1
 Chicken Breasts (157) 22.9 0.0 [0.0 - 2.3] 75.2 1.9 18.5 4.5
 Ground Turkey (142) 5.6 0.0 [0.0 - 2.6] 94.4 2.1 3.5
 Ground Beef (14) 7.1 7.1 [0.2 - 33.9] 85.7 7.1 7.1
 Pork Chops (11) 0.0 0.0 [0.0 - 28.5] 100.0
 Chickens (1280) 10.6 0.5 [0.2 - 1.0] 87.4 0.1 0.2 0.2 1.1 9.5 1.1 0.5
 Turkeys (236) 4.2 0.4 [0.0 - 2.3] 95.3 2.1 2.1 0.4
 Cattle (607) 10.7 1.3 [0.6 - 2.6] 86.5 1.5 5.6 5.1 0.8 0.5
 Swine (308) 1.3 0.0 [0.0 - 1.2] 97.7 0.3 0.3 0.3 1.0 0.3
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
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0.0
   Chloramphenicol  Humans (1793) 0.9 7.6 [6.4 - 8.9] 2.1 45.1 44.3 0.9 7.6
 Pork Chops (11) 0.0 18.2 [2.3 - 51.8] 81.8 18.2
 Swine (308) 2.9 12.7 [9.2 - 16.9] 19.5 64.9 2.9 0.3 12.3
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
Table 7c. Distribution of MICs and Occurrence of Resistance among all Salmonella (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 2004        
 Isolate Source Distribution (%) of MICs (µg/ml)
4
 Antimicrobial  (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Cephamycins
   Cefoxitin  Humans (1793) 0.3 3.5 [2.7 - 4.4] 0.2 25.5 56.1 12.7 1.8 0.3 1.3 2.1
 Chicken Breasts (157) 0.0 24.8 [18.3 - 32.4] 2.5 56.7 14.6 1.3 5.7 19.1
 Ground Turkey (142) 1.4 4.9 [2.0 - 9.9] 1.4 60.6 28.2 3.5 1.4 0.7 4.2
 Ground Beef (14) 0.0 14.3 [1.8 - 42.8] 50.0 14.3 21.4 14.3
 Pork Chops (11) 0.0 0.0 [0.0 - 28.5] 81.8 18.2
 Chickens (1280) 0.2 12.4 [10.7 - 14.4] 13.8 61.5 11.2 0.9 0.2 9.6 2.8
 Turkeys (236) 0.8 5.1 [2.7 - 8.7] 7.2 59.3 24.2 3.4 0.8 2.1 3.0
 Cattle (607) 0.8 13.2 [10.6 - 16.1] 5.8 33.4 43.5 3.3 0.8 4.8 8.4
 Swine (308) 1.0 1.9 [0.7 - 4.2] 0.6 2.3 37.0 55.8 1.3 1.0 1.3 0.6
 Folate Pathway Inhibitors
   Sulfisoxazole  Humans (1793) N/A 13.2 [11.7 - 14.9] 19.3 55.7 11.5 0.2 0.1 13.2
 Chicken Breasts (157) N/A 28.7 [21.7 - 36.4] 12.1 14.6 43.3 1.3 28.7
 Ground Turkey (142) N/A 28.2 [20.9 - 36.3] 4.9 17.6 49.3 28.2
 Ground Beef (14) N/A 14.3 [1.8 - 42.8] 7.1 7.1 71.4 14.3
 Pork Chops (11) N/A 18.2 [2.3 - 51.8] 9.1 72.7 18.2
 Chickens (1280) N/A 11.9 [10.2 - 13.8] 48.7 35.9 3.0 0.2 0.3 11.9
 Turkeys (236) N/A 36.4 [30.3 - 42.9] 25.4 33.5 3.8 0.8 36.4
 Cattle (607) N/A 22.7 [19.5 - 26.3] 27.3 39.9 8.7 1.2 0.2 22.7
 Swine (308) N/A 37.0 [31.6 - 42.7] 31.5 26.0 4.5 1.0 37.0
   Trimethoprim-Sulfamethoxazole  Humans (1793) N/A 1.8 [1.2 - 2.5] 76.4 21.0 0.6 0.1 0.2 0.1 1.7
 Chicken Breasts (157) N/A 0.0 [0.0 - 2.3] 96.8 3.2
 Ground Turkey (142) N/A 0.0 [0.0 - 2.6] 89.4 6.3 4.2
 Ground Beef (14) N/A 7.1 [0.2 - 33.9] 92.9 7.1
 Pork Chops (11) N/A [0.0 - 28.5] 100.0
 Chickens (1280) N/A 0.2 [0.0 - 0.7] 84.5 15.0 0.2 0.2
 Turkeys (236) N/A 0.8 [0.1 - 3.0] 66.9 27.1 4.2 0.4 0.4 0.8
 Cattle (607) N/A 1.5 [0.7 - 2.8] 72.8 23.1 2.6 0.2 1.3
 Swine (308) N/A 1.6 [0.5 - 3.7] 63.0 31.5 3.2 0.6 1.6
 Phenicols
 Chicken Breasts (157) 0.6 1.9 [0.4 - 5.5] 2.5 14.6 80.3 0.6 1.9
 Ground Turkey (142) 4.2 2.8 [0.8 - 7.1] 12.7 80.3 4.2 2.8
 Ground Beef (14) 0.0 14.3 [1.8 - 42.8] 7.1 78.6 14.3
 Chickens (1280) 0.5 1.3 [0.7 - 2.0] 5.4 54.7 38.1 0.5 1.3
 Turkeys (236) 2.1 4.7 [2.3 - 8.2] 2.5 41.9 48.7 2.1 4.7
 Cattle (607) 0.8 17.6 [14.7 - 20.9] 0.5 30.0 51.1 0.8 0.2 17.5
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
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 Pork Chops (11) 0.0 0.0 [0.0 - 28.5] 100.0
 Swine (308) 0.0 0.0 [0.0 - 1.2] 96.1 3.9
   Nalidixic Acid  Humans (1793) N/A 2.6 [1.9 - 3.5] 0.1 0.4 26.0 69.2 1.5 0.2 0.2 2.5
 Pork Chops (11) N/A 0.0 [0.0 - 28.5] 100.0
 Swine (308) N/A 0.0 [0.0 - 1.2] 14.3 81.8 3.9
   Tetracycline  Humans (1793) 0.3 13.5 [11.9 - 15.2] 86.2 0.3 1.4 4.5 7.6
 Pork Chops (11) 0.0 54.5 [23.4 - 83.3] 45.5 18.2 36.4
 Swine (308) 1.0 58.8 [53.0 - 64.3] 40.3 1.0 3.2 14.3 41.2
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
Table 7d. Distribution of MICs and Occurrence of Resistance among all Salmonella (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 2004        
4
 Antimicrobial
 Isolate Source
 (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.50
D
1
istribu
2
tion (
4
%) of M
8
ICs (µg
16
/ml)
32 64 128 256 512 1024
 Quinolones
   Ciprofloxacin  Humans (1793) 0.1 0.2 [0.1 - 0.6] 95.8 1.4 0.1 1.1 0.9 0.4 0.1 0.2
 Chicken Breasts (157) 0.0 [0.0 - 2.3] 96.2 3.80.0
 Ground Turkey (142) 0.0 0.0 [0.0 - 2.6] 93.7 4.9 1.4
 Ground Beef (14) 0.0 0.0 [0.0 - 23.2] 100.0
 Chickens (1280) 0.0 0.0 [0.0 - 0.3] 98.2 1.4 0.3 0.1
 Turkeys (236) 0.0 0.0 [0.0 - 1.6] 94.1 3.4 0.4 1.7 0.4
 Cattle (607) 0.0 0.0 [0.0 - 0.6] 96.7 1.3 0.2 0.3 0.8 0.7
 Chicken Breasts (157) N/A 0.0 [0.0 - 2.3] 12.1 82.8 5.1
 Ground Turkey (142) N/A 0.0 [0.0 - 2.6] 4.2 85.2 9.9 0.7
 Ground Beef (14) N/A 0.0 [0.0 - 23.2] 7.1 92.9
 Chickens (1280) N/A 0.5 [0.2 - 1.0] 0.5 36.0 62.3 0.7 0.1 0.4
 Turkeys (236) N/A 2.1 [0.7 - 4.9] 15.3 80.5 2.1 2.1
 Cattle (607) N/A 2.0 [1.0 - 3.4] 0.2 0.3 13.5 82.9 1.2 2.0
 Tetracyclines
 Chicken Breasts (157) 0.6 46.5 [38.5 - 54.6] 52.9 0.6 46.5
 Ground Turkey (142) 7.7 56.3 [47.8 - 64.6] 35.9 7.7 4.2 0.7 51.4
 Ground Beef (14) 0.0 14.3 [1.8 - 42.8] 85.7 14.3
 Chickens (1280) 0.8 27.4 [25.0 - 30.0] 71.8 0.8 0.2 0.5 26.6
 Turkeys (236) 0.0 48.3 [41.8 - 54.9] 51.7 5.9 42.4
 Cattle (607) 0.2 31.8 [28.1 - 35.7] 68.0 0.2 1.2 8.2 22.4
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
20
Resistance by Year 
Table 8a. Antimicrobial Resistance among all Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, 
and Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 
Ground Beef 
74 
9 
114 
10 
142
14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 
Cattle 
107 
24 
240 
284 
713 
1610 
518 
1388 
550 
893 
244 
1008 
262 
670 
236
607
 Swine 111 793 876 451 418 379 211 308
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Aminoglycosides  Amikacin 
(MIC ≥ 64 µg/ml) Humans
0.0% 
0 
0.0% 
0 
0.1% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Gentamicin 
(MIC ≥ 16 µg/ml) Humans
4.8% 
63 
2.9% 
38 
2.8% 
41 
2.1% 
32 
2.7% 
37 
1.9% 
27 
1.3% 
27 
1.4% 
26 
1.3%
24 
Chicken Breasts 10.0% 
6 
6.0% 
5 
3.8% 
6 
Ground Turkey 14.9% 
11 
22.8% 
26 
20.4% 
29 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 30.0% 
3 
0.0% 
0 
0.0% 
0 
Chickens 17.8% 
38 
15.3% 
86 
10.4% 
150 
14.9% 
175 
7.9% 
103 
5.5% 
83 
6.3% 
73 
4.9% 
63 
Turkeys 20.6% 
22 
18.3% 
44 
17.5% 
125 
16.2% 
84 
20.9% 
115 
19.3% 
47 
21.0% 
55 
25.4% 
60 
Cattle 0.0% 
0 
1.8% 
5 
1.6% 
25 
2.1% 
29 
2.1% 
19 
2.6% 
26 
2.7% 
18 
1.8% 
11 
Swine 0.9% 
1 
0.8% 
6 
1.1% 
10  
1.3% 
6 
1.4% 
6 
0.8% 
3 
0.5% 
1 
1.3% 
4
 Kanamycin 
(MIC ≥ 64 µg/ml) Humans
5.0% 
66 
5.1% 
67 
5.7% 
83 
4.3% 
65 
5.6% 
77 
4.8% 
68 
3.8% 
76 
3.4% 
64 
2.8%
50 
Chicken Breasts 6.7% 
4 
4.8% 
4 
11.5% 
18 
Ground Turkey 18.9% 
14 
27.2% 
31 
18.3% 
26 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 10.0% 
1 
0.0% 
0 
9.1% 
1 
Chickens 2.3% 
5 
3.2% 
18  
1.2% 
17  
4.1% 
48  
2.4% 
31  
2.0% 
30  
2.8% 
32  
2.7% 
34 
Turkeys 24.3% 
26 
17.1% 
41 
21.5% 
153 
21.4% 
111 
22.9% 
126 
24.2% 
59 
16.0% 
42 
14.4% 
34 
Cattle 8.3% 
2 
9.5% 
27 
7.1% 
115 
6.6% 
92 
6.9% 
62 
10.1% 
102 
13.7% 
92 
8.9% 
54 
Swine 11.7% 
13 
7.2% 
57 
6.7% 
59 
9.3% 
42 
6.9% 
29 
4.2% 
16 
5.7% 
12 
3.9% 
12
 Streptomycin 
(MIC ≥ 64 µg/ml) Humans
20.6% 
273 
21.4% 
278 
18.6% 
272 
16.8% 
251 
16.3% 
224 
17.0% 
241 
13.2% 
265 
15.0% 
279 
11.8%
212 
Chicken Breasts 28.3% 
17 
26.5% 
22 
28.0% 
44 
Ground Turkey 37.8% 
28 
45.6% 
52 
34.5% 
49 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 70.0% 
7 
40.0% 
2 
27.3% 
3 
Chickens 24.3% 
52 
27.8% 
156 
27.5% 
396 
28.6% 
335 
21.0% 
275 
22.9% 
343 
19.6% 
227 
22.2% 
284 
Turkeys 34.6% 
37 
40.8% 
98 
43.6% 
311 
41.9% 
217 
46.7% 
257 
37.7% 
92 
29.4% 
77 
33.9% 
80 
Cattle 12.5% 
3 
16.2% 
46 
15.4% 
248 
21.3% 
296 
20.3% 
181 
25.9% 
261 
28.7% 
192 
20.9% 
127 
Swine 27.9% 
31 
29.4% 
233 
29.3% 
257 
39.2% 
177 
35.6% 
149 
40.1% 
152 
30.8% 
65 
36.4% 
112 
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Table 8b. Antimicrobial Resistance among all Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, 
and Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 
Ground Beef 
74 
9 
114 
10 
142
14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 
Cattle 
107 
24 
240 
284 
713 
1610 
518 
1388 
550 
893 
244 
1008 
262 
670 
236
607
 Swine 111 793 876 451 418 379 211 308
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Aminopenicillins  Ampicillin 
(MIC ≥ 32 µg/ml) Humans
20.7% 
274 
18.3% 
238 
16.5% 
241 
15.6% 
233 
15.9% 
219 
17.4% 
247 
12.9% 
259 
13.6% 
254 
12.0%
216 
Chicken Breasts 16.7% 
10 
33.7% 
28 
30.6% 
48 
Ground Turkey 16.2% 
12 
28.9% 
33 
20.4% 
29 
Ground Beef 22.2% 
2 
40.0% 
4 
21.4% 
3 
Pork Chops 40.0% 
4 
40.0% 
2 
9.1% 
1 
Chickens 11.7% 
25 
12.8% 
72 
12.4% 
179 
13.0% 
152 
9.4% 
123 
14.3% 
215 
13.7% 
159 
14.5% 
185 
Turkeys 12.1% 
13 
10.4% 
25 
17.7% 
126 
16.2% 
84 
19.5% 
107 
18.0% 
44 
18.7% 
49 
22.0% 
52 
Cattle 12.5% 
3 
9.2% 
26 
12.5% 
202 
18.7% 
259 
17.9% 
160 
23.9% 
241 
28.1% 
188 
19.3% 
117 
Swine 16.2% 
18 
12.9% 
102 
10.8% 
95 
18.8% 
85 
11.7% 
49 
13.7% 
52 
12.8% 
27 
16.2% 
50 
β-Lactam/β-Lactamase 
Inhibitor Combinations
 Amoxicillin-
Clavulanic Acid 
(MIC ≥ 32 / 16 µg/ml) 
Humans 1.1% 
15 
1.0% 
13 
1.7% 
25 
2.3% 
35 
3.9% 
54 
4.7% 
66 
5.3% 
106 
4.6% 
86 
3.7%
67
 Chicken Breasts 10.0% 
6 
25.3% 
21  
24.8% 
39 
Ground Turkey 12.2% 
9 
11.4% 
13  
7.7% 
11 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 20.0% 
2 
20.0% 
1 
0.0% 
0 
Chickens 0.5% 
1 
2.0% 
11  
4.9% 
70  
7.3% 
86  
4.5% 
59  
10.2% 
153  
9.7% 
112  
12.4% 
159 
Turkeys 4.7% 
5 
0.4% 
1 
4.3% 
31 
3.5% 
18 
6.9% 
38 
3.7% 
9 
1.5% 
4 
4.7% 
11 
Cattle 8.3% 
2 
2.5% 
7 
3.9% 
62 
9.9% 
138 
11.8% 
105 
17.7% 
178 
21.0% 
141 
13.5% 
82 
Swine 0.0% 
0 
0.4% 
3 
1.0% 
9 
1.8% 
8 
2.6% 
11  
3.7% 
14  
3.8% 
8 
1.9% 
6
 Cephalosporins  Ceftiofur 
(MIC ≥ 8 µg/ml) Humans
0.2% 
2 
0.5% 
6 
0.8% 
12 
2.0% 
30 
3.2% 
44 
4.1% 
58 
4.3% 
87 
4.5% 
83 
3.4%
61 
Chicken Breasts 10.0% 
6 
25.3% 
21  
24.8% 
39 
Ground Turkey 8.1% 
6 
2.6% 
3 
4.9% 
7 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 20.0% 
2 
20.0% 
1 
0.0% 
0 
Chickens 0.5% 
1 
2.0% 
11  
5.2% 
75  
7.6% 
89  
4.1% 
54  
10.2% 
153  
9.8% 
113  
12.4% 
159 
Turkeys 3.7% 
4 
0.4% 
1 
4.6% 
33 
3.3% 
17 
5.1% 
28 
3.3% 
8 
1.5% 
4 
4.7% 
11 
Cattle 0.0% 
0 
2.1% 
6 
4.2% 
67 
9.8% 
136 
11.4% 
102 
17.4% 
175 
21.0% 
141 
13.3% 
81 
Swine 0.0% 
0 
0.1% 
1 
1.9% 
17 
1.3% 
6 
2.2% 
9 
3.2% 
12 
4.3% 
9 
1.9% 
6
 Ceftriaxone 
(MIC ≥ 64 µg/ml) Humans 
0.0% 
0 
0.1% 
1 
0.0% 
0 
0.3% 
5 
0.0% 
0 
0.0% 
0 
0.2% 
4 
0.4% 
8 
0.6%
10 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
10.0% 
1 
7.1% 
1 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.1% 
1 
0.0% 
0 
0.3% 
5 
0.1% 
1 
0.5% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.8% 
6 
0.4% 
2 
0.2% 
1 
0.0% 
0 
0.4% 
1 
0.4% 
1 
Cattle 0.0% 
0 
0.0% 
0 
0.1% 
1 
0.1% 
1 
0.1% 
1 
0.2% 
2 
0.1% 
1 
1.3% 
8 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
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Table 8c. Antimicrobial Resistance among all Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, 
and Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 
Ground Beef 
74 
9 
114 
10 
142
14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 
Cattle 
107 
24 
240 
284 
713 
1610 
518 
1388 
550 
893 
244 
1008 
262 
670 
236
607
 Swine 111 793 876 451 418 379 211 308
 Antimicrobial
 (Resistance Isolate
 Antimicrobial Class  Breakpoint)  Source
 Cephalosporins Cephalothin 
(MIC ≥ 32 µg/ml) Humans
2.9% 
39 
2.2% 
29 
2.3% 
33 
3.6% 
54 
4.0% 
55 
4.0% 
57 
5.0% 
101 
5.4%
100 
Chicken Breasts 13.3% 
8 
28.9% 
24  
Ground Turkey 14.9% 
11 
28.9% 
33 
Ground Beef 22.2% 
2 
40.0% 
4 
Pork Chops 20.0% 
2 
40.0% 
2 
Chickens 1.4% 
3 
4.5% 
25  
5.8% 
83  
7.8% 
91  
4.7% 
62  
10.5% 
158  
10.4% 
121  
Turkeys 5.6% 
6 
5.0% 
12  
10.5% 
75  
8.3% 
43  
13.1% 
72  
9.8% 
24  
11.1% 
29  
Cattle 0.0% 
0 
2.1% 
6 
4.7% 
76 
9.9% 
137 
11.6% 
104 
17.7% 
178 
21.2% 
142 
Swine 0.0% 
0 
0.1% 
1 
0.8% 
7 
2.4% 
11  
2.2% 
9 
3.2% 
12  
3.8% 
8
 Cephamycins  Cefoxitin 
(MIC ≥ 32 µg/ml) Humans
3.2% 
44 
3.4% 
48 
4.3% 
86 
4.2% 
79 
3.5%
62 
Chicken Breasts 10.0% 
6 
25.3% 
21  
24.8% 
39 
Ground Turkey 8.1% 
6 
2.6% 
3 
4.9% 
7 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 20.0% 
2 
20.0% 
1 
0.0% 
0 
Chickens 7.2% 
85 
4.1% 
53 
8.7% 
130 
8.2% 
95 
12.4% 
159 
Turkeys 3.3% 
17 
4.5% 
25 
2.5% 
6 
1.1% 
3 
5.1% 
12 
Cattle 9.1% 
126 
11.1% 
99 
15.9% 
160 
17.8% 
119 
13.2% 
80 
Swine 1.3% 
6 
2.2% 
9 
2.9% 
11 
4.3% 
9 
1.9% 
6
 Folate Pathway Inhibitors  Sulfamethoxazole/ 
Sulfisoxazole1 
(MIC ≥ 512 µg/ml) 
Humans 20.3% 
269 
22.8% 
297 
19.4% 
283 
18.0% 
270 
17.1% 
235 
17.7% 
251 
12.8% 
258 
15.0% 
280 
13.2%
237
 Chicken Breasts 16.7% 
10 
14.5% 
12 
28.7% 
45 
Ground Turkey 20.3% 
15 
33.3% 
38 
28.2% 
40 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 70.0% 
7 
40.0% 
2 
18.2% 
2 
Chickens 24.8% 
53 
23.7% 
133 
15.9% 
229 
18.4% 
216 
11.8% 
154 
8.9% 
133 
10.3% 
119 
11.9% 
152 
Turkeys 37.4% 
40 
32.1% 
77 
36.0% 
257 
25.1% 
130 
38.0% 
209 
30.3% 
74 
28.2% 
74 
36.4% 
86 
Cattle 20.8% 
5 
15.5% 
44 
15.0% 
242 
19.9% 
276 
19.7% 
176 
22.3% 
225 
25.1% 
168 
22.7% 
138 
Swine 34.2% 
38 
29.0% 
230 
30.7% 
269 
35.7% 
161 
34.9% 
146 
34.6% 
131 
25.1% 
53 
37.0% 
114
 Trimethoprim-
Sulfamethoxazole 
(MIC ≥ 4 / 76 µg/ml) 
Humans 3.9% 
51 
1.8% 
24 
2.3% 
34 
2.1% 
31 
2.1% 
29 
2.0% 
28 
1.4% 
28 
1.9% 
36 
1.8%
32
 Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 1.4% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
7.1% 
1 
Pork Chops 20.0% 
2 
0.0% 
0 
0.0% 
0 
Chickens 0.5% 
1 
1.2% 
7 
1.1% 
16 
0.4% 
5 
0.5% 
6 
0.8% 
12 
0.3% 
4 
0.2% 
3 
Turkeys 3.7% 
4 
2.5% 
6 
4.2% 
30 
1.5% 
8 
2.5% 
14 
2.5% 
6 
2.3% 
6 
0.8% 
2 
Cattle 4.2% 
1 
2.5% 
7 
2.4% 
39 
2.2% 
30 
2.6% 
23 
2.5% 
25 
3.3% 
22 
1.5% 
9 
Swine 1.8% 
2 
0.3% 
2 
1.1% 
10  
0.9% 
4 
0.0% 
0 
1.6% 
6 
2.4% 
5 
1.6% 
5 
1 Sulfamethoxazole was tested from 1996 to 2003 and was replaced by sulfisoxazole in 2004
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Table 8d. Antimicrobial Resistance among all Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, 
and Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 
Ground Beef 
74 
9 
114 
10 
142
14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 
Cattle 
107 
24 
240 
284 
713 
1610 
518 
1388 
550 
893 
244 
1008 
262 
670 
236
607
 Swine 111 793 876 451 418 379 211 308
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans
10.6% 
140 
10.1% 
131 
9.9% 
145 
9.2% 
138 
10.1% 
139 
11.6% 
164 
8.6% 
172 
10.0% 
187 
7.6%
136 
Chicken Breasts 0.0% 
0 
2.4% 
2 
1.9% 
3 
Ground Turkey 1.4% 
1 
0.9% 
1 
2.8% 
4 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 40.0% 
4 
40.0% 
2 
18.2% 
2 
Chickens 2.3% 
5 
2.9% 
16  
1.8% 
26  
4.6% 
54  
2.5% 
33  
2.4% 
36  
2.1% 
24  
1.3% 
16 
Turkeys 3.7% 
4 
0.8% 
2 
4.1% 
29 
4.1% 
21 
3.8% 
21 
5.3% 
13 
4.2% 
11 
4.7% 
11 
Cattle 4.2% 
1 
5.6% 
16 
8.5% 
137 
15.1% 
209 
16.5% 
147 
20.6% 
208 
25.1% 
168 
17.6% 
107 
Swine 11.7% 
13 
8.4% 
67 
8.0% 
70 
12.4% 
56 
7.7% 
32 
10.0% 
38 
8.5% 
18 
12.7% 
39
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.1% 
1 
0.1% 
1 
0.4% 
5 
0.2% 
3 
<0.1% 
1 
0.2% 
3 
0.2%
4 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.1% 
1 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Nalidixic Acid 
(MIC ≥ 32 µg/ml) Humans
0.4% 
5 
0.9% 
12  
1.4% 
20  
1.0% 
15  
2.5% 
34  
2.6% 
37  
1.8% 
36  
2.3% 
42  
2.6%
47 
Chicken Breasts 0.0% 
0 
1.2% 
1 
0.0% 
0 
Ground Turkey 8.1% 
6 
4.4% 
5 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.2% 
1 
0.2% 
3 
0.5% 
6 
0.0% 
0 
0.8% 
12  
0.4% 
5 
0.5% 
6 
Turkeys 4.7% 
5 
2.1% 
5 
5.3% 
38 
5.4% 
28 
5.1% 
28 
5.3% 
13 
3.8% 
10 
2.1% 
5 
Cattle 0.0% 
0 
0.4% 
1 
0.1% 
1 
0.4% 
6 
0.4% 
4 
0.4% 
4 
0.4% 
3 
2.0% 
12 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.2% 
1 
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0
 Tetracyclines  Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 24.2% 
320 
21.7% 
282 
20.2% 
295 
19.4% 
290 
18.6% 
256 
19.7% 
280 
14.9% 
299 
16.3% 
303 
13.5%
242 
Chicken Breasts 33.3% 
20 
27.7% 
23 
46.5% 
73 
Ground Turkey 55.4% 
41 
39.5% 
45 
56.3% 
80 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 70.0% 
7 
80.0% 
4 
54.5% 
6 
Chickens 20.6% 
44 
20.5% 
115 
25.0% 
359 
26.3% 
308 
21.9% 
286 
24.9% 
374 
26.2% 
303 
27.4% 
351 
Turkeys 52.3% 
56 
45.8% 
110 
52.9% 
377 
56.2% 
291 
54.9% 
302 
54.5% 
133 
58.8% 
154 
48.3% 
114 
Cattle 25.0% 
6 
24.3% 
69 
20.9% 
336 
25.8% 
358 
26.3% 
235 
32.0% 
323 
36.9% 
247 
31.8% 
193 
Swine 52.3% 
58 
47.5% 
377 
48.4% 
424 
54.3% 
245 
53.1% 
222 
57.8% 
219 
43.1% 
91 
58.8% 
181
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Ceftiofur Resistance 
Table 9. Ceftiofur-Resistant Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 
by Source and Serotype, 2004 
Humans Retail Meats Food Animals
 Source  Serotype n  %
 Meat 
Type Serotype n  % 
Animal 
Source Serotype n %
Newport 29 
Typhimurium 17 
Heidelberg 9 
Humans
 (n=61)
47.5 
27.9 
14.8 
Chicken 
Breasts 
(n=39) 
Typhimurium 
Kentucky 
Heidelberg 
24 
11 
3 
61.5 
28.2 
7.7 
Chickens 
(n=159) 
Typhimurium 
Kentucky 
Heidelberg 
74 
55 
17 
46.5 
34.6 
10.7 
I 4,[5],12:i:- 1 1.6 Enteritidis 1 2.6 I 4,[5],12:r:- 4 2.5 
Agona 1 1.6 I 4,[5],12:i:- 2 1.3 
Anatum 1 1.6 Schwarzengrund 2 1.3 
Dublin 1 1.6 I 4,12:nonmotile 1 0.6 
Uganda 1 1.6 Braenderup 1 0.6 
Incomplete Serotype 1 1.6 Cerro 1 0.6 
Enteritidis 1 0.6 
Thompson 1 0.6 
Ground
 Turkey
 (n=7) 
Derby 
Heidelberg 
Agona 
Bredeney 
Saintpaul 
2 
2 
1 
1 
1 
28.6 
28.6 
14.3 
14.3 
14.3 
Turkeys 
(n=11)
Heidelberg 
Typhimurium 
I 3,10:nonmotile 
I 4,12:r:-
Alachua 
Berta 
Newport 
Reading 
3 
2 
1 
1 
1 
1 
1 
1 
27.3 
18.2 
9.1 
9.1 
9.1 
9.1 
9.1 
9.1 
Ground
 Beef
 (n=2) 
Newport 2 100.0 Cattle
 (n=81)
Newport 
Reading 
Typhimurium 
34 
14 
12 
42.0 
17.3 
14.8 
Agona 10 12.3 
Dublin 4 4.9 
Saintpaul 2 2.5 
I 9,12:nonmotile 1 1.2 
Anatum 1 1.2 
Heidelberg 1 1.2 
Ohio 1 1.2 
Uganda 1 1.2 
Pork Swine Reading 2 33.3 
Chops  (n=6) Agona 1 16.7 
(n=0) Derby 1 16.7 
Thompson 1 16.7 
Typhimurium 1 16.7 
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Figures 6a-d. Ceftiofur-Resistant Salmonella  (non-Typhi) Isolates, by Source1 and Serotype, 2004

6a. Humans, n=61 (of 1793) 
Typhimurium 
27.9% 
Heidelberg 
14.8% 
Other 
9.8% 
Newport 
47.5% 
6b. Chicken Breasts, n=39 (of 157) 
Heidelberg 
7.7% 
Typhimurium 
61.5% 
Enteritidis 
2.6% 
Kentucky 
28.2% 
6d. Chickens, n=159 (of 1280) 
Kentucky 
34.6% 
Heidelberg 
10.7% 
Typhimurium 
46.5% 
Other 
8.2% 
6c. Cattle, n=81 (of 607) 
Newport 
42.0% 
Typhimurium 
14.8% 
Agona 
12.3% 
Reading 
17.3% 
Other 
13.6% 
1 Pie charts are not provided for other sources due to the small number of ceftiofur-resistant isolates (11 from turkeys, 7 from ground turkey, 6 from swine, 2 from 
ground beef, and none from pork chops). Table 9 shows a complete listing of ceftiofur-resistant isolates by source and serotype 
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Figure 7. Percent of Salmonella  (non-Typhi) Isolates from Humans, Retail Poultry, Figure 8. Percent of Salmonella  (non-Typhi) Isolates from Humans, Ground Beef, 
and Poultry Resistant to Ceftiofur, by Year, 1996-2004 Pork Chops, Cattle, and Swine Resistant to Ceftiofur, by Year, 1996-2004 
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Table 10. Number of Salmonella  (non-Typhi) Isolates Tested from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004 
1996 1997 1998 1999 2000 2001 2002 2003 2004
 Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 74 114 142
 Ground Beef 9  10  14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 107 240 713 518 550 244 262 236
 Cattle 24 284 1610 1388 893 1008 670 607
 Swine 111 793 876 451 418 379 211 308 
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Nalidixic Acid Resistance 
Table 11. Naldixic Acid-Resistant Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 
by Source and Serotype, 2004 
Humans Retail Meats Food Animals
 Source  Serotype n %
 Meat 
Type  %nSerotype 
Animal 
Source Serotype n %
 Humans
 (n=47) 
Enteritidis 
Paratyphi A 
Senftenburg 
18 
8 
3 
38.3
17.0 
6.4 
Chicken 
Breasts 
(n=0)
 Chickens 
(n=6) 
Schwarzengrund 
I 4,[5],12:i:-
Braenderup 
2 
1 
1 
33.3 
16.7 
16.7 
Stanley 2 4.3 Kentucky 1 16.7 
Typhimurium 2 4.3 Montevideo 1 16.7 
I 4,[5],12:i:- 1 2.1 
Agona 1 2.1 
Choleraesuis 1 2.1 
Derby 1 2.1 
Durban 1 2.1 
Hadar 1 2.1 
Infantis 1 2.1 
Javiana 
Kentucky 
Montevideo 
Newport 
Saintpaul 
Uganda 
1 
1 
1 
1 
1 
1 
2.1 
2.1
2.1 
2.1 
2.1 
2.1 
Ground
 Turkey
 (n=0) 
Turkeys 
(n=5) 
Typhimurium 
Bredeney 
Hadar 
Saintpaul 
2 
1 
1 
1 
40.0 
20.0 
20.0 
20.0 
Incomplete Serotype 1 2.1
 Ground
 Beef
 (n=0) 
Cattle
 (n=12) 
Dublin 
Typhimurium 
Agona 
3 
3 
2 
25.0 
25.0 
16.7 
Reading 2 16.7 
Mbandaka 1 8.3 
Uganda 1 8.3
 Pork Swine
 Chops  (n=0)
 (n=0)
 Figure 9. Nalidixic Acid-Resistant Salmonella  (non-Typhi) Isolates 
from Humans,1 by Serotype, 2004 
n=47 (of 1793) 
Other 
29.8% 
Stanley 
4.3% 
Typhimurium 
4.3% 
Paratyphi A 
17.0% 
Enteritidis 
38.3% 
Senftenburg 
6.4% 
1 Pie charts are not provided for other sources due to the small number of nalidixic acid-
resistant isolates (12 from cattle, 6 from chickens, 5 from turkeys, and none from swine 
and retail meats). Table 11 shows a complete listing of nalidixic acid-resistant isolates 
by source and serotype 
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Figure 10. Percent of Salmonella  (non-Typhi) Isolates from Humans, Retail Figure 11. Percent of Salmonella  (non-Typhi) Isolates from Humans, Ground Beef, 
Poultry, and Poultry Resistant to Nalidixic Acid, by Year, 1996-2004 Pork Chops, Cattle, and Swine Resistant to Nalidixic Acid, by Year, 1996-2004 
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Table 12. Number of Salmonella  (non-Typhi) Isolates Tested from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004 
1996 1997 1998 1999 2000 2001 2002 2003 2004
 Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 74 114 142
 Ground Beef 9  10  14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 107 240 713 518 550 244 262 236
 Cattle 24 284 1610 1388 893 1008 670 607
 Swine 111 793 876 451 418 379 211 308 
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Multidrug Resistance
Table 13a. Resistance Patterns among all Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 
Ground Beef 
74 
9 
114 
10  
142
14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 
Cattle 
107 
24 
240 
284 
713 
1610 
518 
1388 
550 
893 
244 
1008 
262 
670 
236
607
 Swine 111 793 876 451 418 379 211 308
 Isolate 
Resistance Pattern  Source 
1. No Resistance Detected 
Humans
66.2% 
876 
68.4% 
890 
72.9% 
1064 
74.1% 
1109 
74.4% 
1024 
72.3% 
1026 
79.0% 
1586 
77.7% 
1449 
79.6%
1427 
Chicken Breasts 51.7% 
31 
47.0% 
39 
40.1% 
63 
Ground Turkey 37.8% 
28 
34.2% 
39 
28.9% 
41 
Ground Beef 77.8% 
7 
60.0% 
6 
78.6% 
11 
Pork Chops 20.0% 
2 
20.0% 
1 
45.5% 
5 
Chickens 52.8% 
113 
58.6% 
329 
58.8% 
846 
56.9% 
667 
66.5% 
869 
62.0% 
930 
61.1% 
708 
62.7% 
803 
Turkeys 32.7% 
35 
41.3% 
99 
32.5% 
232 
33.4% 
173 
31.6% 
174 
29.9% 
73 
24.0% 
63 
33.5% 
79 
Cattle 66.7% 
16 
73.2% 
208 
74.5% 
1199 
70.0% 
972 
69.9% 
624 
64.3% 
648 
61.0% 
409 
65.6% 
398 
Swine 44.1% 
49 
49.2% 
390 
48.9% 
428 
43.2% 
195 
43.3% 
181 
40.1% 
152 
53.6% 
113 
37.3% 
115 
2. At Least ACSSuT1 Resistant 
Humans
8.8% 
116 
9.5% 
124 
8.9% 
130 
8.4% 
126 
8.9% 
122 
10.0% 
142 
7.8% 
156 
9.3% 
173 
7.1%
128 
Chicken Breasts 0.0% 
0 
2.4% 
2 
1.9% 
3 
Ground Turkey 1.4% 
1 
0.9% 
1 
2.8% 
4 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 40.0% 
4 
40.0% 
2 
9.1% 
1 
Chickens 1.4% 
3 
2.7% 
15  
1.7% 
24  
4.3% 
50  
2.4% 
32  
1.9% 
29  
1.5% 
17  
0.9% 
12 
Turkeys 3.7% 
4 
0.8% 
2 
3.8% 
27 
3.3% 
17 
3.6% 
20 
4.5% 
11 
2.3% 
6 
4.7% 
11 
Cattle 4.2% 
1 
4.2% 
12 
7.6% 
123 
13.1% 
182 
14.6% 
130 
17.1% 
172 
18.1% 
121 
16.3% 
99 
Swine 4.5% 
5 
7.8% 
62  
7.1% 
62  
8.6% 
39  
7.2% 
30  
7.7% 
29  
7.6% 
16  
12.0% 
37 
3. At Least ACT/S2 Resistant 
Humans
0.8% 
10 
0.4% 
5 
0.9% 
13 
1.0% 
15 
1.0% 
14 
0.5% 
7 
1.0% 
21 
1.2% 
23 
0.6%
10 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 1.4% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
7.1% 
1 
Pork Chops 20.0% 
2 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.2% 
1 
0.1% 
2 
0.0% 
0 
0.1% 
1 
0.0% 
0 
0.0% 
0 
0.1% 
1 
Turkeys 0.0% 
0 
0.4% 
1 
0.4% 
3 
0.8% 
4 
0.7% 
4 
0.8% 
2 
0.0% 
0 
0.4% 
1 
Cattle 0.0% 
0 
2.1% 
6 
2.2% 
35 
1.7% 
23 
2.4% 
21 
2.4% 
24 
2.7% 
18 
1.2% 
7 
Swine 0.0% 
0 
0.5% 
4 
0.5% 
4 
0.0% 
0 
1.0% 
4 
0.5% 
2 
0.9% 
2 
0.6% 
2
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline
 2 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole 
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Table 13b. Resistance Patterns among all Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 1324 1301 1460 1497 1377 1419 2008 1864 1793
 Chicken Breasts 60 83 157
 Ground Turkey 
Ground Beef 
74 
9 
114 
10  
142
14
 Pork Chops 10 5 11
 Chickens 214 561 1438 1173 1307 1500 1158 1280
 Turkeys 
Cattle 
107 
24 
240 
284 
713 
1610 
518 
1388 
550 
893 
244 
1008 
262 
670 
236
607
 Swine 111 793 876 451 418 379 211 308
 Isolate 
Resistance Pattern  Source 
4. At Least ACSSuTAuCf 1 
Humans
0.0% 
0 
0.3% 
4 
0.3% 
5 
1.5% 
23 
2.6% 
36 
2.5% 
36 
3.3% 
67 
3.2% 
60 
2.3%
42
 Resistant Chicken Breasts 0.0% 
0 
0.0% 
0 
1.9% 
3 
Ground Turkey 1.4% 
1 
0.9% 
1 
2.1% 
3 
Ground Beef 22.2% 
2 
40.0% 
4 
14.3% 
2 
Pork Chops 20.0% 
2 
20.0% 
1 
0.0% 
0 
Chickens 0.0% 
0 
0.5% 
3 
0.3% 
5 
2.7% 
32 
1.1% 
14 
0.9% 
13 
1.0% 
12 
0.4% 
5 
Turkeys 3.7% 
4 
0.4% 
1 
3.4% 
24 
1.9% 
10 
2.9% 
16 
1.6% 
4 
0.8% 
2 
2.1% 
5 
Cattle 0.0% 
0 
2.1% 
6 
3.7% 
59 
8.9% 
124 
11.0% 
98 
14.6% 
147 
15.1% 
101 
11.9% 
72 
Swine 0.0% 
0 
0.1% 
1 
0.6% 
5 
1.3% 
6 
2.2% 
9 
1.8% 
7 
1.9% 
4 
1.0% 
3 
5. At Least Ceftiofur and 
Humans 0.0% 
0 
0.2% 
2 
0.0% 
0 
0.1% 
1 
0.1% 
1 
0.1% 
2 
0.2% 
4 
0.1% 
2 
0.1%
2
 Nalidixic Acid Resistant 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.9% 
1 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.1% 
1 
0.1% 
1 
0.0% 
0 
0.6% 
9 
0.1% 
1 
0.2% 
3 
Turkeys 1.9% 
2 
0.0% 
0 
2.7% 
19  
1.2% 
6 
1.5% 
8 
1.2% 
3 
0.4% 
1 
0.8% 
2 
Cattle 0.0% 
0 
0.0% 
0 
0.1% 
1 
0.1% 
1 
0.3% 
3 
0.2% 
2 
0.4% 
3 
1.0% 
6 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0
 1 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur 
31
Table 14. Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals that are at least 
ACSSuT1 Resistant, by Serotype, 2004 
Humans Retail Meats Food Animals
 Source  Serotype n %
 Meat 
Type Serotype n  % 
Animal 
Source Serotype n %
 Humans Typhimurium 89 69.5  Chicken Typhimurium 2 66.7  Chickens Heidelberg 4 33.3 
(n=128) Newport 
Java 
28 
2 
21.9 
1.6 
Breasts 
(n=3) 
Heidelberg 1 33.3 (n=12) Kentucky 
Typhimurium 
3 
3 
25.0 
25.0 
I 4,[5],12:i:- 1 0.8 I 4,[5],12:r:- 1 8.3 
Agona 1 0.8 Thompson 1 8.3 
Anatum 1 0.8 
Dublin 1 0.8 
Enteritidis 1 0.8  Ground Heidelberg 2 50.0  Turkeys Typhimurium 4 36.4 
Heidelberg 1 0.8 Turkey Saintpaul 1 25.0 (n=11) Senftenberg 3 27.3 
Uganda 1 0.8 (n=4) Typhimurium 1 25.0 I 4,12:r:- 1 9.1 
Incomplete Serotyping 1 0.8 IIIa 18:z4,z23:- 1 9.1 
Unknown 1 0.8 Alachua 1 9.1 
Newport 1 9.1
 Ground
 Beef
 (n=2) 
Newport 2 100.0  Cattle
 (n=99) 
Newport 
Typhimurium 
Reading 
33 
26 
14 
33.3 
26.2 
14.1 
Dublin 12 12.1 
Agona 10 10.1 
Anatum 1 1.0 
Heidelberg 1 1.0 
Ohio 1 1.0 
Uganda 1 1.0
 Pork Typhimurium 1 100.0  Swine Typhimurium 32 86.5 
Chops  (n=37) Reading 2 5.4 
(n=1) Agona 1 2.7 
Derby 1 2.7 
Krefeld 1 2.7
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline 
Table 15. Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals that are at least 
ACT/S1 Resistant, by Serotype, 2004 
Humans Retail Meats Food Animals
 Source  Serotype n %
 Meat 
Type  %nSerotype 
Animal 
Source Serotype n %
 Humans
 (n=10) 
Typhimurium 
Newport 
Agona 
Dublin 
6 
2 
1 
1 
60.0
20.0 
10.0 
10.0
 Chicken 
Breasts 
(n=0)
 Chickens 
(n=1) 
Kentucky 1 100.0 
Ground
 Turkey
 (n=0) 
Turkeys 
(n=1) 
Newport 1 100.0
 Ground
 Beef
 (n=1) 
Newport 1 100.0  Cattle
 (n=7) 
Agona 
Typhimurium 
Heidelberg 
Newport 
3 
2 
1 
1 
42.9 
28.6 
14.3 
14.3
 Pork 
Chops
 (n=0)
 Swine
 (n=2) 
Typhimurium 
Agona 
1 
1 
50.0 
50.0
 1 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole 
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Table 16. Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals that are at least 
ACSSuTAuCf1 Resistant, by Serotype, 2004 
Humans Retail Meats Food Animals
 Source  Serotype n %
 Meat 
Type Serotype n  % 
Animal 
Source Serotype n %
 Humans Newport 28 66.7  Chicken Typhimurium 2 66.7  Chickens Heidelberg 4 80.0 
(n=42) Typhimurium 
Agona 
10 
1 
23.8 
2.4 
Breasts 
(n=3) 
Heidelberg 1 33.3 (n=5) I 4,[5],12:r:- 1 10.0 
Anatum 1 2.4 
Uganda 1 2.4 
Incomplete Serotyping 1 2.4
 Ground Heidelberg 2 66.7  Turkeys Typhimurium 2 40.0 
Turkey Saintpaul 1 33.3 (n=5) I 4,12:r:- 1 20.0 
(n=3) Alachua 1 20.0 
Newport 1 20.0
 Ground
 Beef
 (n=2) 
Newport 2 100.0  Cattle
 (n=72) 
Newport 
Reading 
Agona 
Typhimurium 
Dublin 
Anatum 
Heidelberg 
Ohio 
Uganda 
32 
14 
10 
10 
2 
1 
1 
1 
1 
44.4 
19.4 
13.9 
13.9 
2.8 
1.4 
1.4 
1.4 
1.4
 Pork 
Chops
 (n=0)
 Swine
 (n=3) 
Reading 
Agona 
2 
1 
66.7 
33.3
 1 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur 
Table 17. Salmonella  (non-Typhi) Isolates from Humans, Retail Meats, and Food Animals that are at least 
Ceftiofur and Nalidixic Acid Resistant, by Serotype, 2004 
Humans Retail Meats Food Animals
 Source  %nSerotype 
Meat 
Type  %nSerotype 
Animal 
Source Serotype n %
 Humans Newport 1 50.0  Chicken Chickens I 4,[5],12:i:- 1 33.3 
(n=2) Uganda 1 50.0 Breasts (n=3) Braenderup 1 33.3 
(n=0) Kentucky 1 33.3
 Ground  Turkeys Typhimurium 2 100.0
 Turkey  (n=2) 
(n=0) 
Ground
 Beef
 (n=0) 
Cattle
 (n=6) 
Reading 
Typhimurium 
Agona 
Uganda 
2 
2 
1 
1 
33.3 
33.3 
16.7 
16.7
 Pork Swine
 Chops  (n=0) 
(n=0)
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E. Antimicrobial Susceptibility among Salmonella Typhimurium
MIC Distributions
Table 18a. Distribution of MICs and Occurrence of Resistance among  Salmonella Typhimurium Isolates from Humans, Retail Meats, and Food Animals, 2004             
 Isolate Source Distribution of MICs (µg/ml)5
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminoglycosides
   Amikacin  Humans (382) 0.0 0.0 [0.0 - 1.0] 1.8 74.3 21.7 2.1
 Chicken Breasts (49) 0.0 0.0 [0.0 - 7.3] 20.4 49.0 28.6 2.0
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 0.0 0.0 [0.0 - 2.1] 32.7 57.3 9.4 0.6
 Turkeys (14) 0.0 0.0 [0.0 - 23.2] 92.9 7.1
 Cattle (48) 0.0 0.0 [0.0 - 7.4] 2.1 75.0 20.8 2.1
 Swine (53) 0.0 0.0 [0.0 - 6.7] 3.8 69.8 20.8 5.7
   Gentamicin  Humans (382) 0.0 2.1 [0.9 - 4.1] 64.1 32.5 1.0 0.3 0.5 1.6
 Chicken Breasts (49) 0.0 2.0 [0.1 - 10.9] 71.4 22.4 4.1 2.0
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 0.0 4.1 [1.7 - 8.3] 74.9 20.5 0.6 2.9 1.2
 Turkeys (14) 0.0 64.3 [35.1 - 87.2] 28.6 7.1 50.0 14.3
 Cattle (48) 0.0 0.0 [0.0 - 7.4] 62.5 35.4 2.1
 Swine (53) 0.0 3.8 [0.5 - 13.0] 47.2 49.1 3.8
   Kanamycin  Humans (382) 0.0 5.8 [3.6 - 8.6] 93.7 0.5 0.3 5.5
 Chicken Breasts (49) 0.0 34.7 [21.7 - 49.6] 65.3 34.7
 Ground Turkey (2) 0.0 50.0 [1.3 - 98.7] 50.0 50.0
 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 0.0 9.9 [5.9 - 15.4] 90.1 9.9
 Turkeys (14) 0.0 21.4 [4.7 - 50.8] 78.6 21.4
 Cattle (48) 0.0 14.6 [6.1 - 27.8] 85.4 14.6
 Swine (53) 0.0 9.4 [3.1 - 20.7] 90.6 9.4
   Streptomycin  Humans (382) N/A 31.7 [27.0 - 36.6] 68.3 20.4 11.3
 Chicken Breasts (49) N/A 14.3 [5.9 - 27.2] 85.7 4.1 10.2
 Ground Turkey (2) N/A 50.0 [1.3 - 98.7] 50.0 50.0
 Pork Chops (2) N/A 100.0 [15.8 - 100.0] 100.0
 Chickens (171) N/A 8.2 [4.5 - 13.4] 91.8 4.7 3.5
 Turkeys (14) N/A 64.3 [35.1 - 87.2] 35.7 42.9 21.4
 Cattle (48) N/A 56.3 [41.2 - 70.5] 43.8 27.1 29.2
 Swine (53) N/A 77.4 [63.8 - 87.7] 22.6 41.5 35.8
1 There were no Salmonella  Typhimurium isolates from ground beef
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
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Table 18b. Distribution of MICs and Occurrence of Resistance among  Salmonella Typhimurium Isolates from Humans, Retail Meats, and Food Animals, 2004             
 Isolate Source Distribution (14) of MICs (µg/ml)5
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminopenicillins
   Ampicillin  Humans (382) 0.0 31.9 [27.3 - 36.9] 43.2 23.3 1.6 31.9
 Chicken Breasts (49) 0.0 53.1 [38.3 - 67.5] 44.9 2.0 53.1
 Ground Turkey (2) 0.0 50.0 [1.3 - 98.7] 50.0 50.0
 Pork Chops (2) 0.0 50.0 [1.3 - 98.7] 50.0 50.0
 Chickens (171) 0.0 46.8 [39.1 - 54.6] 45.0 7.6 0.6 0.6 46.2
 Turkeys (14) 0.0 28.6 [8.4 - 58.1] 64.3 7.1 28.6
 Cattle (48) 0.0 60.4 [45.3 - 74-2] 35.4 2.1 2.1 60.4
 Swine (53) 0.0 71.7 [57.7 - 83.2] 18.9 7.5 1.9 71.7
β-Lactam/β-Lactamase
 Inhibitor Combinations
   Amoxicillin-Clavulanic Acid  Humans (382) 21.2 4.7 [2.8 - 7.3] 66.2 2.1 5.8 21.2 0.3 4.5
 Chicken Breasts (49) 0.0 49.0 [34.4 - 63.7] 40.8 6.1 4.1 49.0
 Ground Turkey (2) 50.0 0.0 [0.0 - 84.2] 50.0 50.0
 Pork Chops (2) 50.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 1.2 43.3 [35.7 - 51.1] 52.0 1.2 2.3 1.2 43.3
 Turkeys (14) 14.3 14.3 [1.8 - 42.8] 64.3 7.1 14.3 14.3
 Cattle (48) 16.7 25.0 [13.6 - 39.6] 35.4 4.2 18.8 16.7 25.0
 Swine (53) 45.3 0.0 [0.0 - 6.7] 24.5 3.8 26.4 45.3
 Cephalosporins
   Ceftiofur  Humans (382) 0.0 4.5 [2.6 - 7.0] 0.3 1.0 77.2 16.2 0.8 4.5
 Chicken Breasts (49) 0.0 49.0 [34.4 - 63.7] 38.8 12.2 49.0
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Chickens (171) 0.0 43.3 [35.7 - 51.1] 0.6 50.3 5.8 0.6 42.7
 Turkeys (14) 0.0 14.3 [1.8 - 42.8] 71.4 14.3 14.3
 Cattle (48) 0.0 25.0 [13.6 - 39.6] 66.7 6.2 2.1 2.1 22.9
 Swine (53) 0.0 1.9 [0.0 - 10.1] 77.4 17.0 3.8 1.9
   Ceftriaxone  Humans (382) 3.4 0.8 [0.2 - 2.3] 95.5 0.3 2.9 0.5 0.8
 Chicken Breasts (49) 49.0 0.0 [0.0 - 7.3] 51.0 34.7 14.3
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 40.4 1.8 [0.4 - 5.0] 56.7 1.2 36.3 4.1 1.8
 Turkeys (14) 14.3 0.0 [0.0 - 23.2] 85.7 7.1 7.1
 Cattle (48) 20.8 2.1 [0.1 - 11.1] 75.0 2.1 12.5 8.3 2.1
 Swine (53) 0.0 0.0 [0.0 - 6.7] 98.1 1.9
1 There were no Salmonella  Typhimurium isolates from ground beef
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
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1.9 1.9
   Chloramphenicol  Humans (382) 0.3 24.1 [19.9 - 28.7] 1.8 38.2 35.6 0.3 24.1
 Pork Chops (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Swine (53) 7.5 60.4 [46.0 - 73.5] 3.8 28.3 7.5 1.9 58.5
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
Table 18c. Distribution of MICs and Occurrence of Resistance among  Salmonella Typhimurium Isolates from Humans, Retail Meats, and Food Animals, 2004             
 Isolate Source Distribution (14) of MICs (µg/ml)
5
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Cephamycins
   Cefoxitin  Humans (382) 0.3 4.7 [2.8 - 7.3] 0.3 19.6 66.2 6.5 2.4 0.3 2.6 2.1
 Chicken Breasts (49) 0.0 49.0 [34.4 - 63.7] 4.1 36.7 10.2 49.0
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 0.0 43.3 [35.7 - 51.1] 5.3 45.6 4.7 1.2 29.8 13.5
 Turkeys (14) 0.0 14.3 [1.8 - 42.8] 85.7 7.1 7.1
 Cattle (48) 2.1 25.0 [13.6 - 39.6] 6.2 62.5 4.2 2.1 12.5 12.5
 Swine (53) 3.8 0.0 [0.0 - 6.7] 1.9 5.7 69.8 18.9 3.8
 Folate Pathway Inhibitors
   Sulfisoxazole  Humans (382) N/A 35.9 [31.0 - 40.9] 11.8 49.2 2.9 0.3 35.9
 Chicken Breasts (49) N/A 73.5 [58.9 - 85.1] 2.0 10.2 14.3 73.5
 Ground Turkey (2) N/A 100.0 [15.8 - 100.0] 100.0
 Pork Chops (2) N/A 100.0 [15.8 - 100.0] 100.0
 Chickens (171) N/A 47.4 [39.7 - 55.1] 31.6 18.7 1.8 0.6 47.4
 Turkeys (14) N/A 78.6 [49.2 - 95.3] 14.3 7.1 78.6
 Cattle (48) N/A 60.4 [45.3 - 74.2] 22.9 16.7 60.4
 Swine (53) N/A 81.1 [68.0 - 90.6] 7.5 11.3 81.1
   Trimethoprim-Sulfamethoxazole  Humans (382) N/A 2.6 [1.3 - 4.8] 63.4 33.5 0.3 0.3 2.6
 Chicken Breasts (49) N/A 0.0 [0.0 - 7.3] 93.9 6.1
 Ground Turkey (2) N/A 0.0 [0.0 - 84.2] 100.0
 Pork Chops (2) N/A 0.0 [0.0 - 84.2] 100.0
 Chickens (171) N/A 0.0 [0.0 - 2.1] 63.2 35.7 1.2
 Turkeys (14) N/A 0.0 [0.0 - 23.2] 50.0 50.0
 Cattle (48) N/A [0.5 - 14.3] 45.8 43.8 6.2
 Swine (53) N/A
4.2
[0.0 - 10.1] 24.5 58.5 11.3 3.8
4.2
 Phenicols
 Chicken Breasts (49) 0.0 4.1 [0.5 - 14.0] 12.2 83.7 4.1
 Ground Turkey (2) 0.0 50.0 [1.3 - 98.7] 50.0 50.0
 Chickens (171) 0.0 1.8 [0.4 - 5.0] 0.6 46.2 51.5 1.8
 Turkeys (14) 0.0 28.6 [8.4 - 58.1] 7.1 21.4 42.9 28.6
 Cattle (48) 2.1 54.2 [39.2 - 68.6] 18.8 25.0 2.1 54.2
1 There were no Salmonella  Typhimurium isolates from ground beef
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
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 Pork Chops (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (53) 0.0 0.0 [0.0 - 6.7] 88.7 11.3
   Nalidixic Acid  Humans (382) N/A 0.5 [0.1 - 1.9] 0.5 24.6 72.8 1.3 0.3 0.5
 Pork Chops (2) N/A 0.0 [0.0 - 84.2] 100.0
 Swine (53) N/A 0.0 [0.0 - 6.7] 9.4 77.4 13.2
   Tetracycline  Humans (382) 0.0 30.1 [25.5 - 35.0] 69.9 5.2 15.2 9.7
 Pork Chops (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Swine (53) 0.0 90.6 [79.3 - 96.9] 9.4 15.1 32.1 43.4
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
Table 18d. Distribution of MICs and Occurrence of Resistance among  Salmonella Typhimurium Isolates from Humans, Retail Meats, and Food Animals, 2004             
5
 Antimicrobial
 Isolate Source
 (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1
Distribu
2
tion (1
4
4) of M
8
ICs (µg
16
/ml)
32 64 128 256 512 1024
 Quinolones
   Ciprofloxacin  Humans (382) 0.0 0.0 [0.0 - 1.0] 97.9 1.3 0.5 0.3
 Chicken Breasts (49) 0.0 [0.0 - 7.3] 95.9 4.10.0
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Chickens (171) 0.0 0.0 [0.0 - 2.1] 100.0
 Turkeys (14) 0.0 0.0 [0.0 - 23.2] 85.7 14.3
 Cattle (48) 0.0 0.0 [0.0 - 7.4] 93.8 2.1 2.1 2.1
 Chicken Breasts (49) N/A 0.0 [0.0 - 7.3] 4.1 89.8 6.1
 Ground Turkey (2) N/A 0.0 [0.0 - 84.2] 100.0
 Chickens (171) N/A 0.0 [0.0 - 2.1] 8.2 90.1 1.8
 Turkeys (14) N/A 14.3 [1.8 - 42.8] 7.1 78.6 14.3
 Cattle (48) N/A 6.3 [1.3 - 17.2] 10.4 83.3 6.3
 Tetracyclines
 Chicken Breasts (49) 0.0 71.4 [56.7 - 83.4] 28.6 71.4
 Ground Turkey (2) 0.0 100.0 [15.8 - 100.0] 50.0 50.0
 Chickens (171) 0.0 44.4 [36.9 - 52.2] 55.6 0.6 1.2 42.7
 Turkeys (14) 0.0 78.6 [49.2 - 95.3] 21.4 14.3 64.3
 Cattle (48) 0.0 60.4 [45.3 - 74.2] 39.6 6.2 27.1 27.1
1 There were no Salmonella  Typhimurium isolates from ground beef
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
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Resistance by Year
Table 19a. Antimicrobial Resistance among Salmonella  Typhimurium Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9 22 49
 Ground Turkey 
Ground Beef 
2 
2 
2 
1 
2
0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 
Cattle 
11 
2 
6 
33 
37 
189 
18 
187 
15 
87 
9 
98 
6 
78 
14
48
 Swine 25 105 114 81 44 48 27 53
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Aminoglycosides  Amikacin 
(MIC ≥ 64 µg/ml) Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Gentamicin 
(MIC ≥ 16 µg/ml) Humans
4.2% 
13  
4.6% 
15  
3.7% 
14  
2.2% 
8 
2.6% 
8 
1.5% 
5 
2.3% 
9 
2.0% 
8 
2.1%
8 
Chicken Breasts 0.0% 
0 
0.0% 
0 
2.0% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 20.8% 
5 
18.2% 
12  
16.9% 
26  
15.2% 
22  
3.1% 
4 
12.7% 
19  
5.1% 
8 
4.1% 
7 
Turkeys 45.5% 
5 
50.0% 
3 
29.7% 
11  
33.3% 
6 
53.3% 
8 
44.4% 
4 
83.3% 
5 
64.3% 
9 
Cattle 0.0% 
0 
3.0% 
1 
2.6% 
5 
1.6% 
3 
0.0% 
0 
2.0% 
2 
1.3% 
1 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
1.8% 
2 
0.0% 
0 
2.3% 
1 
2.1% 
1 
0.0% 
0 
3.8% 
2
 Kanamycin 
(MIC ≥ 64 µg/ml) Humans
14.4% 
44 
15.5% 
51 
15.9% 
60 
13.0% 
47 
13.2% 
40 
8.3% 
27 
7.6% 
30 
7.2% 
29 
5.8%
22 
Chicken Breasts 0.0% 
0 
18.2% 
4 
34.7% 
17 
Ground Turkey 0.0% 
0 
50.0% 
1 
50.0% 
1 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 8.3% 
2 
4.5% 
3 
3.9% 
6 
3.4% 
5 
3.1% 
4 
5.3% 
8 
7.7% 
12  
9.9% 
17 
Turkeys 81.8% 
9 
66.7% 
4 
59.5% 
22 
44.4% 
8 
73.3% 
11 
55.6% 
5 
50.0% 
3 
21.4% 
3 
Cattle 0.0% 
0 
54.5% 
18  
36.5% 
69  
27.3% 
51  
24.1% 
21  
26.5% 
26  
16.7% 
13  
14.6% 
7 
Swine 16.0% 
4 
18.1% 
19  
21.1% 
24  
14.8% 
12  
13.6% 
6 
2.1% 
1 
0.0% 
0 
9.4% 
5
 Streptomycin 
(MIC ≥ 64 µg/ml) Humans
51.6% 
158 
55.2% 
181 
47.4% 
179 
43.1% 
156 
39.3% 
119 
40.0% 
130 
31.8% 
125 
34.9% 
141 
31.7%
121 
Chicken Breasts 0.0% 
0 
18.2% 
4 
14.3% 
7 
Ground Turkey 0.0% 
0 
50.0% 
1 
50.0% 
1 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 50.0% 
1 
100.0% 
1 
100.0% 
2 
Chickens 41.7% 
10 
45.5% 
30 
40.9% 
63 
35.9% 
52 
16.9% 
22 
30.0% 
45 
16.7% 
26 
8.2% 
14 
Turkeys 81.8% 
9 
83.3% 
5 
81.1% 
30 
72.2% 
13 
93.3% 
14 
77.8% 
7 
100.0% 
6 
64.3% 
9 
Cattle 100.0% 
2 
57.6% 
19 
63.0% 
119 
63.1% 
118 
46.0% 
40 
66.3% 
65 
52.6% 
41 
56.3% 
27 
Swine 44.0% 
11 
82.9% 
87 
80.7% 
92 
77.8% 
63 
70.5% 
31 
77.1% 
37 
59.3% 
16 
77.4% 
41 
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Table 19b. Antimicrobial Resistance among Salmonella  Typhimurium Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9 22 49
 Ground Turkey 
Ground Beef 
2 
2 
2 
1 
2
0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 
Cattle 
11 
2 
6 
33 
37 
189 
18 
187 
15 
87 
9 
98 
6 
78 
14
48
 Swine 25 105 114 81 44 48 27 53
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Aminopenicillins  Ampicillin 
(MIC ≥ 32 µg/ml) Humans
50.0% 
153 
50.3% 
165 
45.2% 
171 
41.2% 
149 
41.9% 
127 
42.5% 
138 
33.6% 
132 
35.6% 
144 
31.9%
122 
Chicken Breasts 33.3% 
3 
72.7% 
16  
53.1% 
26 
Ground Turkey 0.0% 
0 
100.0% 
2 
50.0% 
1 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 50.0% 
1 
100.0% 
1 
50.0% 
1 
Chickens 33.3% 
8 
30.3% 
20  
43.5% 
67  
42.1% 
61  
26.2% 
34  
45.3% 
68  
32.1% 
50  
46.8% 
80 
Turkeys 72.7% 
8 
50.0% 
3 
64.9% 
24 
66.7% 
12 
80.0% 
12 
55.6% 
5 
66.7% 
4 
28.6% 
4 
Cattle 100.0% 
2 
57.6% 
19 
66.1% 
125 
63.1% 
118 
57.5% 
50 
71.4% 
70 
59.0% 
46 
60.4% 
29 
Swine 72.0% 
18 
75.2% 
79 
64.0% 
73 
82.7% 
67 
63.6% 
28 
62.5% 
30 
51.9% 
14 
71.7% 
38 
β-Lactam/β-Lactamase 
Inhibitor Combinations
 Amoxicillin-
Clavulanic Acid 
(MIC ≥ 32 / 16 µg/ml) 
Humans 2.6% 
8 
3.4% 
11  
4.5% 
17  
2.8% 
10  
6.3% 
19  
6.2% 
20  
7.6% 
30  
5.4% 
22  
4.7%
18
 Chicken Breasts 33.3% 
3 
63.6% 
14  
49.0% 
24 
Ground Turkey 0.0% 
0 
100.0% 
2 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
9.1% 
6 
29.2% 
45 
25.5% 
37 
14.6% 
19 
28.7% 
43 
25.6% 
40 
43.3% 
74 
Turkeys 63.6% 
7 
0.0% 
0 
51.4% 
19  
38.9% 
7 
53.3% 
8 
22.2% 
2 
16.7% 
1 
14.3% 
2 
Cattle 50.0% 
1 
6.1% 
2 
6.9% 
13 
12.8% 
24 
13.8% 
12 
17.3% 
17 
20.5% 
16 
25.0% 
12 
Swine 0.0% 
0 
1.9% 
2 
1.8% 
2 
2.5% 
2 
4.5% 
2 
8.3% 
4 
0.0% 
0 
0.0% 
0
 Cephalosporins  Ceftiofur 
(MIC ≥ 8 µg/ml) Humans
0.0% 
0 
1.5% 
5 
1.9% 
7 
1.9% 
7 
3.6% 
11  
3.1% 
10  
4.3% 
17  
5.0% 
20  
4.5%
17 
Chicken Breasts 33.3% 
3 
63.6% 
14  
49.0% 
24 
Ground Turkey 0.0% 
0 
100.0% 
2 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
9.1% 
6 
29.9% 
46 
26.2% 
38 
14.60% 
19 
28.0% 
42 
25.6% 
40 
43.3% 
74 
Turkeys 63.6% 
7 
0.0% 
0 
48.6% 
18  
38.9% 
7 
53.3% 
8 
22.2% 
2 
16.7% 
1 
14.3% 
2 
Cattle 0.0% 
0 
3.0% 
1 
6.9% 
13 
11.8% 
22 
11.5% 
10 
15.3% 
15 
20.5% 
16 
25.0% 
12 
Swine 0.0% 
0 
0.0% 
0 
1.8% 
2 
0.0% 
0 
0.0% 
0 
4.2% 
2 
0.0% 
0 
1.9% 
1
 Ceftriaxone 
(MIC ≥ 64 µg/ml) Humans
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0 
0.3% 
1 
0.2% 
1 
0.8%
3 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.3% 
2 
0.0% 
0 
1.8% 
3 
Turkeys 0.0% 
0 
0.0% 
0 
8.1% 
3 
11.1% 
2 
6.7% 
1 
0.0% 
0 
16.7% 
1 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
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Table 19c. Antimicrobial Resistance among Salmonella  Typhimurium Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9 22 49
 Ground Turkey 
Ground Beef 
2 
2 
2 
1 
2
0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 
Cattle 
11 
2 
6 
33 
37 
189 
18 
187 
15 
87 
9 
98 
6 
78 
14
48
 Swine 25 105 114 81 44 48 27 53
 Antimicrobial
 (Resistance Isolate
 Antimicrobial Class  Breakpoint)  Source
 Cephalosporins  Cephalothin 
(MIC ≥ 32 µg/ml) Humans
2.0% 
6 
4.3% 
14  
4.0% 
15  
4.4% 
16  
4.3% 
13  
3.1% 
10  
5.6% 
22  
6.2%
25  
Chicken Breasts 33.3% 
3 
63.6% 
14  
Ground Turkey 0.0% 
0 
100.0% 
2 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
100.0% 
1 
Chickens 0.0% 
0 
9.1% 
6 
29.9% 
46 
25.5% 
37 
13.8% 
18 
28.0% 
42 
25.6% 
40 
Turkeys 63.6% 
7 
50.0% 
3 
51.4% 
19  
38.9% 
7 
60.0% 
9 
22.2% 
2 
33.3% 
2 
Cattle 0.0% 
0 
3.0% 
1 
13.2% 
25 
12.8% 
24 
12.6% 
11 
16.3% 
16 
21.8% 
17 
Swine 0.0% 
0 
0.0% 
0 
0.9% 
1 
2.5% 
2 
0.0% 
0 
4.2% 
2 
0.0% 
0
 Cephamycins  Cefoxitin 
(MIC ≥ 32 µg/ml) Humans
3.6% 
11 
3.1% 
10 
4.3% 
17 
4.5% 
18 
4.7%
18 
Chicken Breasts 33.3% 
3 
63.6% 
14  
49.0% 
24 
Ground Turkey 0.0% 
0 
100.0% 
2 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 24.8% 
36 
14.6% 
19 
26.7% 
40 
23.7% 
37 
43.3% 
74 
Turkeys 38.9% 
7 
53.3% 
8 
22.2% 
2 
16.7% 
1 
14.3% 
2 
Cattle 9.1% 
17 
11.5% 
10 
11.2% 
11 
16.7% 
13 
25.0% 
12 
Swine 12.1% 
1 
0.0% 
0 
4.2% 
2 
3.7% 
1 
0.0% 
0
 Folate Pathway Inhibitors  Sulfamethoxazole/ 
Sulfisoxazole1 
(MIC ≥ 512 µg/ml) 
Humans 53.3% 
163 
56.7% 
186 
49.7% 
188 
45.6% 
165 
45.2% 
137 
43.1% 
140 
31.2% 
126 
38.2% 
154 
35.9%
137
 Chicken Breasts 44.4% 
4 
31.8% 
7 
73.5% 
36 
Ground Turkey 0.0% 
0 
50.0% 
1 
100.0% 
2 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 50.0% 
1 
100.0% 
1 
100.0% 
2 
Chickens 41.7% 
10 
37.9% 
25 
32.5% 
50 
34.5% 
50 
18.5% 
24 
31.3% 
47 
28.2% 
44 
47.4% 
81 
Turkeys 81.8% 
9 
83.3% 
5 
75.7% 
28 
66.7% 
12 
86.7% 
13 
77.8% 
7 
100.0% 
6 
78.6% 
11 
Cattle 100.0% 
2 
60.6% 
20 
64.6% 
122 
64.2% 
120 
54.0% 
47 
58.2% 
57 
44.9% 
35 
60.4% 
29 
Swine 80.0% 
20 
83.8% 
88 
78.9% 
90 
86.4% 
70 
75.0% 
33 
68.8% 
33 
63.0% 
17 
81.1% 
43
 Trimethoprim-
Sulfamethoxazole 
(MIC ≥ 4 / 76 µg/ml) 
Humans 4.6% 
14 
3.0% 
10 
4.5% 
17 
2.8% 
10 
3.6% 
11 
2.5% 
8 
2.3% 
9 
3.5% 
14 
2.6%
10
 Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
1.5% 
1 
1.3% 
2 
0.0% 
0 
0.8% 
1 
13.0% 
2 
0.6% 
1 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
11.1% 
2 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
6.1% 
2 
9.0% 
17  
2.1% 
4 
2.3% 
2 
4.1% 
4 
2.6% 
2 
4.2% 
2 
Swine 4.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
3.7% 
1 
1.9% 
1 
1 Sulfamethoxazole was tested from 1996 to 2003 and was replaced by sulfisoxazole in 2004
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Table 19d. Antimicrobial Resistance among Salmonella  Typhimurium Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9 22 49
 Ground Turkey 
Ground Beef 
2 
2 
2 
1 
2
0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 
Cattle 
11 
2 
6 
33 
37 
189 
18 
187 
15 
87 
9 
98 
6 
78 
14
48
 Swine 25 105 114 81 44 48 27 53
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans
39.9% 
122 
36.0% 
118 
33.6% 
127 
28.7% 
104 
30.7% 
93 
31.7% 
103 
23.2% 
91 
27.5% 
111 
24.1%
92 
Chicken Breasts 0.0% 
0 
9.1% 
2 
4.1% 
2 
Ground Turkey 0.0% 
0 
50.0% 
1 
50.0% 
1 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 50.0% 
1 
100.0% 
1 
100.0% 
2 
Chickens 20.8% 
5 
19.7% 
13  
10.4% 
16  
14.5% 
21  
11.5% 
15  
16.0% 
24  
5.1% 
8 
1.8% 
3 
Turkeys 63.6% 
7 
0.0% 
0 
54.1% 
20 
55.6% 
10 
73.3% 
11 
66.7% 
6 
50.0% 
3 
28.6% 
4 
Cattle 100.0% 
2 
27.3% 
9 
37.0% 
70 
42.8% 
80 
37.9% 
33 
49.0% 
48 
42.3% 
33 
54.2% 
26 
Swine 52.0% 
13 
57.1% 
60 
49.1% 
56 
53.1% 
43 
47.7% 
21 
56.3% 
27 
48.1% 
13 
60.4% 
32
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Nalidixic Acid 
(MIC ≥ 32 µg/ml) Humans
0.3% 
1 
0.9% 
3 
0.5% 
2 
0.0% 
0 
1.3% 
4 
0.6% 
2 
1.3% 
5 
1.2% 
5 
0.5%
2 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
50.0% 
1 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
6.0% 
1 
7.0% 
1 
0.0% 
0 
2.7% 
4 
0.0% 
0 
0.0% 
0 
Turkeys 45.5% 
5 
0.0% 
0 
51.4% 
19  
33.3% 
6 
60.0% 
9 
55.6% 
5 
33.3% 
2 
14.3% 
2 
Cattle 0.0% 
0 
0.0% 
0 
0.5% 
1 
0.0% 
0 
0.0% 
0 
1.0% 
1 
0.0% 
0 
6.3% 
3 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
1.2% 
1 
0.0% 
0 
2.1% 
1 
0.0% 
0 
0.0% 
0
 Tetracyclines  Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 49.3% 
151 
52.4% 
172 
46.0% 
174 
41.7% 
151 
43.2% 
131 
43.4% 
141 
31.8% 
125 
37.6% 
152 
30.1%
115 
Chicken Breasts 44.4% 
4 
31.8% 
7 
71.4% 
35 
Ground Turkey 0.0% 
0 
50.0% 
1 
100.0% 
2 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 100.0% 
2 
100.0% 
1 
100.0% 
2 
Chickens 33.3% 
8 
31.8% 
21  
32.5% 
50  
32.4% 
47  
16.2% 
21  
28.0% 
42  
33.3% 
52  
44.4% 
76 
Turkeys 90.9% 
10  
83.3% 
5 
78.4% 
29  
83.3% 
15  
93.3% 
14  
77.8% 
7 
100.0% 
6 
78.6% 
11 
Cattle 100.0% 
2 
63.6% 
21 
58.7% 
111 
61.5% 
115 
44.8% 
39 
64.3% 
63 
53.8% 
42 
60.4% 
29 
Swine 84.0% 
21 
89.5% 
94 
84.2% 
96 
91.1% 
73 
79.5% 
35 
89.6% 
43 
74.1% 
20 
90.6% 
48
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Ceftiofur Resistance 
Figure 12. Percent of Salmonella  Typhimurium Isolates from Humans, Retail Chicken Breasts,1 
and Food Animals Resistant to Ceftiofur, by Year, 1996-2004 
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1 Data for ground turkey, ground beef, and pork chops are not included due to the small number of Salmonella Typhimurium 
isolates from these sources. Table 19 contains resistance data for Salmonella  Typhimurium isolates from each source, by year 
Table 20. Number of Salmonella  Typhimurium Isolates Tested from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
1996 1997 1998 1999 2000 2001 2002 2003 2004
 Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9  22  49
 Ground Turkey 2 2 2
 Ground Beef 2 1 0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 11  6  37  18  15  9  6  14
 Cattle 2 33 189 187 87 98 78 48
 Swine 25 105 114 81 44 48 27 53 
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Multidrug Resistance
Table 21a. Resistance Patterns among Salmonella  Typhimurium Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9  22  49
 Ground Turkey 
Ground Beef 
2 
2 
2 
1 
2
0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 
Cattle 
11 
2 
6 
33 
37 
189 
18 
187 
15 
87 
9 
98 
6 
78 
14
48
 Swine 25 105 114 81 44 48 27 53
 Resistance Pattern  Isolate Source 
1. No Resistance Detected 
Humans
37.9% 
116 
39.0% 
128 
46.8% 
177 
50.6% 
183 
49.5% 
150 
49.2% 
160 
60.3% 
237 
55.2% 
223 
60.7%
232 
Chicken Breasts 22.2% 
2 
22.7% 
5 
14.3% 
7 
Ground Turkey 100.0% 
2 
0.0% 
0 
0.0% 
0 
Ground Beef 100.0% 
2 
100.0% 
1 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 37.5% 
9 
39.4% 
26  
29.2% 
45  
32.4% 
47  
64.6% 
84  
37.3% 
56  
45.5% 
71  
40.9% 
70 
Turkeys 0.0% 
0 
16.7% 
1 
10.8% 
4 
5.6% 
1 
6.7% 
1 
0.0% 
0 
0.0% 
0 
14.3% 
2 
Cattle 0.0% 
0 
36.4% 
12  
29.1% 
55  
26.7% 
50  
34.5% 
30  
19.4% 
19  
39.7% 
31  
35.4% 
17 
Swine 12.0% 
3 
7.6% 
8 
7.9% 
9 
2.5% 
2 
13.6% 
6 
8.3% 
4 
18.5% 
5 
3.8% 
2 
2. At Least ACSSuT1 Resistant 
Humans 33.7% 
103 
35.1% 
115 
32.0% 
121 
27.6% 
100 
27.7% 
84 
29.5% 
96 
21.4% 
84 
25.7% 
104 
23.3%
89 
Chicken Breasts 0.0% 
0 
9.1% 
2 
4.1% 
2 
Ground Turkey 0.0% 
0 
50.0% 
1 
50.0% 
1 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 50.0% 
1 
100.0% 
1 
50.0% 
1 
Chickens 12.5% 
3 
16.7% 
11  
9.7% 
15  
13.1% 
19  
11.5% 
15  
12.7% 
19  
3.2% 
5 
1.8% 
3 
Turkeys 27.3% 
3 
0.0% 
0 
51.4% 
19 
50.0% 
9 
66.7% 
10 
44.4% 
4 
50.0% 
3 
28.6% 
4 
Cattle 50.0% 
1 
21.2% 
7 
32.8% 
62 
37.4% 
70 
31.0% 
27 
31.6% 
31 
28.2% 
22 
54.2% 
26 
Swine 20.0% 
5 
54.3% 
57  
46.5% 
53  
39.5% 
32  
45.5% 
20  
47.9% 
23  
44.4% 
12  
60.4% 
32 
3. At Least ACT/S2 Resistant 
Humans
2.0% 
6 
0.6% 
2 
2.6% 
10  
2.2% 
8 
1.7% 
5 
0.9% 
3 
2.0% 
8 
3.2% 
13  
1.6%
6 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.6% 
1 
0.7% 
1 
0.0% 
0 
2.7% 
4 
0.0% 
0 
0.0% 
0 
Turkeys 18.2% 
2 
0.0% 
0 
48.6% 
18  
33.3% 
6 
53.3% 
8 
22.2% 
2 
16.7% 
1 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
4.2% 
2 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
0.0% 
0 
1.9% 
1
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline
 2 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole 
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Table 21b. Resistance Patterns among Salmonella  Typhimurium Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 306 328 378 362 303 325 393 404 382
 Chicken Breasts 9  22  49
 Ground Turkey 
Ground Beef 
2 
2 
2 
1 
2
0
 Pork Chops 2 1 2
 Chickens 24 66 154 145 130 150 156 171
 Turkeys 
Cattle 
11 
2 
6 
33 
37 
189 
18 
187 
15 
87 
9 
98 
6 
78 
14
48
 Swine 25 105 114 81 44 48 27 53
 Resistance Pattern  Isolate Source 
4. At Least ACSSuTAuCf 1 
Humans
0.0% 
0 
1.2% 
4 
1.1% 
4 
0.6% 
2 
2.0% 
6 
1.2% 
4 
1.8% 
7 
2.2% 
9 
2.6%
10
 Resistant Chicken Breasts 0.0% 
0 
0.0% 
0 
4.1% 
2 
Ground Turkey 0.0% 
0 
50.0% 
1 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.6% 
1 
0.7% 
1 
0.0% 
0 
2.0% 
3 
0.6% 
1 
0.0% 
0 
Turkeys 27.3% 
3 
0.0% 
0 
45.9% 
17  
33.3% 
6 
53.3% 
8 
11.1% 
1 
16.7% 
1 
14.3% 
2 
Cattle 0.0% 
0 
3.0% 
1 
6.3% 
12 
11.8% 
22 
10.3% 
9 
11.2% 
11 
12.8% 
10 
20.8% 
10 
Swine 0.0% 
0 
0.0% 
0 
1.8% 
2 
0.0% 
0 
0.0% 
0 
4.2% 
2 
0.0% 
0 
0.0% 
0 
5. At Least Ceftiofur and 
Humans 0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0 
0.3% 
1 
0.3% 
1 
0.5% 
2 
0.0% 
0 
0.3%
1
 Nalidixic Acid Resistant 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
50.0% 
1 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.6% 
1 
0.7% 
1 
0.0% 
0 
2.7% 
4 
0.0% 
0 
0.0% 
0 
Turkeys 18.2% 
2 
0.0% 
0 
48.6% 
18  
33.3% 
6 
53.3% 
8 
22.2% 
2 
16.7% 
1 
14.3% 
2 
Cattle 0.0% 
0 
0.0% 
0 
0.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
4.2% 
2 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
0.0% 
0 
0.0% 
0
 1 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur
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F. Antimicrobial Susceptibility among Salmonella  Enteritidis 
MIC Distributions 
Table 22a. Distribution of MICs and Occurrence of Resistance among Salmonella Enteritidis Isolates from Humans, Retail Meats, and Food Animals, 2004 
Isolate Source
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1  2  4  8  16  32  64  128  256  512  1024
 Aminoglycosides
 Amikacin  Humans (271) 0.0 0.0 [0.0 - 1.4] 23.6 64.9 9.2 2.2
 Chicken Breasts (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (84) 0.0 0.0 [0.0 - 4.3] 45.2 51.2 3.6
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Gentamicin  Humans (271) 0.0 0.4 [0.0 - 2.0] 85.2 12.9 1.1 0.4 0.4
 Chicken Breasts (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (84) 0.0 1.2 [0.0 - 6.5] 89.3 9.5 1.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Kanamycin  Humans (271) 0.0 0.7 [0.1 - 2.6] 99.3 0.7
 Chicken Breasts (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (84) 0.0 0.0 [0.0 - 4.3] 100.0
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Streptomycin  Humans (271) N/A 2.2 [0.8 - 4.8] 97.8 1.5 0.7
 Chicken Breasts (3) N/A 0.0 [0.0 - 70.8] 100.0
 Chickens (84) N/A 1.2 [0.0 - 6.5] 98.8 1.2
 Cattle (2) N/A 0.0 [0.0 - 84.2] 100.0
 Swine (1) N/A 0.0 [0.0 - 97.5] 100.0
 Aminopenicillins
 Ampicillin  Humans (271) 0.0 4.1 [2.0 - 7.1] 57.2 38.4 0.4 0.4 3.7
 Chicken Breasts (3) 0.0 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (84) 0.0 1.2 [0.0 - 6.5] 81.0 15.5 2.4 1.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0 
Distribution (%) of MICs (µg/ml)5 
1 There were no Salmonella Enteritidis isolates from ground turkey, ground beef, pork chops, and turkeys 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
resistance. Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the 
percentages of isolates with MICs equal to or less than the lowest tested concentration 
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Table 22b. Distribution of MICs and Occurrence of Resistance among Salmonella Enteritidis Isolates from Humans, Retail Meats, and Food Animals, 2004 
Isolate Source
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1  2  4  8  16  32  64  128  256  512  1024 
β-Lactam/β-Lactamase
 Inhibitor Combinations
 Amoxicillin-Clavulanic Acid  Humans (271) 1.5 0.0 [0.0 - 1.4] 91.9 4.4 0.7 1.5 1.5
 Chicken Breasts (3) 0.0 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (84) 0.0 1.2 [0.0 - 6.5] 97.6 1.2 1.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Cephalosporins
 Ceftiofur  Humans (271) 0.4 0.0 [0.0 - 1.4] 1.1 0.7 66.1 31.7 0.4
 Chicken Breasts (3) 0.0 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (84) 1.2 1.2 [0.0 - 6.5] 82.1 15.5 1.2 1.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Ceftriaxone  Humans (271) 0.0 0.0 [0.0 - 1.4] 99.6 0.4
 Chicken Breasts (3) 0.0 0.0 [0.0 - 70.8] 66.7 33.3
 Chickens (84) 0.0 0.0 [0.0 - 4.3] 97.6 1.2 1.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Cephamycins
 Cefoxitin  Humans (271) 0.0 0.0 [0.0 - 1.4] 0.4 23.2 69.4 5.9 1.1
 Chicken Breasts (3) 0.0 33.3 [0.8 - 90.6] 33.3 33.3 33.3
 Chickens (84) 0.0 1.2 [0.0 - 6.5] 8.3 85.7 3.6 1.2 1.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Folate Pathway Inhibitors
 Sulfisoxazole  Humans (271) N/A 1.8 [0.6 - 4.3] 15.9 77.1 4.8 0.4 1.8
 Chicken Breasts (3) N/A 33.3 [0.8 - 90.6] 33.3 33.3 33.3
 Chickens (84) N/A 1.2 [0.0 - 6.5] 26.2 66.7 6.0 1.2
 Cattle (2) N/A 0.0 [0.0 - 84.2] 100.0
 Swine (1) N/A 0.0 [0.0 - 97.5] 100.0 
Distribution (%) of MICs (µg/ml)5 
1 There were no Salmonella Enteritidis isolates from ground turkey, ground beef, pork chops, and turkeys 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
resistance. Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the 
percentages of isolates with MICs equal to or less than the lowest tested concentration 
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Table 22c. Distribution of MICs and Occurrence of Resistance among Salmonella Enteritidis Isolates from Humans, Retail Meats, and Food Animals, 2004 
Isolate Source
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1  2  4  8  16  32  64  128  256  512  1024
 Trimethoprim-Sulfamethoxazole  Humans (271) N/A 0.0 [0.0 - 1.4] 81.2 18.1 0.7
 Chicken Breasts (3) N/A 0.0 [0.0 - 70.8] 100.0
 Chickens (84) N/A 0.0 [0.0 - 4.3] 90.5 9.5
 Cattle (2) N/A 0.0 [0.0 - 84.2] 100.0
 Swine (1) N/A 0.0 [0.0 - 97.5] 100.0
 Phenicols
 Chloramphenicol  Humans (271) 0.4 0.4 [0.0 - 2.0] 1.8 51.3 46.1 0.4 0.4
 Chicken Breasts (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (84) 0.0 0.0 [0.0 - 4.3] 29.8 70.2
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 50.0 50.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Quinolones
 Ciprofloxacin  Humans (271) 0.4 0.0 [0.0 - 1.4] 93.0 0.4 3.3 3.0 0.4
 Chicken Breasts (3) 0.0 0.0 [0.0 - 70.8] 33.3 66.7
 Chickens (84) 0.0 0.0 [0.0 - 4.3] 92.9 7.1
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Nalidixic Acid  Humans (271) N/A 6.6 [4.0 - 10.3] 0.4 0.4 11.1 80.4 1.1 0.4 6.3
 Chicken Breasts (3) N/A 0.0 [0.0 - 70.8] 100.0
 Chickens (84) N/A 0.0 [0.0 - 4.3] 92.9 7.1
 Cattle (2) N/A 0.0 [0.0 - 84.2] 50.0 50.0
 Swine (1) N/A 0.0 [0.0 - 97.5] 100.0
 Tetracyclines
 Tetracycline  Humans (271) 1.1 3.3 [1.5 - 6.2] 95.6 1.1 0.4 3.0
 Chicken Breasts (3) 0.0 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (84) 1.2 2.4 [0.3 - 8.3] 96.4 1.2 2.4
 Cattle (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Swine (1) 0.0 0.0 [0.0 - 97.5] 100.0 
Distribution (%) of MICs (µg/ml)5 
1 There were no Salmonella Enteritidis isolates from ground turkey, ground beef, pork chops, and turkeys 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
resistance. Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the 
percentages of isolates with MICs equal to or less than the lowest tested concentration 
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Resistance by Year
Table 23a. Antimicrobial Resistance among Salmonella  Enteritidis Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 351 301 244 269 319 277 337 257 271
 Chicken Breasts 4 3 3
 Ground Turkey 
Ground Beef 
5 
1 
1 
1 
0
0
 Pork Chops 0 0 0
 Chickens 1 13 41 31 21 48 42 84
 Turkeys 
Cattle 
0 
1 
0 
1 
1 
8 
1 
4 
0 
4 
0 
6 
0 
3 
0
2
 Swine 0 0 2 1 1 1 1 1
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Aminoglycosides  Amikacin 
(MIC ≥ 64 µg/ml) Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Gentamicin 
(MIC ≥ 16 µg/ml) 
Humans 4.8% 
17  
0.3% 
1 
0.4% 
1 
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.3% 
1 
0.4% 
1 
0.4%
1 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.2% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Kanamycin 
(MIC ≥ 64 µg/ml) 
Humans 0.0% 
0 
0.7% 
2 
0.4% 
1 
0.4% 
1 
0.3% 
1 
0.7% 
2 
0.3% 
1 
0.0% 
0 
0.7%
2 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
12.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
100.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Streptomycin 
(MIC ≥ 64 µg/ml) 
Humans 2.0% 
7 
4.3% 
13  
1.6% 
4 
2.2% 
6 
0.0% 
0 
1.4% 
4 
1.8% 
6 
1.2% 
3 
2.2%
6 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
0.0% 
0 
1.2% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
12.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
100.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
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Table 23b. Antimicrobial Resistance among Salmonella  Enteritidis Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 351 301 244 269 319 277 337 257 271
 Chicken Breasts 4 3 3
 Ground Turkey 
Ground Beef 
5 
1 
1 
1 
0
0
 Pork Chops 0 0 0
 Chickens 1 13 41 31 21 48 42 84
 Turkeys 
Cattle 
0 
1 
0 
1 
1 
8 
1 
4 
0 
4 
0 
6 
0 
3 
0
2
 Swine 0 0 2 1 1 1 1 1
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Aminopenicillins  Ampicillin 
(MIC ≥ 32 µg/ml) Humans 
20.5% 
72 
11.3% 
34 
6.1% 
15 
10.8% 
29 
7.5% 
24 
8.7% 
24 
7.1% 
24 
2.3% 
6 
4.1%
11 
Chicken Breasts 0.0% 
0 
66.7% 
2 
33.3% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 100.0% 
1 
30.8% 
4 
12.2% 
5 
9.7% 
3 
0.0% 
0 
4.2% 
2 
0.0% 
0 
1.2% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
100.0% 
1 
12.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
100.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
β-Lactam/β-Lactamase 
Inhibitor Combinations
 Amoxicillin-
Clavulanic Acid 
(MIC ≥ 32 / 16 µg/ml) 
Humans 0.6% 
2 
0.0% 
0 
0.0% 
0 
0.4% 
1 
0.0% 
0 
1.4% 
4 
0.6% 
2 
0.0% 
0 
0.0%
0
 Chicken Breasts 0.0% 
0 
33.3% 
1 
33.3% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
2.4% 
1 
3.2% 
1 
0.0% 
0 
4.2% 
2 
0.0% 
0 
1.2% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Cephalosporins  Ceftiofur 
(MIC ≥ 8 µg/ml) 
Humans 0.0% 
0 
0.3% 
1 
0.0% 
0 
0.4% 
1 
0.0% 
0 
2.2% 
6 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
33.3% 
1 
33.3% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
4.9% 
2 
3.2% 
1 
0.0% 
0 
4.2% 
2 
0.0% 
0 
1.2% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Ceftriaxone 
(MIC ≥ 64 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
2.1% 
1 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
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Table 23c. Antimicrobial Resistance among Salmonella  Enteritidis Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 351 301 244 269 319 277 337 257 271
 Chicken Breasts 4 3 3
 Ground Turkey 
Ground Beef 
5 
1 
1 
1 
0
0
 Pork Chops 0 0 0
 Chickens 1 13 41 31 21 48 42 84
 Turkeys 
Cattle 
0 
1 
0 
1 
1 
8 
1 
4 
0 
4 
0 
6 
0 
3 
0
2
 Swine 0 0 2 1 1 1 1 1
 Antimicrobial Class
 Antimicrobial
 (Resistance 
Breakpoint)
 Isolate
 Source
 Cephalosporins  Cephalothin 
(MIC ≥ 32 µg/ml) Humans
4.0% 
14  
1.3% 
4 
0.0% 
0 
1.9% 
5 
0.9% 
3 
1.1% 
3 
0.6% 
2 
1.2%
3 
Chicken Breasts 0.0% 
0 
66.7% 
2 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 7.7% 
1 
4.9% 
2 
0.0% 
0 
0.0% 
0 
4.2% 
2 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Cephamycins  Cefoxitin 
(MIC ≥ 32 µg/ml) 
Humans 0.0% 
0 
0.4% 
1 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
33.3% 
1 
33.3% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
2.1% 
1 
0.0% 
0 
1.2% 
1 
Turkeys 0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Folate Pathway Inhibitors  Sulfamethoxazole/ 
Sulfisoxazole1 
(MIC ≥ 512 µg/ml) 
Humans 8.5% 
30  
9.0% 
27  
2.0% 
5 
3.0% 
8 
0.9% 
3 
2.2% 
6 
1.8% 
6 
1.2% 
3 
1.8%
5
 Chicken Breasts 0.0% 
0 
0.0% 
0 
33.3% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
4.9% 
2 
3.2% 
1 
0.0% 
0 
4.2% 
2 
2.4% 
1 
1.2% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Trimethoprim-
Sulfamethoxazole 
(MIC ≥ 4 / 76 µg/ml) 
Humans 6.6% 
23  
1.3% 
4 
0.8% 
2 
0.7% 
2 
0.0% 
0 
0.7% 
2 
0.6% 
2 
0.8% 
2 
0.0%
0
 Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1 Sulfamethoxazole was tested from 1996 to 2003 and was replaced by sulfisoxazole in 2004 
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Table 23d. Antimicrobial Resistance among Salmonella  Enteritidis Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 351 301 244 269 319 277 337 257 271
 Chicken Breasts 4 3 3
 Ground Turkey 
Ground Beef 
5 
1 
1 
1 
0
0
 Pork Chops 0 0 0
 Chickens 1 13 41 31 21 48 42 84
 Turkeys 
Cattle 
0 
1 
0 
1 
1 
8 
1 
4 
0 
4 
0 
6 
0 
3 
0
2
 Swine 0 0 2 1 1 1 1 1
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans 
0.0% 
0 
0.7% 
2 
0.0% 
0 
0.4% 
1 
0.0% 
0 
0.0% 
0 
0.6% 
2 
0.4% 
1 
0.4%
1 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Nalidixic Acid 
(MIC ≥ 32 µg/ml) 
Humans 0.9% 
3 
1.7% 
5 
2.0% 
5 
2.2% 
6 
2.2% 
7 
4.3% 
12  
3.9% 
13  
4.7% 
12  
6.6%
18 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Tetracyclines  Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 16.8% 
59 
9.6% 
29 
6.6% 
16 
8.2% 
22 
1.9% 
6 
1.8% 
5 
4.5% 
15 
1.6% 
4 
3.3%
9 
Chicken Breasts 0.0% 
0 
0.0% 
0 
33.3% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
7.3% 
3 
0.0% 
0 
0.0% 
0 
2.1% 
1 
2.4% 
1 
2.4% 
2 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
100.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
100.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0
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Multidrug Resistance
Table 24a. Resistance Patterns among Salmonella  Enteritidis Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 351 301 244 269 319 277 337 257 271
 Chicken Breasts 4 3 3
 Ground Turkey 
Ground Beef 
5 
1 
1 
1 
0
0
 Pork Chops 0 0 0
 Chickens 1 13 41 31 21 48 42 84
 Turkeys 
Cattle 
0 
1 
0 
1 
1 
8 
1 
4 
0 
4 
0 
6 
0 
3 
0
2
 Swine 0 0 2 1 1 1 1 1
 Resistance Pattern  Isolate Source 
1. No Resistance Detected 
Humans
73.5% 
258 
77.4% 
233 
87.7% 
214 
83.6% 
225 
89.0% 
284 
86.6% 
240 
87.2% 
294 
91.8% 
236 
87.1%
236 
Chicken Breasts 100.0% 
4 
33.3% 
1 
66.7% 
2 
Ground Turkey 100.0% 
5 
100.0% 
1 
Ground Beef 100.0% 
1 
100.0% 
1 
Pork Chops
 Chickens 0.0% 
0 
69.2% 
9 
82.9% 
34 
90.3% 
28 
100.0% 
21 
95.8% 
46 
97.6% 
41 
97.6% 
82 
Turkeys 100.0% 
1 
100.0% 
1 
Cattle 100.0% 
1 
0.0% 
0 
87.5% 
7 
100.0% 
4 
100.0% 
4 
100.0% 
6 
100.0% 
3 
100.0% 
2 
Swine 0.0% 
0 
0.0% 
0 
100.0% 
2 
100.0% 
1 
0.0% 
0 
100.0% 
1 
100.0% 
1 
100.0% 
1 
2. At Least ACSSuT1 Resistant 
Humans
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.4% 
1 
0.0% 
0 
0.0% 
0 
0.3% 
1 
0.4% 
1 
0.4%
1 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
3. At Least ACT/S2 Resistant 
Humans
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.4% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.4% 
1 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline
 2 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole 
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Table 24b. Resistance Patterns among Salmonella Enteritidis Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 351 301 244 269 319 277 337 257 271
 Chicken Breasts 4 3 3
 Ground Turkey 
Ground Beef 
5 
1 
1 
1 
0
0
 Pork Chops 0 0 0
 Chickens 1 13 41 31 21 48 42 84
 Turkeys 
Cattle 
0 
1 
0 
1 
1 
8 
1 
4 
0 
4 
0 
6 
0 
3 
0
2
 Swine 0 0 2 1 1 1 1 1
 Resistance Pattern  Isolate Source 
4. At Least ACSSuTAuCf 1 
Humans 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.4% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0
 Resistant Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
5. At Least Ceftiofur and 
Humans 0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0
 Nalidixic Acid Resistant Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
Pork Chops
 Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 1 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur 
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G. Antimicrobial Susceptibility among Salmonella  Newport 
MIC Distributions 
Table 25a. Distribution of MICs and Occurrence of Resistance among Salmonella  Newport Isolates from Humans, Retail Meats, and Food Animals, 2004 
Isolate Source
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminoglycosides
 Amikacin  Humans (191) 0.0 0.0 [0.0 - 1.9] 6.8 71.7 17.8 3.1 0.5
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Turkeys (7) 0.0 0.0 [0.0 - 43.9] 71.4 28.6
 Cattle (44) 0.0 0.0 [0.0 - 10.0] 31.8 56.8 11.4
 Gentamicin  Humans (191) 0.0 0.5 [0.0 - 2.9] 78.5 19.4 1.6 0.5
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Turkeys (7) 0.0 14.3 [0.8 - 58.0] 57.1 28.6 14.3
 Cattle (44) 2.3 0.0 [0.0 - 10.0] 72.7 25.0 2.3
 Kanamycin  Humans (191) 0.0 2.6 [0.9 - 6.0] 97.4 2.6
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Turkeys (7) 0.0 14.3 [0.8 - 58.0] 85.7 14.3
 Cattle (44) 0.0 25.0 [13.7 - 40.6] 75.0 25.0
 Streptomycin  Humans (191) N/A 15.7 [10.9 - 21.7] 84.3 15.7
 Ground Turkey (2) N/A 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) N/A 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) N/A 14.3 [0.8 - 58.0] 85.7 14.3
 Cattle (44) N/A 84.1 [69.3 - 92.8] 15.9 2.3 81.8
 Aminopenicillins
 Ampicillin  Humans (191) 0.0 15.7 [10.9 - 21.7] 57.6 25.7 1.0 15.7
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) 0.0 28.6 [5.1 - 69.8] 42.9 28.6 28.6
 Cattle (44) 0.0 81.8 [66.7 - 91.3] 18.2 81.8 
Distribution (%) of MICs (µg/ml)5 
1 There were no Salmonella Newport isolates from chicken breasts, pork chops, chickens, and swine 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
resistance. Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the 
percentages of isolates with MICs equal to or less than the lowest tested concentration 
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Table 25b. Distribution of MICs and Occurrence of Resistance among Salmonella Newport Isolates from Humans, Retail Meats, and Food Animals, 2004 
Isolate Source
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024 
β-Lactam/β-Lactamase
 Inhibitor Combinations
 Amoxicillin-Clavulanic Acid  Humans (191) 0.0 15.2 [10.4 - 21.1] 81.1 2.1 0.5 1.0 3.7 11.5
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) 0.0 14.3 [0.8 - 58.0] 71.4 14.3 14.3
 Cattle (44) 2.3 77.3 [61.8 - 88.0] 18.2 2.3 2.3 2.3 75.0
 Cephalosporins
 Ceftiofur  Humans (191) 0.0 15.2 [10.5 - 21.1] 0.5 0.5 73.8 9.9 0.5 14.7
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) 0.0 14.3 [0.8 - 58.0] 85.7 14.3
 Cattle (44) 0.0 77.3 [61.8 - 88.0] 20.5 2.3 77.3
 Ceftriaxone  Humans (191) 12.1 2.6 [0.9 - 6.0] 84.3 1.0 4.7 7.3 2.1 0.5
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 50.0 50.0 [1.3 - 98.7] 50.0 50.0
 Turkeys (7) 14.3 0.0 [0.0 - 84.2] 85.7 14.3
 Cattle (44) 63.6 11.4 [4.3 - 25.4] 22.7 2.3 27.3 36.4 9.1 2.3
 Cephamycins
 Cefoxitin  Humans (191) 0.0 15.2 [10.4 - 21.1] 23.6 56.0 3.7 1.6 3.1 12.0
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) 0.0 14.3 [0.8 - 58.0] 14.3 71.4 14.3
 Cattle (44) 0.0 77.3 [61.8 - 88.0] 9.1 13.6 22.7 54.5
 Folate Pathway Inhibitors
 Sulfisoxazole  Humans (191) N/A 16.8 [11.8 - 22.8] 5.8 41.9 35.1 0.5 16.8
 Ground Turkey (2) N/A 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) N/A 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) N/A 14.3 [0.8 - 58.0] 28.6 57.1 14.3
 Cattle (44) N/A 84.1 [69.3 - 92.8] 4.5 9.1 2.3 84.1 
Distribution (%) of MICs (µg/ml)5 
1 There were no Salmonella Newport isolates from chicken breasts, pork chops, chickens, and swine 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
resistance. Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the 
percentages of isolates with MICs equal to or less than the lowest tested concentration 
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Table 25c. Distribution of MICs and Occurrence of Resistance among Salmonella Newport Isolates from Humans, Retail Meats, and Food Animals, 2004 
Antimicrobial
 Isolate Source
 (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
Distribution (%) of MICs (µg/ml)5 
Trimethoprim-Sulfamethoxazole
 Humans (191) N/A 2.1 [0.6 - 5.3] 73.3 23.0 0.5 0.5 0.5 2.1
 Ground Turkey (2) N/A 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) N/A 50.0 [1.3 - 98.7] 50.0 50.0
 Turkeys (7) N/A 14.3 [0.8 - 58.0] 28.6 42.9 14.3 14.3
 Cattle (44) N/A 2.3 [0.1 - 13.5] 40.9 50.0 6.8 2.3
 Phenicols
 Chloramphenicol  Humans (191) 0.0 15.2 [10.5 - 21.1] 2.1 54.5 28.3 15.2
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 100.0 [15.8 - 100.0] 100.0
 Turkeys (7) 0.0 14.3 [0.8 - 58.0] 57.1 28.6 14.3
 Cattle (44) 0.0 77.3 [61.8 - 88.0] 20.5 2.3 77.3
 Quinolones
 Ciprofloxacin  Humans (191) 0.0 0.0 [0.0 - 1.9] 98.4 1.0 0.5
 Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) 0.0 0.0 [0.0 - 84.2] 100.0
 Turkeys (7) 0.0 0.0 [0.0 - 43.9] 100.0
 Cattle (44) 0.0 0.0 [0.0 - 10.0] 97.7 2.3
 Nalidixic Acid  Humans (191) N/A 0.5 [0.0 - 2.9] 1.0 34.6 62.3 1.6 0.5
 Ground Turkey (2) N/A 0.0 [0.0 - 84.2] 100.0
 Ground Beef (2) N/A 0.0 [0.0 - 84.2] 50.0 50.0
 Turkeys (7) N/A 0.0 [0.0 - 43.9] 14.3 85.7
 Cattle (44) N/A 0.0 [0.0 - 10.0] 15.9 84.1
 Tetracyclines
 Tetracycline  Humans (191) 0.0 16.8 [11.8 - 22.8] 
Ground Turkey (2) 0.0 0.0 [0.0 - 84.2] 
Ground Beef (2) 0.0 100.0 [15.8 - 100.0] 
Turkeys (7) 0.0 28.6 [5.1 - 69.8] 
Cattle (44) 0.0 84.1 [69.3 - 92.8] 
83.2 
100.0
71.4 
15.9 
4.2 
9.1 
12.6
100.0
28.6
75.0 
1 There were no Salmonella Newport isolates from chicken breasts, pork chops, chickens, and swine 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
resistance. Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the 
percentages of isolates with MICs equal to or less than the lowest tested concentration 
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Resistance by Year 
Table 26a. Antimicrobial Resistance among Salmonella  Newport Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0
 Ground Turkey 
Ground Beef 
3 
3 
2 
1 
2
2
 Pork Chops 2 1 0
 Chickens 0 1 7 5 8 6 7 0
 Turkeys 
Cattle 
0 
0 
1 
8 
4 
54 
6 
109 
16  
87 
10  
113 
19  
75 
7
44
 Swine 0 1 5 2 7 0 3 0
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Aminoglycosides  Amikacin 
(MIC ≥ 64) Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts
 Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Gentamicin 
(MIC ≥ 16) 
Humans 5.9% 
3 
4.3% 
2 
0.0% 
0 
0.0% 
0 
2.5% 
3 
3.2% 
4 
3.3% 
8 
3.1% 
7 
0.5%
1 
Chicken Breasts
 Ground Turkey 0.0% 
0 
50.0% 
1 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 100.0% 
1 
0.0% 
0 
20.0% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
16.7% 
1 
6.3% 
1 
0.0% 
0 
52.6% 
10  
14.3% 
1 
Cattle 0.0% 
0 
1.9% 
1 
11.0% 
12 
6.9% 
6 
7.1% 
8 
1.3% 
1 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Kanamycin 
(MIC ≥ 64) 
Humans 2.0% 
1 
0.0% 
0 
1.3% 
1 
1.0% 
1 
5.0% 
6 
7.3% 
9 
9.6% 
23  
4.5% 
10  
2.6%
5 
Chicken Breasts
 Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
10.0% 
1 
21.1% 
4 
14.3% 
1 
Cattle 0.0% 
0 
0.0% 
0 
9.2% 
10 
6.9% 
6 
15.9% 
18 
17.3% 
13 
25.0% 
11 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
57.1% 
4 
0.0% 
0
 Streptomycin 
(MIC ≥ 64) 
Humans 7.8% 
4 
4.3% 
2 
2.6% 
2 
19.2% 
19 
24.0% 
29 
31.5% 
39 
24.7% 
59 
24.2% 
54 
15.7%
30 
Chicken Breasts
 Ground Turkey 33.3% 
1 
50.0% 
1 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 100.0% 
1 
0.0% 
0 
20.0% 
1 
37.5% 
3 
0.0% 
0 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
16.7% 
1 
12.5% 
2 
0.0% 
0 
31.6% 
6 
14.3% 
1 
Cattle 12.5% 
1 
37.0% 
20  
79.8% 
87  
73.6% 
64  
80.5% 
91  
84.0% 
63  
84.1% 
37 
Swine 0.0% 
0 
0.0% 
0 
50.0% 
1 
85.7% 
6 
100.0% 
3 
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Table 26b. Antimicrobial Resistance among Salmonella  Newport Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0
 Ground Turkey 
Ground Beef 
3 
3 
2 
1 
2
2
 Pork Chops 2 1 0
 Chickens 0 1 7 5 8 6 7 0
 Turkeys 
Cattle 
0 
0 
1 
8 
4 
54 
6 
109 
16  
87 
10  
113 
19  
75 
7
44
 Swine 0 1 5 2 7 0 3 0
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Aminopenicillins  Ampicillin 
(MIC ≥ 32 µg/ml) Humans 
5.9% 
3 
6.5% 
3 
2.6% 
2 
18.2% 
18 
23.1% 
28 
29.8% 
37 
24.3% 
58 
22.9% 
51 
15.7%
30 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 100.0% 
1 
0.0% 
0 
0.0% 
0 
37.5% 
3 
16.7% 
1 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
15.8% 
3 
28.6% 
2 
Cattle 12.5% 
1 
37.0% 
20  
77.1% 
84  
70.1% 
61  
78.8% 
89  
82.7% 
62  
81.8% 
36 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
85.7% 
6 
100.0% 
3 
β-Lactam/β-Lactamase 
Inhibitor Combinations
 Amoxicillin-
Clavulanic Acid 
(MIC ≥ 32 / 16 µg/ml) 
Humans 2.0% 
1 
0.0% 
0 
2.6% 
2 
18.2% 
18 
22.3% 
27 
26.6% 
33 
22.2% 
53 
21.5% 
48 
15.2%
29
 Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
10.5% 
2 
14.3% 
1 
Cattle 12.5% 
1 
37.0% 
20  
76.1% 
83  
69.0% 
60  
78.8% 
89  
81.3% 
61  
77.3% 
34 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
85.7% 
6 
100.0% 
3
 Cephalosporins  Ceftiofur 
(MIC ≥ 8 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
1.3% 
1 
18.2% 
18 
22.3% 
27 
27.4% 
34 
22.2% 
53 
22.0% 
49 
15.2%
29 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
10.5% 
2 
14.3% 
1 
Cattle 12.5% 
1 
37.0% 
20  
76.1% 
83  
69.0% 
60  
78.8% 
89  
81.3% 
61  
77.3% 
34 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
85.7% 
6 
100.0% 
3
 Ceftriaxone 
(MIC ≥ 64 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
3.0% 
3 
0.0% 
0 
0.0% 
0 
0.8% 
2 
1.8% 
4 
2.6%
5 
Chicken Breasts
 Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
50.0% 
1 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.9% 
1 
1.1% 
1 
0.9% 
1 
1.3% 
1 
11.4% 
5 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
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Table 26c. Antimicrobial Resistance among Salmonella  Newport Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0 0
 Ground Turkey 
Ground Beef 
0 
0 
3 
3 
2 
1 
2
2
 Pork Chops 0 2 1 0
 Chickens 0 1 7 5 8 6 7 0
 Turkeys 
Cattle 
0 
0 
1 
8 
4 
54 
6 
109 
16  
87 
10  
113 
19  
75 
7
44
 Swine 0 1 5 2 7 0 3 0
 Antimicrobial Class
 Antimicrobial
 (Resistance 
Breakpoint)
 Isolate
 Source
 Cephalosporins  Cephalothin 
(MIC ≥ 32 µg/ml) Humans
3.9% 
2 
4.3% 
2 
2.6% 
2 
18.2% 
18 
22.3% 
27 
26.6% 
33 
22.2% 
53 
22.4%
50 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
10.5% 
2 
Cattle 12.5% 
1 
37.0% 
20  
74.3% 
81  
69.0% 
60  
78.8% 
89  
81.3% 
61  
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
85.7% 
6 
100.0% 
3
 Cephamycins  Cefoxitin 
(MIC ≥ 32 µg/ml) 
Humans 22.3% 
27 
25.8% 
32 
22.2% 
53 
21.5% 
48 
15.2%
29 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
37.5% 
3 
0.0% 
0 
71.4% 
5 
Turkeys 0.0% 
0 
12.5% 
2 
0.0% 
0 
10.5% 
2 
14.3% 
1 
Cattle 73.4% 
80 
66.7% 
58 
77.9% 
88 
74.7% 
56 
77.3% 
34 
Swine 0.0% 
0 
85.7% 
6 
100.0% 
3
 Folate Pathway Inhibitors  Sulfamethoxazole/ 
Sulfisoxazole1 
(MIC ≥ 512 µg/ml) 
Humans 11.8% 
6 
4.3% 
2 
3.9% 
3 
22.2% 
22 
23.1% 
28 
32.3% 
40 
25.1% 
60 
24.7% 
55 
16.8%
32
 Chicken Breasts
 Ground Turkey 33.3% 
1 
50.0% 
1 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 100.0% 
1 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
71.4% 
5 
Turkeys 0.0% 
0 
0.0% 
0 
16.7% 
1 
12.5% 
2 
0.0% 
0 
52.6% 
10  
14.3% 
1 
Cattle 12.5% 
1 
35.2% 
19  
73.4% 
80  
72.4% 
63  
74.3% 
84  
73.3% 
55  
84.1% 
37 
Swine 0.0% 
0 
0.0% 
0 
50.0% 
1 
85.7% 
6 
100.0% 
3
 Trimethoprim-
Sulfamethoxazole 
(MIC ≥ 4 / 76 µg/ml) 
Humans 3.9% 
2 
4.3% 
2 
1.3% 
1 
2.0% 
2 
4.1% 
5 
1.6% 
2 
4.2% 
10  
0.9% 
2 
2.1%
4
 Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
50.0% 
1 
Pork Chops 100.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
14.3% 
1 
Cattle 0.0% 
0 
1.9% 
1 
14.7% 
16 
12.6% 
11 
7.1% 
8 
0.0% 
0 
2.3% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
33.3% 
1 
1 Sulfamethoxazole was tested from 1996 to 2003 and was replaced by sulfisoxazole in 2004 
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Table 26d. Antimicrobial Resistance among Salmonella  Newport Isolates from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0
 Ground Turkey 
Ground Beef 
3 
3 
2 
1 
2
2
 Pork Chops 2 1 0
 Chickens 0 1 7 5 8 6 7 0
 Turkeys 
Cattle 
0 
0 
1 
8 
4 
54 
6 
109 
16  
87 
10  
113 
19  
75 
7
44
 Swine 0 1 5 2 7 0 3 0
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans 
5.9% 
3 
4.3% 
2 
2.6% 
2 
18.2% 
18 
23.1% 
28 
28.2% 
35 
24.7% 
59 
22.4% 
50 
15.2%
29 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
21.1% 
4 
14.3% 
1 
Cattle 12.5% 
1 
37.0% 
20  
78.9% 
86  
73.6% 
64  
77.9% 
88  
78.7% 
59  
77.3% 
34 
Swine 0.0% 
0 
0.0% 
0 
50.0% 
1 
85.7% 
6 
100.0% 
3
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts
 Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Nalidixic Acid 
(MIC ≥ 32 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.8% 
1 
0.0% 
0 
0.8% 
2 
0.4% 
1 
0.5%
1 
Chicken Breasts
 Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.3% 
1 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Tetracyclines Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 7.8% 
4 
4.3% 
2 
2.6% 
2 
19.2% 
19 
23.1% 
28 
30.6% 
38 
25.1% 
60 
24.2% 
54 
16.8%
32 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 100.0% 
1 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
85.7% 
6 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
40.0% 
4 
36.8% 
7 
28.6% 
2 
Cattle 12.5% 
1 
38.9% 
21  
80.7% 
88  
73.6% 
64  
80.5% 
91  
84.0% 
63  
84.1% 
37 
Swine 100.0% 
1 
20.0% 
1 
50.0% 
1 
85.7% 
6 
100.0% 
3
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Ceftiofur Resistance 
Figure 13. Percent of Salmonella  Newport Isolates from Humans, Turkeys, and Cattle1 
Resistant to Ceftiofur, by Year, 1996-2004 
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1 Data for other sources are not included due to the small number of Salmonella  Newport isolates. 
Table 26 contains resistance data for Salmonella  Newport isolates from each source, by year 
Table 27. Number of Salmonella  Newport Isolates Tested from Humans, Retail Meats, and Food 
Animals, by Year, 1996-2004 
1996 1997 1998 1999 2000 2001 2002 2003 2004
 Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0
 Ground Turkey 3 2 2
 Ground Beef 3 1 2
 Pork Chops 2 1 0
 Chickens 1 7 5 8 6 7 0
 Turkeys 1 4 6 16 10 19 7
 Cattle 8 54 109 87 113 75 44
 Swine 1 5 2 7 0 3 0 
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Multidrug Resistance
Table 28a. Resistance Patterns among Salmonella  Newport Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0
 Ground Turkey 
Ground Beef 
3 
3 
2 
1 
2
2
 Pork Chops 2 1 0
 Chickens 0 1 7 5 8 6 7 0
 Turkeys 
Cattle 
0 
0 
1 
8 
4 
54 
6 
109 
16  
87 
10  
113 
19  
75 
7
44
 Swine 0 1 5 2 7 0 3 0
 Resistance Pattern  Isolate Source 
1. No Resistance Detected 
Humans
86.3% 
44 
93.5% 
43 
94.8% 
73 
75.8% 
75 
75.2% 
91 
65.3% 
81 
72.8% 
174 
73.5% 
164 
82.2%
157 
Chicken Breasts
 Ground Turkey 66.7% 
2 
50.0% 
1 
100.0% 
2 
Ground Beef 33.3% 
1 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
100.0% 
7 
80.0% 
4 
62.5% 
5 
83.3% 
5 
14.3% 
1 
Turkeys 0.0% 
0 
100.0% 
1 
100.0% 
4 
83.3% 
5 
87.5% 
14  
60.0% 
6 
21.1% 
4 
57.1% 
4 
Cattle 0.0% 
0 
87.5% 
7 
61.1% 
33 
19.3% 
21 
25.3% 
22 
19.5% 
22 
14.7% 
11 
15.9% 
7 
Swine 0.0% 
0 
0.0% 
0 
80.0% 
4 
50.0% 
1 
14.3% 
1 
0.0% 
0 
2. At Least ACSSuT1 Resistant 
Humans 5.9% 
3 
4.3% 
2 
1.3% 
1 
18.2% 
18 
23.1% 
28 
25.8% 
32 
23.0% 
55 
22.0% 
49 
14.7%
28 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
71.4% 
5 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
5.3% 
1 
14.3% 
1 
Cattle 0.0% 
0 
12.5% 
1 
35.2% 
19 
70.6% 
77 
67.8% 
59 
70.8% 
80 
66.7% 
50 
75.0% 
33 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
85.7% 
6 
100.0% 
3 
3. At Least ACT/S2 Resistant 
Humans 3.9% 
2 
4.3% 
2 
1.3% 
1 
2.0% 
2 
4.1% 
5 
0.8% 
1 
3.8% 
9 
0.9% 
2 
1.0%
2 
Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
50.0% 
1 
Pork Chops 100.0% 
2 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
14.3% 
1 
Cattle 0.0% 
0 
0.0% 
0 
1.9% 
1 
13.8% 
15  
11.5% 
10  
7.1% 
8 
0.0% 
0 
2.3% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
33.3% 
1
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline
 2 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole 
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Table 28b. Resistance Patterns among Salmonella  Newport Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 51 46 77 99 121 124 239 223 191
 Chicken Breasts 0 0 0
 Ground Turkey 
Ground Beef 
3 
3 
2 
1 
2
2
 Pork Chops 2 1 0
 Chickens 0 1 7 5 8 6 7 0
 Turkeys 
Cattle 
0 
0 
1 
8 
4 
54 
6 
109 
16  
87 
10  
113 
19  
75 
7
44
 Swine 0 1 5 2 7 0 3 0
 Resistance Pattern  Isolate Source 
4. At Least ACSSuTAuCf 1 
Humans 
0.0% 
0 
0.0% 
0 
1.3% 
1 
18.2% 
18 
22.3% 
27 
25.0% 
31 
22.2% 
53 
21.1% 
47 
14.7%
28
 Resistant Chicken Breasts
 Ground Turkey 33.3% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef 66.7% 
2 
100.0% 
1 
100.0% 
2 
Pork Chops 100.0% 
2 
100.0% 
1 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
37.5% 
3 
0.0% 
0 
71.4% 
5 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
12.5% 
2 
0.0% 
0 
5.3% 
1 
14.3% 
1 
Cattle 0.0% 
0 
12.5% 
1 
35.2% 
19 
69.7% 
76 
66.7% 
58 
70.8% 
80 
66.7% 
50 
72.7% 
32 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
85.7% 
6 
100.0% 
3 
5. At Least Ceftiofur and Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.4% 
1 
0.0% 
0 
0.5%
1
 Nalidixic Acid Resistant 
Chicken Breasts
 Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.3% 
1 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 1 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur
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H. Antimicrobial Susceptibility among Salmonella  Heidelberg
MIC Distributions
Table 29a. Distribution of MICs and Occurrence of Resistance among Salmonella Heidelberg Isolates from Humans, Retail Meats, and Food Animals, 2004                
 Isolate Source Distribution (%) of MICs (µg/ml)5
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminoglycosides
   Amikacin  Humans (93) 0.0 0.0 [0.0 - 3.9] 10.8 71.0 15.1 3.2
 Chicken Breasts (31) 0.0 0.0 [0.0 - 11.2] 29.0 58.1 12.9
 Ground Turkey (37) 0.0 0.0 [0.0 - 9.5] 67.6 27.0 5.4
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 66.7 33.3
 Chickens (167) 0.0 0.0 [0.0 - 2.2] 16.8 70.1 12.0 1.2
 Turkeys (46) 0.0 0.0 [0.0 - 7.7] 17.4 78.3 4.3
 Cattle (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 50.0 50.0
   Gentamicin  Humans (93) 2.2 4.3 [1.2 - 10.6] 71.0 20.4 2.2 2.2 2.2 2.2
 Chicken Breasts (31) 0.0 9.7 [2.0 - 25.8] 32.3 51.6 6.5 6.5 3.2
 Ground Turkey (37) 2.7 35.1 [20.2 - 52.5] 21.6 40.5 2.7 2.7 32.4
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 33.3 66.7
 Chickens (167) 0.0 10.2 [6.0 - 15.8] 73.1 16.2 0.6 7.8 2.4
 Turkeys (46) 8.7 17.4 [7.8 - 31.4] 67.4 6.5 8.7 15.2 2.2
 Cattle (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 100.0
   Kanamycin  Humans (93) 0.0 8.6 [3.8 - 16.2] 90.3 1.1 1.1 7.5
 Chicken Breasts (31) 0.0 0.0 [0.0 - 11.2] 93.5 6.5
 Ground Turkey (37) 2.7 27.0 [13.8 - 44.1] 64.9 5.4 2.7 27.0
 Pork Chops (3) 0.0 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (167) 0.0 6.0 [2.9 - 10.7] 93.4 0.6 3.0 3.0
 Turkeys (46) 6.5 19.6 [9.4 - 33.9] 73.9 6.5 2.2 17.4
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
 Swine (4) 0.0 75.0 [19.4 - 99.4] 25.0 75.0
   Streptomycin  Humans (93) N/A 15.1 [8.5 - 24.0] 84.9 7.5 7.5
 Chicken Breasts (31) N/A 22.6 [9.6 - 41.1] 77.4 16.1 6.5
 Ground Turkey (37) N/A 43.2 [27.1 - 60.5] 56.8 16.2 27.0
 Pork Chops (3) N/A 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (167) N/A 18.0 [12.5 - 24.6] 82.0 4.8 13.2
 Turkeys (46) N/A 21.7 [10.9 - 36.4] 78.3 8.7 13.0
 Cattle (1) N/A 100.0 [2.5 - 100.0] 100.0
 Swine (4) N/A 75.0 [19.4 - 99.4] 25.0 50.0 25.0
1 There were no Salmonella Heidelberg isolates from ground beef 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for resistance.  
Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the percentages of isolates 
with MICs equal to or less than the lowest tested concentration
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Table 29b. Distribution of MICs and Occurrence of Resistance among Salmonella Heidelberg Isolates from Humans, Retail Meats, and Food Animals, 2004                 
 Isolate Source Distribution (%) of MICs (µg/ml)5
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminopenicillins
   Ampicillin  Humans (93) 0.0 25.8 [17.3 - 35.9] 44.1 29.0 1.1 25.8
 Chicken Breasts (31) 0.0 25.8 [11.9 - 44.6] 67.7 6.5 25.8
 Ground Turkey (37) 0.0 13.5 [4.5 - 28.8] 70.3 16.2 13.5
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (167) 0.0 16.2 [10.9 - 22.6] 72.5 11.4 16.2
 Turkeys (46) 0.0 17.4 [7.8 - 31.4] 65.2 17.4 17.4
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 100.0
β-Lactam/β-Lactamase
 Inhibitor Combinations
   Amoxicillin-Clavulanic Acid  Humans (93) 6.5 10.8 [5.3 - 18.9] 72.0 3.2 1.1 6.5 6.5 2.2 8.6
 Chicken Breasts (31) 3.2 9.7 [2.0 - 25.8] 64.5 9.7 12.9 3.2 9.7
 Ground Turkey (37) 5.4 5.4 [0.7 - 18.2] 81.1 5.4 2.7 5.4 5.4
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 66.7 33.3
 Chickens (167) 4.8 10.2 [6.0 - 15.8] 83.2 0.6 1.2 4.8 1.2 9.0
 Turkeys (46) 6.5 6.5 [1.4 - 17.9] 80.4 2.2 4.3 6.5 6.5
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 75.0 25.0
 Cephalosporins
   Ceftiofur  Humans (93) 1.1 9.7 [4.5 - 17.6] 1.1 84.9 3.2 1.1 9.7
 Chicken Breasts (31) 0.0 9.7 [2.0 - 25.8] 3.2 51.6 35.5 9.7
 Ground Turkey (37) 0.0 5.4 [0.7 - 18.2] 51.4 43.2 5.4
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 33.3 66.7
 Chickens (167) 0.0 10.2 [6.0 - 15.8] 0.6 85.0 3.0 1.2 10.2
 Turkeys (46) 0.0 6.5 [1.4 - 17.9] 89.1 4.3 6.5
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 75.0 25.0
   Ceftriaxone  Humans (93) 7.5 0.0 [0.0 - 3.9] 90.3 2.2 4.3 3.2
 Chicken Breasts (31) 6.5 0.0 [0.0 - 11.2] 90.3 3.2 6.5
 Ground Turkey (37) 5.4 0.0 [0.0 - 9.5] 94.6 5.4
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (167) 9.0 0.6 [0.0 - 3.3] 89.2 0.6 0.6 7.2 1.8 0.6
 Turkeys (46) 6.5 0.0 [0.0 - 7.7] 93.5 4.3 2.2
 Cattle (1) 100.0 0.0 [0.0 - 97.5] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 100.0
1 There were no Salmonella Heidelberg isolates from ground beef 
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for resistance.  
Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the percentages of isolates 
with MICs equal to or less than the lowest tested concentration
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0.0
 Pork Chops (3) N/A 0.0 [0.0 - 70.8] 100.0
 Swine (4) N/A 0.0 [0.0 - 60.2] 100.0
   Chloramphenicol  Humans (93) 0.0 1.1 [0.0 - 5.8] 44.1 54.8 1.1
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 25.0 75.0
with MICs equal to or less than the lowest tested concentration
Table 29c. Distribution of MICs and Occurrence of Resistance among Salmonella Heidelberg Isolates from Humans, Retail Meats, and Food Animals, 2004                
 Isolate Source Distribution (%) of MICs (µg/ml)
5
 Antimicrobial  (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Cephamycins
   Cefoxitin  Humans (93) 1.1 8.6 [3.8 - 16.2] 65.6 18.3 5.4 1.1 1.1 6.5 2.2
 Chicken Breasts (31) 0.0 9.7 [2.0 - 25.8] 3.2 83.9 3.2 3.2 6.5
 Ground Turkey (37) 0.0 5.4 [0.7 - 18.2] 83.8 10.8 5.4
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 66.7 33.3
 Chickens (167) 0.0 10.2 [6.0 - 15.8] 29.9 56.3 3.0 0.6 7.8 2.4
 Turkeys (46) 0.0 6.5 [1.4 - 17.9] 23.9 65.2 4.3 4.3 2.2
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 100.0
 Folate Pathway Inhibitors
   Sulfisoxazole  Humans (93) N/A 7.5 [3.1 - 14.9] 43.0 46.2 3.2 7.5
 Chicken Breasts (31) N/A 12.9 [3.6 - 29.8] 25.8 41.9 19.4 12.9
 Ground Turkey (37) N/A 37.8 [22.5 - 55.2] 2.7 24.3 35.1 37.8
 Pork Chops (3) N/A 0.0 [0.0 - 70.8] 33.3 66.7
 Chickens (167) N/A 12.6 [8.0 - 18.6] 73.1 13.8 0.6 12.6
 Turkeys (46) N/A [14.3 - 41.1] 41.3 30.4 2.2
 Cattle (1) N/A
26.1
[2.5 - 100.0]
26.1
 Swine (4) N/A
100.0
0.0 [0.0 - 60.2] 75.0
100.0
25.0
   Trimethoprim-Sulfamethoxazole  Humans (93) N/A [0.0 - 3.9] 76.3 22.6 1.1
 Chicken Breasts (31) N/A [0.0 - 11.2] 100.0
 Ground Turkey (37) N/A
0.0
[0.0 - 9.5] 97.3 2.70.0
 Chickens (167) N/A 0.0 [0.0 - 2.2] 85.6 14.4
 Turkeys (46) N/A 0.0 [0.0 - 7.7] 71.7 28.3
 Cattle (1) N/A 100.0 [2.5 - 100.0] 100.0
 Phenicols
 Chicken Breasts (31) 3.2 3.2 [0.1 - 16.7] 6.5 87.1 3.2 3.2
 Ground Turkey (37) 0.0 5.4 [0.7 - 18.2] 94.6 5.4
 Chickens (167) 2.4 4.2 [1.7 - 8.4] 1.2 28.1 64.1 2.4 4.2
 Turkeys (46) 0.0 0.0 [0.0 - 7.7] 34.8 65.2
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
1 There were no Salmonella Heidelberg isolates from ground beef
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for resistance.  
Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the percentages of isolates 
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0.0
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Swine (4) 0.0 0.0 [0.0 - 60.2] 100.0
   Nalidixic Acid  Humans (93) N/A 0.0 [0.0 - 3.9] 11.8 88.2
 Pork Chops (3) N/A 0.0 [0.0 - 70.8] 100.0
 Swine (4) N/A 0.0 [0.0 - 60.2] 100.0
   Tetracycline  Humans (93) 0.0 19.4 [11.9 - 28.9] 80.6 3.2 16.1
 Pork Chops (3) 0.0 100.0 [29.2 - 100.0] 100.0
 Swine (4) 0.0 75.0 [19.4 - 99.4] 25.0 75.0
with MICs equal to or less than the lowest tested concentration
Table 29d. Distribution of MICs and Occurrence of Resistance among Salmonella Heidelberg Isolates from Humans, Retail Meats, and Food Animals, 2004                
5
 Antimicrobial
 Isolate Source
 (# of Isolates)1 %I2 %R3 [95% CI]4 0.015 0.03 0.06 0.125 0.25 0.50
D
1
istribu
2
tion (%
4
) of MI
8
Cs (µg
16
/ml)
32 64 128 256 512 1024
 Quinolones
   Ciprofloxacin  Humans (93) 0.0 [0.0 - 3.9] 100.0
 Chicken Breasts (31) 0.0 0.0 [0.0 - 11.2] 100.0
 Ground Turkey (37) 0.0 0.0 [0.0 - 9.5] 97.3 2.7
 Chickens (167) 0.0 0.0 [0.0 - 2.2] 98.2 1.8
 Turkeys (46) 0.0 0.0 [0.0 - 7.7] 95.7 4.3
 Cattle (1) 0.0 0.0 [0.0 - 97.5] 100.0
 Chicken Breasts (31) N/A 0.0 [0.0 - 11.2] 3.2 90.3 6.5
 Ground Turkey (37) N/A 0.0 [ 0.0 - 9.5] 91.9 8.1
 Chickens (167) N/A 0.0 [0.0 - 2.2] 1.2 3.6 95.2
 Turkeys (46) N/A 0.0 [0.0 - 7.7] 2.2 97.8
 Cattle (1) N/A 0.0 [0.0 - 97.5] 100.0
 Tetracyclines
 Chicken Breasts (31) 3.2 6.5 [0.8 - 21.4] 90.3 3.2 6.5
 Ground Turkey (37) 0.0 70.3 [53.0  84.1] 29.7 70.3
 Chickens (167) 1.8 15.0 [9.9 - 21.3] 83.2 1.8 0.6 0.6 13.8
 Turkeys (46) 0.0 73.9 [58.9 - 85.7] 26.1 2.2 71.7
 Cattle (1) 0.0 100.0 [2.5 - 100.0] 100.0
1 There were no Salmonella Heidelberg isolates from ground beef
2 Percent of isolates with intermediate susceptibility 
3 Percent of isolates that were resistant
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
5 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for resistance.  
Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent the percentages of isolates 
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Resistance by Year
Table 30a. Antimicrobial Resistance among Salmonella  Heidelberg Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 
Ground Beef 
21 
0 
32 
0 
37
0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 
Cattle 
14 
1 
39 
11 
139 
28 
125 
6 
142 
10 
60 
8 
57 
9 
46
1
 Swine 7 37 33 22 16 11 11 4
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Aminoglycosides  Amikacin 
(MIC ≥ 64) Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Gentamicin 
(MIC ≥ 16) 
Humans 23.0% 
17  
17.3% 
13  
16.8% 
17  
14.6% 
13  
8.9% 
7 
7.8% 
8 
3.8% 
4 
5.2% 
5 
4.3%
4 
Chicken Breasts 45.5% 
5 
18.8% 
3 
9.7% 
3 
Ground Turkey 28.6% 
6 
12.5% 
4 
35.1% 
13 
Ground Beef
 Pork Chops 100.0% 
3 
0.0% 
0 
Chickens 41.2% 
21 
26.6% 
38 
18.5% 
55 
32.0% 
83 
12.5% 
41 
8.9% 
36 
7.5% 
17 
10.2% 
17 
Turkeys 0.0% 
0 
17.9% 
7 
16.5% 
23 
12.0% 
15 
13.4% 
19 
18.3% 
11 
12.3% 
7 
17.4% 
8 
Cattle 0.0% 
0 
27.3% 
3 
39.3% 
11  
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
9.1% 
2 
0.0% 
0 
9.1% 
1 
0.0% 
0 
0.0% 
0
 Kanamycin 
(MIC ≥ 64) 
Humans 14.9% 
11 
8.0% 
6 
12.9% 
13 
9.0% 
8 
15.2% 
12 
19.6% 
20 
10.5% 
11 
8.3% 
8 
8.6%
8 
Chicken Breasts 36.4% 
4 
0.0% 
0 
0.0% 
0 
Ground Turkey 42.9% 
9 
34.4% 
11  
27.0% 
10 
Ground Beef
 Pork Chops 0.0% 
0 
33.3% 
1 
Chickens 0.0% 
0 
0.7% 
1 
1.3% 
4 
12.0% 
31 
4.3% 
14 
3.7% 
15 
5.3% 
12 
6.0% 
10 
Turkeys 7.1% 
1 
5.1% 
2 
17.3% 
24 
43.2% 
54 
31.0% 
44 
30.0% 
18 
21.1% 
12 
19.6% 
9 
Cattle 0.0% 
0 
63.6% 
7 
42.9% 
12  
16.7% 
1 
10.0% 
1 
37.5% 
3 
55.6% 
5 
100.0% 
1 
Swine 85.7% 
6 
64.9% 
24  
60.6% 
20  
77.3% 
17  
75.0% 
12  
54.5% 
6 
100.0% 
11  
75.0% 
3
 Streptomycin 
(MIC ≥ 64) 
Humans 40.5% 
30 
24.0% 
18 
30.7% 
31 
24.7% 
22 
22.8% 
18 
25.5% 
26 
17.1% 
18 
12.5% 
12 
15.1%
14 
Chicken Breasts 63.6% 
7 
12.5% 
2 
22.6% 
7 
Ground Turkey 61.9% 
13 
37.5% 
12 
43.2% 
16 
Ground Beef
 Pork Chops 100.0% 
3 
33.3% 
1 
Chickens 35.3% 
18 
32.9% 
47 
23.9% 
71 
36.7% 
95 
20.4% 
67 
18.6% 
75 
17.7% 
40 
18.0% 
30 
Turkeys 14.3% 
2 
30.8% 
12  
30.2% 
42  
52.8% 
66  
40.1% 
57  
35.0% 
21  
28.1% 
16  
21.7% 
10 
Cattle 0.0% 
0 
72.7% 
8 
57.1% 
16  
16.7% 
1 
20.0% 
2 
37.5% 
3 
55.6% 
5 
100.0% 
1 
Swine 57.1% 
4 
81.1% 
30  
63.6% 
21  
86.4% 
19  
75.0% 
12  
45.5% 
5 
100.0% 
11  
75.0% 
3 
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Table 30b. Antimicrobial Resistance among Salmonella  Heidelberg Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 
Ground Beef 
21 
0 
32 
0 
37
0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 
Cattle 
14 
1 
39 
11 
139 
28 
125 
6 
142 
10 
60 
8 
57 
9 
46
1
 Swine 7 37 33 22 16 11 11 4
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Aminopenicillins  Ampicillin 
(MIC ≥ 32 µg/ml) Humans 
14.9% 
11 
13.3% 
10 
16.8% 
17 
7.9% 
7 
10.1% 
8 
9.8% 
10 
12.4% 
13 
10.4% 
10 
25.8%
24 
Chicken Breasts 18.2% 
2 
18.8% 
3 
25.8% 
8 
Ground Turkey 19.0% 
4 
9.4% 
3 
13.5% 
5 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 21.6% 
11 
25.2% 
36 
16.2% 
48 
24.7% 
64 
16.7% 
55 
14.9% 
60 
19.0% 
43 
16.2% 
27 
Turkeys 7.1% 
1 
12.8% 
5 
8.6% 
12 
4.0% 
5 
9.2% 
13 
13.3% 
8 
3.5% 
2 
17.4% 
8 
Cattle 0.0% 
0 
27.3% 
3 
50.0% 
14  
0.0% 
0 
0.0% 
0 
50.0% 
4 
55.6% 
5 
100.0% 
1 
Swine 0.0% 
0 
5.4% 
2 
0.0% 
0 
9.1% 
2 
0.0% 
0 
18.2% 
2 
9.1% 
1 
0.0% 
0 
β-Lactam/β-Lactamase 
Inhibitor Combinations
 Amoxicillin-
Clavulanic Acid 
(MIC ≥ 32 / 16 µg/ml) 
Humans 2.7% 
2 
1.3% 
1 
1.0% 
1 
1.1% 
1 
3.8% 
3 
2.9% 
3 
9.5% 
10  
5.2% 
5 
10.8%
10
 Chicken Breasts 0.0% 
0 
6.3% 
1 
9.7% 
3 
Ground Turkey 19.0% 
4 
9.4% 
3 
5.4% 
2 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 2.0% 
1 
1.4% 
2 
1.3% 
4 
13.5% 
35 
7.0% 
23 
8.7% 
35 
9.3% 
21 
10.2% 
17 
Turkeys 0.0% 
0 
2.6% 
1 
0.7% 
1 
2.4% 
3 
5.6% 
8 
5.0% 
3 
0.0% 
0 
6.5% 
3 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
0.0% 
0 
50.0% 
4 
55.6% 
5 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
4.5% 
1 
0.0% 
0 
9.1% 
1 
9.1% 
1 
0.0% 
0
 Cephalosporins  Ceftiofur 
(MIC ≥ 8 µg/ml) 
Humans 1.4% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
3.8% 
3 
2.9% 
3 
7.6% 
8 
5.2% 
5 
9.7%
9 
Chicken Breasts 0.0% 
0 
6.3% 
1 
9.7% 
3 
Ground Turkey 19.0% 
4 
0.0% 
0 
5.4% 
2 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 2.0% 
1 
1.4% 
2 
1.7% 
5 
13.9% 
36 
5.8% 
19 
8.9% 
36 
9.3% 
21 
10.2% 
17 
Turkeys 0.0% 
0 
2.6% 
1 
0.7% 
1 
3.2% 
4 
5.6% 
8 
5.0% 
3 
0.0% 
0 
6.5% 
3 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
0.0% 
0 
37.5% 
3 
55.6% 
5 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
4.5% 
1 
0.0% 
0 
9.1% 
1 
9.1% 
1 
0.0% 
0
 Ceftriaxone 
(MIC ≥ 64 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.4% 
1 
0.0% 
0 
0.2% 
1 
0.0% 
0 
0.6% 
1 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
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Table 30c. Antimicrobial Resistance among Salmonella  Heidelberg Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 
Ground Beef 
21 
0 
32 
0 
37
0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 
Cattle 
14 
1 
39 
11 
139 
28 
125 
6 
142 
10 
60 
8 
57 
9 
46
1
 Swine 7 37 33 22 16 11 11 4
 Antimicrobial Class
 Antimicrobial
 (Resistance 
Breakpoint)
 Isolate
 Source
 Cephalosporins  Cephalothin 
(MIC ≥ 32 µg/ml) Humans
6.8% 
5 
2.7% 
2 
5.9% 
6 
3.4% 
3 
5.1% 
4 
3.9% 
4 
10.5% 
11  
7.3%
7 
Chicken Breasts 18.2% 
2 
12.5% 
2 
Ground Turkey 19.0% 
4 
12.5% 
4 
Ground Beef
 Pork Chops 0.0% 
0 
Chickens 2.0% 
1 
9.8% 
14  
5.7% 
17  
15.4% 
40  
8.5% 
28  
9.9% 
40  
12.8% 
29  
Turkeys 0.0% 
0 
5.1% 
2 
2.2% 
3 
2.4% 
3 
7.0% 
10  
5.0% 
3 
1.8% 
1 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
0.0% 
0 
50.0% 
4 
55.6% 
5 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
4.5% 
1 
0.0% 
0 
9.1% 
1 
9.1% 
1
 Cephamycins  Cefoxitin 
(MIC ≥ 32 µg/ml) 
Humans 2.5% 
2 
2.9% 
3 
8.6% 
9 
5.2% 
5 
8.6%
8 
Chicken Breasts 0.0% 
0 
6.3% 
1 
9.7% 
3 
Ground Turkey 19.0% 
4 
0.0% 
0 
5.4% 
2 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 13.5% 
35 
5.2% 
17 
7.4% 
30 
7.1% 
16 
10.2% 
17 
Turkeys 2.4% 
3 
4.9% 
7 
1.7% 
1 
0.0% 
0 
6.5% 
3 
Cattle 0.0% 
0 
0.0% 
0 
37.5% 
3 
44.4% 
4 
100.0% 
1 
Swine 4.5% 
1 
0.0% 
0 
9.1% 
1 
9.1% 
1 
0.0% 
0
 Folate Pathway Inhibitors  Sulfamethoxazole/ 
Sulfisoxazole1 
(MIC ≥ 512 µg/ml) 
Humans 17.6% 
13  
21.3% 
16  
21.8% 
22  
19.1% 
17  
11.4% 
9 
8.8% 
9 
6.7% 
7 
7.3% 
7 
7.5%
7
 Chicken Breasts 45.5% 
5 
12.5% 
2 
12.9% 
4 
Ground Turkey 33.3% 
7 
15.6% 
5 
37.8% 
14 
Ground Beef
 Pork Chops 100.0% 
3 
0.0% 
0 
Chickens 45.1% 
23 
33.6% 
48 
26.6% 
79 
33.2% 
86 
16.4% 
54 
9.7% 
39 
11.1% 
25 
12.6% 
21 
Turkeys 50.0% 
7 
35.9% 
14  
33.8% 
47  
15.2% 
19  
27.5% 
39  
30.0% 
18  
19.3% 
11  
26.1% 
12 
Cattle 0.0% 
0 
36.4% 
4 
57.1% 
16  
0.0% 
0 
10.0% 
1 
12.5% 
1 
44.4% 
4 
100.0% 
1 
Swine 0.0% 
0 
21.6% 
8 
21.2% 
7 
13.6% 
3 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Trimethoprim-
Sulfamethoxazole 
(MIC ≥ 4 / 76 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
2.0% 
2 
1.1% 
1 
1.3% 
1 
2.0% 
2 
1.0% 
1 
2.1% 
2 
0.0%
0
 Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.7% 
1 
0.7% 
2 
0.4% 
1 
0.3% 
1 
0.7% 
3 
0.9% 
2 
0.0% 
0 
Turkeys 7.1% 
1 
5.1% 
2 
4.3% 
6 
0.8% 
1 
3.5% 
5 
3.3% 
2 
3.5% 
2 
0.0% 
0 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
10.0% 
1 
0.0% 
0 
55.6% 
5 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
9.1% 
1 
0.0% 
0 
0.0% 
0 
1 Sulfamethoxazole was tested from 1996 to 2003 and was replaced by sulfisoxazole in 2004 
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Table 30d. Antimicrobial Resistance among Salmonella  Heidelberg Isolates from Humans, Retail Meats, and 
Food Animals, by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 
Ground Beef 
21 
0 
32 
0 
37
0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 
Cattle 
14 
1 
39 
11 
139 
28 
125 
6 
142 
10 
60 
8 
57 
9 
46
1
 Swine 7 37 33 22 16 11 11 4
 Antimicrobial Class
 Antimicrobial
 (Resistance
 Breakpoint)
 Isolate
 Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans 
1.4% 
1 
0.0% 
0 
1.0% 
1 
2.2% 
2 
1.3% 
1 
1.0% 
1 
1.0% 
1 
0.0% 
0 
1.1%
1 
Chicken Breasts 0.0% 
0 
0.0% 
0 
3.2% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
5.4% 
2 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.7% 
1 
1.3% 
4 
11.6% 
30  
3.3% 
11  
1.7% 
7 
3.1% 
7 
4.2% 
7 
Turkeys 0.0% 
0 
2.6% 
1 
0.7% 
1 
1.6% 
2 
2.8% 
4 
1.7% 
1 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
10.0% 
1 
25.0% 
2 
44.4% 
4 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
3.0% 
1 
4.5% 
1 
0.0% 
0 
9.1% 
1 
0.0% 
0 
0.0% 
0
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Nalidixic Acid 
(MIC ≥ 32 µg/ml) 
Humans 0.0% 
0 
0.0% 
0 
1.0% 
1 
1.1% 
1 
1.3% 
1 
0.0% 
0 
0.0% 
0 
1.0% 
1 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 4.8% 
1 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.3% 
1 
0.0% 
0 
0.0% 
0 
0.7% 
3 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.7% 
1 
0.8% 
1 
0.0% 
0 
1.7% 
1 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Tetracyclines  Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 20.3% 
15  
12.0% 
9 
19.8% 
20  
19.1% 
17  
21.5% 
17  
24.5% 
25  
19.0% 
20  
16.7% 
16  
19.4%
18 
Chicken Breasts 45.5% 
5 
0.0% 
0 
6.5% 
2 
Ground Turkey 57.1% 
12 
43.8% 
14 
70.3% 
26 
Ground Beef
 Pork Chops 66.7% 
2 
100.0% 
3 
Chickens 2.0% 
1 
7.7% 
11  
7.7% 
23  
20.1% 
52  
14.9% 
49  
11.7% 
47  
16.4% 
37  
15.0% 
25 
Turkeys 14.3% 
2 
23.1% 
9 
38.1% 
53 
64.0% 
80 
54.2% 
77 
70.0% 
42 
84.2% 
48 
73.9% 
34 
Cattle 0.0% 
0 
63.6% 
7 
60.7% 
17  
33.3% 
2 
40.0% 
4 
62.5% 
5 
55.6% 
5 
100.0% 
1 
Swine 85.7% 
6 
73.0% 
27  
72.7% 
24  
81.8% 
18  
93.8% 
15  
72.7% 
8 
100.0% 
11  
75.0% 
3
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Ceftiofur Resistance 
Figure 14. Percent of Salmonella  Heidelberg Isolates from Humans, Retail Poultry, and Food Animals1 
Resistant to Ceftiofur, by Year, 1996-2004 
0% 
5% 
10% 
15% 
20% 
25% 
30% 
1996 1997 1998 1999 2000 2001 2002 2003 2004 
Year 
Pe
rc
en
t R
es
is
ta
nc
e
 Humans
 Chicken Breasts
 Ground Turkey
 Chickens
 Turkeys
 Swine 
1 Data for ground beef, pork chops, and cattle are not included due to the small number of Salmonella Heidelberg isolates from these sources.  
Table 30 contains resistance data for Salmonella Heidelburg isolates from each source, by year 
Table 31. Number of Salmonella  Heidelberg Isolates Tested from Humans, Food Animals, 
and Retail Meats, by Year, 1996-2004 
1996 1997 1998 1999 2000 2001 2002 2003 2004
 Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 21 32 37
 Ground Beef 0 0 0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 14 39 139 125 142 60 57 46
 Cattle 1  11  28  6  10  8  9  1
 Swine 7  37  33  22  16  11  11  4  
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Multidrug Resistance
Table 32a. Resistance Patterns among Salmonella  Heidelberg Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004 
Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 
Ground Beef 
21 
0 
32 
0 
37
0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 
Cattle 
14 
1 
39 
11 
139 
28 
125 
6 
142 
10 
60 
8 
57 
9 
46
1
 Swine 7 37 33 22 16 11 11 4
 Resistance Pattern  Isolate Source 
1. No Resistance Detected 
Humans
54.1% 
40 
66.7% 
50 
56.4% 
57 
67.4% 
60 
63.3% 
50 
64.7% 
66 
67.6% 
71 
68.8% 
66 
55.9%
52 
Chicken Breasts 27.3% 
3 
62.5% 
10  
58.1% 
18  
Ground Turkey 33.3% 
7 
50.0% 
16  
16.2% 
6 
Ground Beef 
Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 35.3% 
18 
50.3% 
72 
61.6% 
183 
48.3% 
125 
63.5% 
209 
66.5% 
268 
62.8% 
142 
68.3% 
114 
Turkeys 50.0% 
7 
46.2% 
18  
43.2% 
60  
28.8% 
36  
31.0% 
44  
15.0% 
9 
8.8% 
5 
15.2% 
7 
Cattle 100.0% 
1 
27.3% 
3 
25.0% 
7 
66.7% 
4 
60.0% 
6 
12.5% 
1 
44.4% 
4 
0.0% 
0 
Swine 14.3% 
1 
18.9% 
7 
27.3% 
9 
13.6% 
3 
6.3% 
1 
27.3% 
3 
0.0% 
0 
0.0% 
0 
2. At Least ACSSuT1 Resistant 
Humans
1.4% 
1 
0.0% 
0 
0.0% 
0 
1.1% 
1 
1.3% 
1 
1.0% 
1 
1.0% 
1 
0.0% 
0 
1.1%
1 
Chicken Breasts 0.0% 
0 
0.0% 
0 
3.2% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
5.4% 
2 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.7% 
1 
1.3% 
4 
11.2% 
29  
3.0% 
10  
1.5% 
6 
2.2% 
5 
2.4% 
4 
Turkeys 0.0% 
0 
2.6% 
1 
0.7% 
1 
1.6% 
2 
2.8% 
4 
1.7% 
1 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
0.0% 
0 
12.5% 
1 
33.3% 
3 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
4.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
3. At Least ACT/S2 Resistant 
Humans
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.0% 
1 
0.0% 
0 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.4% 
2 
1.7% 
1 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
0.0% 
0 
0.0% 
0 
44.4% 
4 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
9.1% 
1 
0.0% 
0 
0.0% 
0
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline
 2 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole 
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Table 32b. Resistance Patterns among Salmonella Heidelberg Isolates from Humans, Retail Meats, and Food Animals, 
by Year, 1996-2004
 Year 1996 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 74 75 101 89 79 102 105 96 93
 Chicken Breasts 11 16 31
 Ground Turkey 
Ground Beef 
21 
0 
32 
0 
37
0
 Pork Chops 3 0 3
 Chickens 51 143 297 259 329 403 226 167
 Turkeys 
Cattle 
14 
1 
39 
11 
139 
28 
125 
6 
142 
10 
60 
8 
57 
9 
46
1
 Swine 7 37 33 22 16 11 11 4
 Resistance Pattern  Isolate Source 
4. At Least ACSSuTAuCf 1 
Humans 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.3% 
1 
1.0% 
1 
1.0% 
1 
0.0% 
0 
0.0%
0
 Resistant Chicken Breasts 0.0% 
0 
0.0% 
0 
3.2% 
1 
Ground Turkey 0.0% 
0 
0.0% 
0 
5.4% 
2 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.7% 
1 
0.7% 
2 
11.2% 
29  
2.7% 
9 
1.5% 
6 
2.2% 
5 
2.4% 
4 
Turkeys 0.0% 
0 
2.6% 
1 
0.7% 
1 
0.8% 
1 
2.8% 
4 
1.7% 
1 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
27.3% 
3 
42.9% 
12  
0.0% 
0 
0.0% 
0 
12.5% 
1 
33.3% 
3 
100.0% 
1 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
4.5% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
5. At Least Ceftiofur and 
Humans 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0
 Nalidixic Acid Resistant Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.7% 
3 
0.0% 
0 
0.0% 
0 
Turkeys 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1.7% 
1 
0.0% 
0 
0.0% 
0 
Cattle 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Swine 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
1 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur 
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 IV. Campylobacter Data
 A. Campylobacter jejuni and Campylobacter coli Isolates Tested 
Table 33. Number of Campylobacter jejuni  Isolates Tested, by Source and Year, 1997-2004 
Source 
Year 
1997 1998 1999 2000 2001 2002 2003 2004
 Humans 
Chicken Breasts 
Ground Turkey 
Ground Beef 
Pork Chops 
Chickens 
209 297 293 306 365 
641 
329 
198 
2 
0 
2 
526 
303 
325 
4 
1 
0 
374 
320
510
7
0
0
508
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
Table 34. Number of Campylobacter coli  Isolates Tested, by Source and Year, 1997-2004 
Source 
Year 
1997 1998 1999 2000 2001 2002 2003 2004
 Humans 
Chicken Breasts 
Ground Turkey 
Ground Beef 
Pork Chops 
Chickens 
6 8 20 12 17 
521 
25 
90 
2 
0 
3 
288 
22 
142 
1 
0 
4 
247 
26
196
5
0
3
186
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
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 B. Isolation of Campylobacter  from Retail Meats 
Table 35. Number and Percent of Retail Meat Samples Positive for Campylobacter , 2004 
Chicken 
Breast 
Ground 
Turkey 
Ground 
Beef 
Pork 
Chops 
Number Positive for Campylobacter 
Number of Meat Samples Tested
 Percent Positive for Campylobacter 
1172 
706 
60.2% 
1165 
12 
1.0% 
1186 
0 
0.0% 
1176
3 
0.3%
 Figure 15. Percent of Retail Meat Samples Positive for Campylobacter , 2004 
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Figure 16. Percent of Retail Meat Samples Positive for Campylobacter , 
2002-2004
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C. Campylobacter Species 
Table 36. Campylobacter  Species Isolated from Humans, Retail Meats, and Chickens, 2004
Humans Retail Meats Food Animals
 Campylobacter 
Species 
Humans 
(n=347) 
Chicken 
Breast 
(n=706) 
Ground 
Turkey 
(n=12) 
Ground 
Beef 
(n=0) 
Pork 
Chops 
(n=3)
Chickens 
(n=694) 
C. jejuni 92.2% 
320 
72.2% 
510 
58.3% 
7 
0.0% 
0 
0.0% 
0 
73.2% 
508 
C. coli 7.5% 
26 
27.8% 
196 
41.7% 
5 
0.0% 
0 
100.0% 
3 
26.8% 
186 
Other 0.3% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
Figure 17. Campylobacter Species Isolated from Humans, Chicken Breasts, and 
Chickens, 2004 
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D. Antimicrobial Susceptibility among Campylobacter jejuni 
MIC Distributions 
Table 37. Distribution of MICs and Occurrence of Resistance among Campylobacter jejuni  Isolates from Humans, Retail Meats, and Chickens, 2004 
Isolate Source
 Antimicrobial (# of Isolates)
1 %I2 %R3 [95% CI]4 0.002 0.004 0.008 0.015 0.03 0.06 0.125 0.25 0.50 1  2  4  8  16  32  64  128  256  512
 Aminoglycosides
 Gentamicin  Humans (320) 1.9 0.3 [0.0 - 1.7] 0.3 9.4 45.3 28.8 14.1 1.9 0.3
 Chicken Breasts (510) 0.0 0.0 [0.0 - 0.7] 1.8 5.1 85.1 8.0
 Ground Turkey (7) 0.0 0.0 [0.0 - 41.0] 14.3 85.7
 Chickens (508) 0.0 0.2 [0.0 - 1.1] 2.8 7.7 38.2 39.6 10.8 0.8 0.2
 Ketolides
 Telithromycin  Chicken Breasts (510) 0.4 0.4 [0.0 - 1.4] 0.2 0.4 0.2 13.1 56.5 23.7 4.9 0.2 0.4 0.4
 Ground Turkey (7) 0.0 0.0 [0.0 - 41.0] 14.3 28.6 57.1
 Lincosamides
 Clindamycin  Humans (320) 0.3 2.2 [0.9 - 4.5] 0.3 0.3 2.2 25.3 48.1 18.1 2.2 0.9 0.3 0.3 1.3 0.6
 Chicken Breasts (510) 0.0 0.4 [0.0 - 1.4] 0.6 10.2 55.5 29.6 2.0 1.2 0.6 0.4
 Ground Turkey (7) 0.0 0.0 [0.0 - 41.0] 42.9 42.9 14.3
 Chickens (508) 0.6 0.2 [0.0 - 1.1] 0.2 3.7 16.5 38.2 30.9 7.1 2.0 0.6 0.6 0.2
 Macrolides
 Azithromycin  Humans (320) 1.6 0.6 [0.1 - 2.2] 5.9 40.3 44.4 5.3 1.6 0.3 1.6 0.3 0.3
 Chicken Breasts (510) 0.0 0.8 [0.2 - 2.0] 4.9 49.6 38.2 5.3 0.2 0.2 0.6 0.2 0.8
 Ground Turkey (7) 0.0 0.0 [0.0 - 41.0] 14.3 14.3 57.1 14.3
 Chickens (508) 0.0 1.6 [0.7 - 3.1] 12.6 46.5 29.9 8.3 0.8 0.4 1.6
 Erythromycin  Humans (320) 0.3 0.3 [0.0 - 1.7] 0.6 0.9 10.0 49.7 28.4 7.8 1.6 0.3 0.3 0.3
 Chicken Breasts (510) 0.0 0.8 [0.2 - 2.0] 0.4 2.5 53.1 35.3 7.8 0.8
 Ground Turkey (7) 0.0 0.0 [0.0 - 41.0] 14.3 14.3 28.6 42.9
 Chickens (508) 0.4 1.2 [0.4 - 2.6] 0.2 0.2 2.2 22.0 43.9 24.6 5.3 0.4 1.2
 Phenicols
 Chloramphenicol  Humans (320) 3.1 1.6 [0.5 - 3.6] 0.6 2.5 45.9 35.3 8.4 2.5 3.1 1.6
 Chickens (508) 0.0 0.0 [0.0 - 0.7] 0.2 2.0 21.3 52.8 20.9 2.8 0.2
 Florfenicol
6  Chicken Breasts (510) N/A 0.0 [0.0 - 0.7] 0.6 5.1 85.9 8.0 0.4
 Ground Turkey (7) N/A 0.0 [0.0 - 41.0] 28.6 14.3 57.1
 Quinolones
 Ciprofloxacin  Humans (320) 0.0 18.1 [14.1 - 22.8] 0.6 0.9 35.9 37.8 5.6 0.9 1.6 16.6
 Chicken Breasts (510) 0.0 15.1 [12.1 - 18.5] 0.2 39.8 37.3 7.6 0.4 9.0 4.5 1.2
 Ground Turkey (7) 0.0 28.6 [3.7 - 71.0] 28.6 42.9 28.6
 Chickens (508) 0.0 21.3 [17.8 - 25.1] 0.8 5.9 34.8 32.7 4.1 0.2 0.2 0.4 0.4 0.6 19.9
 Nalidixic acid  Humans (320) 0.6 18.4 [14.3 - 23.1] 0.6 11.9 39.4 20.6 6.9 1.6 0.6 0.3 18.1
 Chicken Breasts (510) 0.2 15.1 [12.1 - 18.5] 64.3 20.4 0.2 0.4 14.7
 Ground Turkey (7) 0.0 28.6 [3.7 - 71.0] 42.9 28.6 28.6
 Chickens (508) 0.4 21.7 [18.1 - 25.5] 0.4 15.0 40.0 17.5 5.1 0.4 0.4 0.2 21.1
 Tetracyclines
 Tetracycline  Humans (320) 0.3 46.9 [41.3 - 52.5] 2.2 22.2 21.3 5.3 1.3 0.3 0.3 0.3 1.6 4.7 5.6 5.6 1.3 28.1
 Chicken Breasts (510) 0.2 50.2 [45.8 - 54.6] 0.6 24.3 15.3 7.6 1.8 0.2 2.2 4.9 25.9 17.3
 Ground Turkey (7) 0.0 42.9 [9.9 - 81.6] 14.3 28.6 14.3 14.3 28.6
 Chickens (508) 0.6 42.3 [38.0 - 46.8] 0.2 1.6 14.8 17.1 15.6 5.7 1.8 0.4 0.6 3.0 2.6 6.9 2.6 27.4 
Distribution (%) of MICs (µg/ml)5 
1 There were no C. jejuni  isolates from ground beef or pork chops 
2 Percent of isolates with intermediate susceptibility 
3 Percent resistant; for florfenicol, percent non-susceptible 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the range of dilutions tested for each antimicrobial. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for resistance. Numbers in the shaded area indicate the percentages of 
isolates with MICs greater than the highest tested concentrations. Numbers listed for the lowest tested concentrations represent the percentages of isolates with MICs equal to or less than the lowest tested concentration.  Etest was used to test human and food animal 
isolates while a broth microdilution method was used to test retail meat isolates. Isolates with an MIC of 0.016 µg/ml by Etest are included in the 0.015 µg/ml column 
6 For florfenicol, only a susceptible breakpoint (≤ 4 µg/ml) has been established. In this report, isolates with an MIC ≥ 8 µg/ml are categorized as resistant 78
Resistance by Year
Table 38a. Antimicrobial Resistance among Campylobacter jejuni Isolates from Humans, Retail Meats, and Chickens, 
by Year, 1997-2004
 Year 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 209 297 293 306 365 329 303 320
 Chicken Breasts 198 325 510
 Ground Turkey 
Ground Beef 
2 
0 
4 
1 
7
0
 Pork Chops 2 0 0
 Chickens 641 526 374 508
 Antimicrobial
 (Resistance
 Antimicrobial Class  Breakpoint)  Isolate Source
 Aminoglycosides  Gentamicin 
(MIC ≥ 8 µg/ml) 
Humans
0.3% 
1 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.3%
1 
Chicken Breasts 0.0% 
0 
0.3% 
1 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
Pork Chops 0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.2% 
1
 Ketolides  Telithromycin 
(MIC ≥ 16 µg/ml) 
Chicken Breasts 0.4%
2 
Ground Turkey 0.0% 
0
 Ground Beef
 Pork Chops
 Lincosamides  Clindamycin 
(MIC ≥ 8 µg/ml) 
Humans 1.0% 
2 
1.0% 
3 
0.7% 
2 
0.7% 
2 
1.9% 
7 
1.8% 
6 
0.0% 
0 
2.2%
7 
Chicken Breasts 0.4% 
2 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops
 Chickens 0.0% 
0 
0.4% 
2 
0.8% 
3 
0.2% 
1
 Macrolides  Azithromycin 
(MIC ≥ 8 µg/ml) 
Humans 0.3% 
1 
1.7% 
5 
1.6% 
5 
1.9% 
7 
1.8% 
6 
0.3% 
1 
0.6%
2 
Chicken Breasts 0.8% 
4 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops
 Chickens 3.1% 
2 
0.6% 
3 
1.3% 
5 
1.6% 
8
 Erythromycin 
(MIC ≥ 32 µg/ml) 
Humans 1.4% 
3 
0.7% 
2 
1.4% 
4 
1.0% 
3 
1.9% 
7 
1.2% 
4 
0.3% 
1 
0.3%
1 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.8% 
4 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
Pork Chops 0.0% 
0 
Chickens 3.1% 
2 
0.6% 
3 
1.6% 
6 
1.2% 
6 
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
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Table 38b. Antimicrobial Resistance among Campylobacter jejuni Isolates from Humans, Retail Meats, and Chickens, 
by Year, 1997-2004
 Year 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 209 297 293 306 365 329 303 320
 Chicken Breasts 198 325 510
 Ground Turkey 
Ground Beef 
2 
0 
4 
1 
7
0
 Pork Chops 2 0 0
 Chickens 641 526 374 508
 Antimicrobial
 (Resistance
 Antimicrobial Class  Breakpoint)  Isolate Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans
3.8% 
8 
1.0% 
3 
0.7% 
2 
0.0% 
0 
0.3% 
1 
0.3% 
1 
0.0% 
0 
1.6%
5 
Chickens 0.0% 0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Flofenicol 
(MIC ≥ 8)2 
Chicken Breasts
0.0%
0 
Ground Turkey 0.0% 
0
 Ground Beef
 Pork Chops 
Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Humans 12.4% 
26 
13.8% 
41 
17.7% 
52 
14.7% 
45 
18.4% 
67 
20.7% 
68 
17.2% 
52 
18.1%
58 
Chicken Breasts 15.2% 
30 
14.5% 
47 
15.1% 
77 
Ground Turkey 50.0% 
1 
0.0% 
0 
28.6% 
2 
Ground Beef 0.0% 
0 
Pork Chops 0.0% 
0 
Chickens 20.3% 
13 
18.6% 
98 
14.7% 
55 
21.3% 
108
 Nalidixic acid 
(MIC ≥ 64 µg/ml) 
Humans 13.4% 
28 
15.5% 
46 
20.1% 
59 
16.0% 
49 
18.9% 
69 
21.3% 
70 
17.8% 
54 
18.4%
59 
Chicken Breasts 15.1% 
77 
Ground Turkey 28.6% 
2 
Ground Beef
 Pork Chops
 Chickens 20.3% 
13 
22.1% 
116 
15.5% 
58 
21.7% 
110
 Tetracyclines  Doxycycline 
(MIC ≥ 8 µg/ml) 
Chicken Breasts 38.4% 
76 
40.6%
132 
Ground Turkey 100.0% 
2 
75.0% 
3 
Ground Beef 0.0% 
0 
Pork Chops 0.0% 
0
 Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 47.8% 
100 
46.1% 
137 
45.4% 
133 
39.2% 
120 
40.3% 
147 
41.3% 
136 
38.3% 
116 
46.9%
150 
Chicken Breasts 50.2% 
256 
Ground Turkey 42.9% 
3 
Ground Beef
 Pork Chops
 Chickens 35.9% 
23 
45.1% 
237 
47.6% 
178 
42.3% 
215
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
2 For florfenicol, only a susceptible breakpoint (≤ 4 µg/ml) has been established. In this report, isolates with an MIC ≥ 8 µg/ml are categorized as resistant 
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Ciprofloxacin Resistance 
Figure 18. Percent of Campylobacter jejuni  Isolates from Humans, Chicken Breasts, 
and Chickens Resistant to Ciprofloxacin, by Year, 1997-2004 
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1 Data for ground turkey, ground beef, and pork chops are not included due to the small number of C. jejuni 
isolates from these sources. Table 38 contains resistance data for C. jejuni  isolates from each source, by year 
Erythromycin Resistance 
Figure 19. Percent of Campylobacter jejuni  Isolates from Humans, Chicken Breasts, 
and Chickens Resistant to Erythromycin, by Year, 1997-2004 
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1 Data for ground turkey, ground beef, and pork chops are not included due to the small number of C. jejuni 
isolates from these sources. Table 38 contains resistance data for C. jejuni  isolates from each source, by year 
Table 39. Number of Campylobacter jejuni Isolates Tested from Humans, Retail Meats, and 
Chickens, by Year, 1997-2004 
1997 1998 1999 2000 2001 2002 2003 2004
 Humans 209 297 293 306 365 329 303 320
 Chicken Breasts 198 325 510
 Ground Turkey 2 4 7
 Ground Beef 0 1 0
 Pork Chops 2 0 0
 Chickens 641 526 374 508 
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
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E. Antimicrobial Susceptibility among Campylobacter coli 
MIC Distributions 
Table 40. Distribution of MICs and Occurrence of Resistance among Campylobacter coli Isolates from Humans, Retail Meats, and Chickens, 2004 
Isolate Source
 Antimicrobial (# of Isolates)
1 %I2 %R3 [95% CI]4 0.002 0.004 0.008 0.015 0.03 0.06 0.125 0.25 0.50 1  2  4  8  16  32  64  128  256  512
 Aminoglycosides
 Gentamicin  Humans (26) 3.8 0.0 [0.0 - 13.2] 7.7 30.8 42.3 15.4 3.8
 Chicken Breasts (196) 0.0 0.0 [0.0 - 1.9] 0.5 4.1 85.7 9.7
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 40.0 60.0
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (186) 0.0 0.0 [0.0 - 2.0] 0.5 5.9 43.0 48.4 2.2
 Ketolides
 Telithromycin  Chicken Breasts (196) 2.6 8.2 [4.7 - 12.9] 0.5 1.0 20.4 5.6 18.9 35.7 7.1 2.6 8.2
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 100.0
 Pork Chops (3) 33.3 0.0 [0.0 - 70.8] 33.3 33.3 33.3
 Lincosamides
 Clindamycin  Humans (26) 0.0 0.0 [0.0 - 13.2] 53.8 19.2 15.4 11.5
 Chicken Breasts (196) 2.0 7.1 [4.0 - 11.7] 1.5 19.4 51.0 14.3 4.6 2.0 3.1 4.1
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 20.0 80.0
 Pork Chops (3) 0.0 33.3 [0.8 - 90.6] 66.7 33.3
 Chickens (186) 5.9 1.1 [0.1 - 3.8] 0.5 4.8 17.7 30.1 26.9 5.9 2.7 4.3 5.9 0.5 0.5
 Macrolides
 Azithromycin  Humans (26) 0.0 0.0 [0.0 - 13.2] 34.6 46.2 15.4 3.8
 Chicken Breasts (196) 0.0 9.2 [5.5 - 14.1] 14.3 42.9 29.6 3.1 0.5 0.5 9.2
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 100.0
 Pork Chops (3) 0.0 33.3 [0.8 - 90.6] 33.3 33.3 33.3
 Chickens (186) 0.0 9.1 [5.4 - 14.2] 1.6 30.6 39.8 16.7 1.6 0.5 9.1
 Erythromycin  Humans (26) 3.8 0.0 [0.0 - 13.2] 15.4 34.6 15.4 26.9 3.8 3.8
 Chicken Breasts (196) 0.0 9.2 [5.5 - 14.1] 1.0 21.9 17.3 39.8 8.7 1.5 0.5 9.2
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 100.0
 Pork Chops (3) 0.0 33.3 [0.8 - 90.6] 33.3 33.3 33.3
 Chickens (186) 0.0 9.1 [5.4 - 14.2] 1.1 0.5 16.7 22.0 30.1 18.8 1.6 9.1
 Phenicols
 Chloramphenicol  Humans (26) 0.0 0.0 [0.0 - 13.2] 7.7 38.5 38.5 15.4
 Chickens (186) 0.0 0.0 [0.0 - 2.0] 3.8 38.2 50.5 7.0 0.5
 Florfenicol
6  Chicken Breasts (196) N/A 0.0 [0.0 - 1.9] 1.5 64.3 33.7 0.5
 Ground Turkey (5) N/A 0.0 [0.0 - 52.2] 20.0 80.0
 Pork Chops (3) N/A 0.0 [0.0 - 70.8] 66.7 33.3
 Quinolones
 Ciprofloxacin  Humans (26) 0.0 30.8 [14.3 - 51.8] 26.9 15.4 19.2 3.8 3.8 3.8 26.9
 Chicken Breasts (196) 0.0 16.3 [11.4 - 22.3] 23.0 36.7 23.5 0.5 2.0 12.8 1.5
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 20.0 80.0
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 100.0
 Chickens (186) 0.0 26.9 [20.7 - 33.9] 2.7 11.8 37.6 18.8 2.2 0.5 0.5 0.5 25.3
 Nalidixic acid  Humans (26) 0.0 34.6 [17.2 - 55.7] 19.2 30.8 7.7 7.7 34.6
 Chicken Breasts (196) 0.0 16.3 [11.4 - 22.3] 47.4 34.7 1.5 3.6 12.8
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 20.0 80.0
 Pork Chops (3) 0.0 0.0 [0.0 - 70.8] 66.7 33.3
 Chickens (186) 1.1 27.4 [21.1 - 34.4] 1.6 26.3 37.1 6.5 1.1 1.1  26.3
 Tetracyclines
 Tetracycline  Humans (26) 0.0 38.5 [20.2 - 59.4] 42.3 15.4 3.8 3.8 7.7 7.7 19.2
 Chicken Breasts (196) 0.0 46.4 [39.3 - 53.7] 6.6 21.4 9.7 9.7 5.6 0.5 1.0 2.6 42.9
 Ground Turkey (5) 0.0 0.0 [0.0 - 52.2] 60.0 40.0
 Pork Chops (3) 0.0 66.7 [9.4 - 99.2] 33.3 66.7
 Chickens (186) 0.0 48.4 [41.0 - 55.8] 3.8 7.0 16.7 18.3 5.4 0.5 0.5 1.6 2.7 3.2 40.3 
Distribution (%) of MICs (µg/ml)5 
1 There were no C. coli  isolates from ground beef 
2 Percent of isolates with intermediate susceptibility 
3 Percent resistant; for florfenicol, percent non-susceptible 
4 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method 
5 The unshaded areas indicate the range of dilutions tested for each antimicrobial. Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for resistance. Numbers in the shaded area indicate the percentages of 
isolates with MICs greater than the highest tested concentrations. Numbers listed for the lowest tested concentrations represent the percentages of isolates with MICs equal to or less than the lowest tested concentration.  Etest was used to test human and food animal 
isolates while a broth microdilution method was used to test retail meat isolates. Isolates with an MIC of 0.016 µg/ml by Etest are included in the 0.015 µg/ml column  
6 For florfenicol, only a susceptible breakpoint (≤ 4 µg/ml) has been established. In this report, isolates with an MIC≥ 8 µg/ml are categorized as resistant 
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Resistance by Year 
Table 41a. Antimicrobial Resistance among Campylobacter coli  Isolates from Humans, Retail Meats, and Chickens, 
by Year, 1997-2004
 Year 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 6 8 20 12 17 25 22 26
 Chicken Breasts 90 142 196
 Ground Turkey 
Ground Beef 
2 
0 
1 
0 
5
0
 Pork Chops 3 4 3
 Chickens 521 288 247 186
 Antimicrobial
 (Resistance
 Antimicrobial Class  Breakpoint)  Isolate Source
 Aminoglycosides  Gentamicin 
(MIC ≥ 8 µg/ml) 
Humans
0.0% 
0 
0.0% 
0 
8.3% 
1 
0.0% 
0 
0.0% 
0 
4.5% 
1 
0.0%
0 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Ketolides  Telithromycin 
(MIC ≥ 16 µg/ml) 
Chicken Breasts 8.2%
16 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0
 Lincosamides  Clindamycin 
(MIC ≥ 8 µg/ml) 
Humans 16.7% 
1 
12.5% 
1 
10.0% 
2 
8.3% 
1 
5.9% 
1 
4.0% 
1 
9.1% 
2 
0.0%
0 
Chicken Breasts 7.1% 
14 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops 33.3% 
1 
Chickens 1.9% 
1 
4.9% 
14  
4.5% 
11  
1.1% 
2
 Macrolides  Azithromycin 
(MIC ≥ 8 µg/ml) 
Humans 12.5% 
1 
10.0% 
2 
8.3% 
1 
5.9% 
1 
4.0% 
1 
9.1% 
2 
0.0%
0 
Chicken Breasts 9.2% 
18 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops 33.3% 
1 
Chickens 11.5% 
6 
19.4% 
56  
20.2% 
50  
9.1% 
17
 Erythromycin 
(MIC ≥ 32 µg/ml) 
Humans 0.0% 
0 
12.5% 
1 
10.0% 
2 
8.3% 
1 
5.9% 
1 
4.0% 
1 
9.1% 
2 
0.0%
0 
Chicken Breasts 7.8% 
7 
7.0% 
10  
9.2% 
18  
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef
 Pork Chops 33.3% 
1 
75.0% 
3 
33.3% 
1 
Chickens 9.6% 
5 
18.8% 
54  
20.2% 
50  
9.1% 
17  
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
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Table 41b. Antimicrobial Resistance among Campylobacter coli  Isolates from Humans, Retail Meats, and Chickens, 
by Year, 1997-2004
 Year 1997 1998 1999 2000 2001 2002 2003 2004
 Number of Isolates Tested  Humans 6 8 20 12 17 25 22 26
 Chicken Breasts 90 142 196
 Ground Turkey 
Ground Beef 
2 
0 
1 
0 
5
0
 Pork Chops 3 4 3
 Chickens 521 288 247 186
 Antimicrobial
 (Resistance
 Antimicrobial Class  Breakpoint)  Isolate Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Humans
50.0% 
3 
37.5% 
3 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0%
0 
Chickens 0.0% 0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Flofenicol 
(MIC > 4)2 
Chicken Breasts 
0.0%
0 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops 0.0% 0
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Humans 33.3% 
2 
0.0% 
0 
30.0% 
6 
25.0% 
3 
47.1% 
8 
12.0% 
3 
22.7% 
5 
30.8%
8 
Chicken Breasts 10.0% 
9 
13.4% 
19  
16.3% 
32  
Ground Turkey 50.0% 
1 
100.0% 
1 
0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 19.2% 
10 
16.0% 
46 
20.2% 
50 
26.9% 
50
 Nalidixic acid 
(MIC ≥ 64 µg/ml) 
Humans 50.0% 
3 
50.0% 
4 
30.0% 
6 
25.0% 
3 
47.1% 
8 
12.0% 
3 
22.7% 
5 
34.6%
9 
Chicken Breasts 16.3% 
32 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops 0.0% 
0 
Chickens 19.2% 
10 
17.7% 
51 
21.5% 
53 
27.4% 
51
 Tetracyclines  Doxycycline 
(MIC ≥ 8 µg/ml) 
Chicken Breasts 44.4% 
40 
50.7%
72 
Ground Turkey 50.0% 
1 
100.0% 
1 
Ground Beef
 Pork Chops 33.3% 
1 
75.0% 
3
 Tetracycline 
(MIC ≥ 16 µg/ml) 
Humans 66.7% 
4 
50.0% 
4 
30.0% 
6 
25.0% 
3 
58.8% 
10  
40.0% 
10  
45.5% 
10  
38.5%
10  
Chicken Breasts 46.4% 
91 
Ground Turkey 0.0% 
0 
Ground Beef
 Pork Chops 66.7% 
2 
Chickens 57.7% 
30 
49.0% 
141 
51.0% 
126 
48.4% 
90 
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
2 For florfenicol, only a susceptible breakpoint (≤ 4 µg/ml) has been established. In this report, isolates with an MIC ≥ 8 µg/ml are categorized as resistant
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Ciprofloxacin Resistance 
Figure 20. Percent of Campylobacter coli  Isolates from Humans, Chicken Breasts, 
and Chickens Resistant to Ciprofloxacin, by Year, 1997-2004 
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1 Data for ground turkey and pork chops are not included due to the small number of C. coli isolates from these 
sources. There were no C. coli isolates from ground beef. Table 41 contains resistance data for C. coli 
isolates from each source, by year 
Erythromycin Resistance 
Figure 21. Percent of Campylobacter coli  Isolates from Humans, Chicken Breasts, 
and Chickens Resistant to Erythromycin, by Year, 1997-2004 
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1 Data for ground turkey and pork chops are not included due to the small number of C. coli isolates from these 
sources. There were no C. coli isolates from ground beef. Table 41 contains resistance data for C. coli 
isolates from each source, by year 
Table 42. Number of Campylobacter coli Isolates Tested from Humans, Retail Meats, and 
and Chickens, by Year, 1997-2004 
1997 1998 1999 2000 2001 2002 2003 2004
 Humans 6 8 20 12 17 25 22 26
 Chicken Breasts 90 142 196
 Ground Turkey 2 1 5
 Ground Beef 0 0 0
 Pork Chops 3 4 3
 Chickens 521 288 247 186 
1 These isolates were recovered from July through December 2001, when the new ARS isolation method was used 
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 V. Escherichia coli Data
 A. Escherichia coli Isolates Tested
Table 43. Number of E. coli  Isolates Tested, by Source and Year, 
2000-2004 
Year 
Source 2000 2001 2002 2003 2004
 Chicken Breasts 
Ground Turkey 
Ground Beef 
Pork Chops 
Chickens 285 1989 
282 
304 
295 
184 
2100 
396 
333 
311 
218 
1365 
400
376
338
232
1697 
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 B. Isolation of E. coli from Retail Meats 
Table 44. Number and Percent of Retail Meat Samples Positive for E. coli , 2004 
Chicken 
Breasts 
Ground 
Turkey 
Ground 
Beef 
Pork 
Chops 
Number Positive for E. coli 
Percent Positive for E. coli 
Number of Meat Samples Tested 476 
400 
84.0% 
466 
376 
80.7% 
480 
338 
70.4% 
478
232 
48.5%
 Figure 22. Percent of Retail Meat Samples Positive for E. coli , 2004 
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Figure 23. Percent of Retail Meat Samples Positive for E. coli , 2002-2004
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C. Antimicrobial Susceptibility among E. coli
MIC Distributions
Table 45a. Distribution of MICs and Occurrence of Resistance among E. coli Isolates from Retail Meats and Chickens, 2004                                                                  
 Isolate Source Distribution (%) of MICs (µg/ml)4
 Antimicrobial  (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Aminoglycosides
   Amikacin  Chicken Breasts (400) 0.0 0.0 [0.0 - 0.9] 15.0 65.0 17.0 2.5 0.5
 Ground Turkey (376) 0.0 0.0 [0.0 - 1.0] 17.3 66.5 13.8 2.4
 Ground Beef (338) 0.0 0.0 [0.0 - 1.1] 15.7 69.8 12.4 1.8 0.3
 Pork Chops (232) 0.0 0.0 [0.0 - 1.6] 0.4 15.5 56.0 26.3 1.3 0.4
 Chickens (1697) 0.0 0.0 [0.0 - 0.2] 1.6 15.3 48.9 28.5 5.5 0.1
   Gentamicin  Chicken Breasts (400) 2.8 30.0 [25.5 - 34.8] 5.8 43.3 14.8 2.5 1.0 2.8 10.0 20.0
 Ground Turkey (376) 2.1 29.3 [24.7 - 34.1] 4.8 42.6 19.1 2.1 2.1 12.5 16.8
 Ground Beef (338) 0.0 0.6 [0.1 - 2.1] 9.2 67.8 20.7 1.8 0.6
 Pork Chops (232) 0.4 1.3 [0.3 - 3.7] 10.3 57.8 26.7 3.4 0.4 1.3
 Chickens (1697) 2.9 39.1 [36.7 - 41.4] 5.8 26.8 20.9 3.9 0.7 2.9 8.6 30.5
   Kanamycin  Chicken Breasts (400) 1.0 6.8 [4.5 - 9.7] 81.8 10.5 1.0 6.8
 Ground Turkey (376) 2.1 16.0 [12.4 - 20.1] 75.0 6.9 2.1 0.3 15.7
 Ground Beef (338) 0.0 2.4 [1.0 - 4.6] 95.6 2.1 2.4
 Pork Chops (232) 0.0 8.2 [5.0 - 12.5] 89.2 2.6 8.2
 Chickens (1697) 6.0 11.5 [10.1 - 13.2] 67.8 14.7 6.0 1.9 9.7
   Streptomycin  Chicken Breasts (400) N/A 56.8 [51.7 - 61.7] 43.3 13.0 43.8
 Ground Turkey (376) N/A 49.2 [44.0 - 54.4] 50.8 18.6 30.6
 Ground Beef (338) N/A 11.8 [8.6 - 15.8] 88.2 4.7 7.1
 Pork Chops (232) N/A 21.1 [16.1 - 26.9] 78.9 8.6 12.5
 Chickens (1697) N/A 64.1 [61.8 - 66.4] 35.9 13.5 50.6
 Aminopenicillins
   Ampicillin  Chicken Breasts (400) 0.3 17.0 [13.4 - 21.0] 6.8 40.3 34.0 1.8 0.3 0.3 16.8
 Ground Turkey (376) 0.3 33.2 [28.5 - 38.3] 6.4 33.2 26.9 0.3 0.8 32.4
 Ground Beef (338) 0.9 5.3 [3.2 - 8.3] 8.9 46.2 37.9 0.9 0.9 0.3 5.0
 Pork Chops (232) 0.9 15.1 [10.7 - 20.4] 12.9 44.4 25.0 1.7 0.9 0.9 14.2
 Chickens (1697) 0.2 17.6 [15.8 - 19.5] 5.4 33.0 30.8 13.0 0.2 0.2 17.3
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
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Table 45b. Distribution of MICs and Occurrence of Resistance among E. coli Isolates from Retail Meats and Chickens, 2004                                                                  
 Isolate Source Distribution (%) of MICs (µg/ml)4
 Antimicrobial  (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1024
β-Lactam/β-Lactamase
 Inhibitor Combinations
   Amoxicillin-Clavulanic Acid  Chicken Breasts (400) 0.5 10.0 [7.2 - 13.4] 1.8 21.8 51.3 14.8 0.5 7.3 2.8
 Ground Turkey (376) 3.5 5.3 [3.3 - 8.1] 1.3 19.9 41.8 28.2 3.5 4.5 0.8
 Ground Beef (338) 0.3 3.8 [2.1 - 6.5] 4.4 23.4 60.9 7.1 0.3 3.6 0.3
 Pork Chops (232) 0.4 5.6 [3.0 - 9.4] 4.3 27.6 46.6 15.5 0.4 4.7 0.9
 Chickens (1697) 1.8 8.8 [7.5 - 10.2] 1.9 26.3 47.9 13.3 1.8 5.5 3.2
 Cephalosporins
   Ceftiofur  Chicken Breasts (400) 1.0 5.8 [3.7 - 8.5] 4.8 50.5 35.3 2.8 1.0 4.3 1.5
 Ground Turkey (376) 0.3 1.1 [0.3 - 2.7] 1.9 47.9 45.2 2.4 1.3 0.3 0.5 0.5
 Ground Beef (338) 0.6 0.9 [0.2 - 2.6] 5.0 49.4 41.7 2.1 0.3 0.6 0.9
 Pork Chops (232) 0.0 0.4 [0.0 - 2.4] 7.3 51.7 39.7 0.9 0.4
 Chickens (1697) 2.0 4.9 [3.9 - 6.0] 7.1 61.6 22.2 1.8 0.4 2.0 3.3 1.6
   Ceftriaxone  Chicken Breasts (400) 3.0 0.0 [0.0 - 0.9] 90.0 1.3 2.0 0.3 3.5 2.0 1.0
 Ground Turkey (376) 0.5 0.0 [0.0 - 1.0] 95.5 1.3 1.9 0.8 0.3 0.3
 Ground Beef (338) 1.2 0.0 [0.0 - 1.1] 95.9 1.8 0.6 0.3 0.3 0.6 0.6
 Pork Chops (232) 0.4 0.0 [0.0 - 1.6] 97.0 1.7 0.9 0.4
 Chickens (1697) 3.7 0.1 [0.0 - 0.3] 90.9 0.4 1.2 0.3 0.5 2.9 3.2 0.5 0.1
 Cephamycins
   Cefoxitin  Chicken Breasts (400) 2.3 8.3 [5.7 - 11.4] 0.3 15.5 53.0 20.8 2.3 3.8 4.5
 Ground Turkey (376) 0.8 4.5 [2.7 - 7.1] 0.8 22.1 55.9 16.0 0.8 2.7 1.9
 Ground Beef (338) 1.8 1.2 [0.3 - 3.0] 4.1 30.2 53.8 8.9 1.8 0.3 0.9
 Pork Chops (232) 0.4 2.2 [0.7 - 5.0] 0.9 2.6 26.7 59.9 7.3 0.4 1.3 0.9
 Chickens (1697) 2.5 8.2 [6.9 - 9.6] 0.1 0.5 16.4 56.3 16.0 2.5 4.5 3.7
 Folate Pathway Inhibitors
   Sulfisoxazole  Chicken Breasts (400) N/A 41.3 [36.4 - 46.2] 48.5 6.3 4.0 41.3
 Ground Turkey (376) N/A 48.4 [43.2 - 53.6] 44.4 3.2 4.0 48.4
 Ground Beef (338) N/A 13.0 [9.6 - 17.1] 84.6 2.4 13.0
 Pork Chops (232) N/A 19.4 [14.5 - 25.1] 69.8 3.0 6.9 0.4 0.4 19.4
 Chickens (1697) N/A 53.2 [50.8 - 55.6] 44.5 1.9 0.1 0.1 0.2 53.2
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
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 Chickens (1697) 1.1 50.3 [47.9 - 52.7] 48.6 1.1 1.6 15.4 33.2
  the percentages of isolates with MICs equal to or less than the lowest tested concentration
Table 45c. Distribution of MICs and Occurrence of Resistance among E. coli Isolates from Retail Meats and Chickens, 2004                                                                   
 Isolate Source Distribution (%) of MICs (µg/ml)4
 Antimicrobial  (# of Isolates) %I1 %R2 [95% CI]3 0.015 0.03 0.06 0.125 0.25 0.50 1 2 4 8 16 32 64 128 256 512 1024
 Folate Pathway Inhibitors
   Trimethoprim-Sulfamethoxazole  Chicken Breasts (400) N/A 4.3 [2.5 - 6.7] 85.5 7.0 2.5 0.5 0.3 4.3
 Ground Turkey (376) N/A 3.7 [2.1 - 6.2] 83.8 9.3 2.7 0.5 3.7
 Ground Beef (338) N/A 0.6 [0.1 - 2.1] 97.0 2.1 0.3 0.6
 Pork Chops (232) N/A 3.9 [1.8 - 7.2] 93.1 2.2 0.9 3.9
 Chickens (1697) N/A 10.7 [9.2 - 12.2] 45.6 28.5 9.3 3.9 2.1 0.5 10.1
 Phenicols
   Chloramphenicol  Chicken Breasts (400) 2.5 1.8 [0.7 - 3.6] 3.3 34.5 58.0 2.5 0.3 1.5
 Ground Turkey (376) 0.8 0.8 [0.2 - 2.3] 1.3 36.7 60.4 0.8 0.8
 Ground Beef (338) 0.9 3.6 [1.8 - 6.1] 0.3 26.9 68.3 0.9 0.3 3.3
 Pork Chops (232) 0.9 4.3 [2.1 - 7.8] 0.9 34.1 59.9 0.9 1.3 3.0
 Chickens (1697) 0.5 1.0 [0.6 - 1.6] 6.2 65.8 26.5 0.5 1.0
 Quinolones
   Ciprofloxacin  Chicken Breasts (400) 0.0 0.0 [0.0 - 0.9] 90.3 2.3 0.5 1.8 4.0 1.3
 Ground Turkey (376) 0.0 0.8 [0.2 - 2.3] 84.3 3.5 0.8 2.9 7.4 0.3 0.8
 Ground Beef (338) 0.0 0.0 [0.0 - 1.1] 94.4 3.8 0.6 0.9 0.3
 Pork Chops (232) 0.0 0.0 [0.0 - 1.6] 97.8 0.9 0.4 0.4 0.4
 Chickens (1697) 0.0 0.2 [0.0 - 0.5] 92.4 0.9 0.4 3.8 2.2 0.1 0.1 0.1
   Nalidixic Acid  Chicken Breasts (400) N/A 7.0 [4.7 - 10.0] 6.5 63.0 23.3 0.3 0.3 6.8
 Ground Turkey (376) N/A 10.6 [7.7 - 14.2] 3.7 62.0 21.5 1.6 0.5 0.5 10.1
 Ground Beef (338) N/A 1.5 [0.5 - 3.4] 3.0 67.5 26.9 1.2 0.9 0.6
 Pork Chops (232) N/A 0.0 [0.0 - 1.6] 9.9 68.5 19.4 1.3 0.9
 Chickens (1697) N/A 6.8 [5.6 - 8.1] 0.2 16.0 64.6 12.0 0.4 0.1 0.8 6.0
 Tetracyclines
   Tetracycline  Chicken Breasts (400) 0.8 48.0 [43.0 - 53.0] 51.3 0.8 0.5 3.3 44.3
 Ground Turkey (376) 0.5 74.2 [69.5 - 78.6] 25.3 0.5 6.9 67.3
 Ground Beef (338) 6.5 22.8 [18.4 - 27.6] 70.7 6.5 2.7 1.2 18.9
 Pork Chops (232) 2.2 56.0 [49.4 - 62.5] 41.8 2.2 6.0 50.0
1 Percent of isolates with intermediate susceptibility 
2 Percent of isolates that were resistant
3 95% confidence intervals for percent resistant (%R) calculated using the Clopper-Pearson exact method
4 The unshaded areas indicate the dilution range of the Sensititre plates used to test 2004 isolates.  Single vertical bars indicate the breakpoints for susceptibility, while double vertical bars indicate the breakpoints for 
  resistance.  Numbers in the shaded area indicate the percentages of isolates with MICs greater than the highest concentrations on the Sensititre plate.  Numbers listed for the lowest tested concentrations represent 
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Resistance by Year 
Table 46a. Antimicrobial Resistance among E. coli Isolates from Retail Meats and Chickens, 
by Year, 2000-2004 
Year 2000 2001 2002 2003 2004
 Number of Isolates Tested  Chicken Breasts 282 396 400
 Ground Turkey 
Ground Beef 
304 
295 
333 
311 
376
338
 Pork Chops 184 218 232
 Chickens 285 1989 2100 1365 1697
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Aminoglycosides  Amikacin 
(MIC ≥ 64 µg/ml) Chicken Breasts
0.0% 
0 
0.0% 
0 
0.0%
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0 
0.0% 
0
 Gentamicin 
(MIC ≥ 16 µg/ml) 
Chicken Breasts 23.0% 
65 
29.3% 
116 
30.0%
120 
Ground Turkey 27.0% 
82 
29.7% 
99 
29.3% 
110 
Ground Beef 0.3% 
1 
1.0% 
3 
0.6% 
2 
Pork Chops 1.1% 
2 
1.4% 
3 
1.3% 
3 
Chickens 40.0% 
114 
33.4% 
664 
38.0% 
799 
38.8% 
530 
39.1% 
663
 Kanamycin 
(MIC ≥ 64 µg/ml) 
Chicken Breasts 6.0% 
17 
6.8% 
27 
6.8%
27 
Ground Turkey 13.2% 
40 
16.8% 
56 
16.0% 
60 
Ground Beef 2.4% 
7 
2.9% 
9 
2.4% 
8 
Pork Chops 5.4% 
10 
8.7% 
19 
8.2% 
19 
Chickens 16.1% 
46 
14.5% 
288 
11.6% 
243 
10.3% 
140 
11.5% 
196
 Streptomycin 
(MIC ≥ 64 µg/ml) 
Chicken Breasts 49.3% 
139 
56.1% 
222 
56.8%
227 
Ground Turkey 57.6% 
175 
54.7% 
182 
49.2% 
185 
Ground Beef 9.5% 
28 
9.0% 
28 
11.8% 
40 
Pork Chops 22.3% 
41 
19.7% 
43 
21.1% 
49 
Chickens 77.5% 
221 
65.8% 
1308 
65.1% 
1368 
64.2% 
877 
64.1% 
1088
 Aminopenicillins  Ampicillin 
(MIC ≥ 32 µg/ml) 
Chicken Breasts 21.6% 
61 
25.3% 
100 
17.0%
68 
Ground Turkey 31.3% 
95 
35.7% 
119 
33.2% 
125 
Ground Beef 6.1% 
18 
5.1% 
16 
5.3% 
18 
Pork Chops 13.6% 
25 
13.3% 
29 
15.1% 
35 
Chickens 20.0% 
57 
19.5% 
388 
19.0% 
399 
18.6% 
254 
17.6% 
298 
β-Lactam/β-Lactamase 
Inhibitor Combinations
 Amoxicillin-
Clavulanic Acid 
(MIC ≥ 32 / 16 µg/ml) 
Chicken Breasts 12.1% 
34 
13.6% 
54 
10.0%
40
 Ground Turkey 5.6% 
17 
3.0% 
10 
5.3% 
20 
Ground Beef 2.0% 
6 
2.3% 
7 
3.8% 
13  
Pork Chops 5.4% 
10 
5.0% 
11 
5.6% 
13 
Chickens 8.1% 
23 
10.0% 
199 
10.9% 
229 
11.1% 
151 
8.8% 
149 
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Table 46b. Antimicrobial Resistance among E. coli Isolates from Retail Meats and Chickens, 
by Year, 2000-2004 
Year 2000 2001 2002 2003 2004
 Number of Isolates Tested  Chicken Breasts 282 396 400
 Ground Turkey 
Ground Beef 
304 
295 
333 
311 
376
338
 Pork Chops 184 218 232
 Chickens 285 1989 2100 1365 1697
 Antimicrobial
 (Resistance Isolate
 Antimicrobial Class  Breakpoint)  Source
 Cephalosporins  Ceftiofur 
(MIC ≥ 8 µg/ml) Chicken Breasts
7.1% 
20 
7.6% 
30 
5.8%
23 
Ground Turkey 1.0% 
3 
0.3% 
1 
1.1% 
4 
Ground Beef 0.0% 
0 
0.3% 
1 
0.9% 
3 
Pork Chops 0.5% 
1 
0.9% 
2 
0.4% 
1 
Chickens 6.3% 
18 
4.4% 
88 
5.5% 
115 
7.1% 
97 
4.9% 
83
 Ceftriaxone 
(MIC ≥ 64 µg/ml) 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0%
0 
Ground Turkey 0.0% 
0 
0.0% 
0 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.0% 
0 
0.0% 
1 
0.0% 
0 
0.1% 
1
 Cephalosporins  Cephalothin 
(MIC ≥ 32 µg/ml) 
Chicken Breasts 21.3% 
60 
22.0%
87 
Ground Turkey 14.8% 
45 
18.9% 
63 
Ground Beef 5.8% 
17 
8.0% 
25 
Pork Chops 10.3% 
19 
11.9% 
26 
Chickens 17.9% 
51 
12.9% 
256 
15.1% 
317 
16.6% 
226
 Cephamycins  Cefoxitin 
(MIC ≥ 32 µg/ml) 
Chicken Breasts 11.0% 
31 
9.3% 
37 
8.3%
33 
Ground Turkey 3.3% 
10 
1.2% 
4 
4.5% 
17 
Ground Beef 1.4% 
4 
0.3% 
1 
1.2% 
4 
Pork Chops 3.3% 
6 
2.3% 
5 
2.2% 
5 
Chickens 7.4% 
21 
8.7% 
173 
8.5% 
178 
8.3% 
113 
8.2% 
139
 Folate Pathway Inhibitors  Sulfamethoxazole/ 
Sulfisoxazole1 
(MIC ≥ 512 µg/ml) 
Chicken Breasts 32.3% 
91 
38.4% 
152 
41.3%
165
 Ground Turkey 48.0% 
146 
51.7% 
172 
48.4% 
182 
Ground Beef 9.8% 
29 
10.3% 
32 
13.0% 
44 
Pork Chops 12.5% 
23 
15.1% 
33 
19.4% 
45 
Chickens 57.9% 
165 
58.2% 
1157 
46.1% 
969 
43.9% 
599 
53.2% 
903
 Trimethoprim-
Sulfamethoxazole 
(MIC ≥ 4 / 76 µg/ml) 
Chicken Breasts 3.5% 
10 
7.1% 
28 
4.3%
17
 Ground Turkey 3.9% 
12 
6.9% 
23 
3.7% 
14 
Ground Beef 0.7% 
2 
0.3% 
1 
0.6% 
2 
Pork Chops 1.1% 
2 
2.8% 
6 
3.9% 
9 
Chickens 17.2% 
49 
12.6% 
251 
10.4% 
218 
10.5% 
144 
10.7% 
181 
1 Sulfamethoxazole was tested from 1996 through 2003 and was replaced by sulfisoxazole in 2004
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Table 46c. Antimicrobial Resistance among E. coli Isolates from Retail Meats and Chickens, 
by Year, 2000-2004 
Year 2000 2001 2002 2003 2004
 Number of Isolates Tested  Chicken Breasts 282 396 400
 Ground Turkey 
Ground Beef 
304 
295 
333 
311 
376
338
 Pork Chops 184 218 232
 Chickens 285 1989 2100 1365 1697
 Antimicrobial
 (Resistance  Isolate
 Antimicrobial Class  Breakpoint)  Source
 Phenicols  Chloramphenicol 
(MIC ≥ 32 µg/ml) Chicken Breasts 
0.7% 
2 
0.0% 
0 
1.8%
7 
Ground Turkey 0.3% 
1 
3.6% 
12  
0.8% 
3 
Ground Beef 1.0% 
3 
2.3% 
7 
3.6% 
12  
Pork Chops 1.6% 
3 
4.1% 
9 
4.3% 
10  
Chickens 4.6% 
13 
2.4% 
47 
1.8% 
38 
1.3% 
18 
1.0% 
17
 Quinolones  Ciprofloxacin 
(MIC ≥ 4 µg/ml) 
Chicken Breasts 0.0% 
0 
0.0% 
0 
0.0%
0 
Ground Turkey 0.0% 
0 
0.3% 
1 
0.8% 
3 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.0% 
0 
0.0% 
0 
0.0% 
0 
Chickens 0.0% 
0 
0.2% 
3 
0.0% 
1 
0.1% 
1 
0.2% 
3
 Nalidixic Acid 
(MIC ≥ 32 µg/ml) 
Chicken Breasts 2.8% 
8 
4.0% 
16 
7.0%
28 
Ground Turkey 4.3% 
13 
11.7% 
39 
10.6% 
40 
Ground Beef 0.0% 
0 
1.0% 
3 
1.5% 
5 
Pork Chops 0.5% 
1 
0.5% 
1 
0.0% 
0 
Chickens 10.2% 
29 
8.4% 
168 
6.8% 
142 
6.2% 
84 
6.8% 
115
 Tetracyclines  Tetracycline 
(MIC ≥ 16 µg/ml) 
Chicken Breasts 46.1% 
130 
42.9% 
170 
48.0%
192 
Ground Turkey 77.0% 
234 
77.8% 
259 
74.2% 
279 
Ground Beef 30.8% 
91 
25.1% 
78 
22.8% 
77 
Pork Chops 52.7% 
97 
46.3% 
101 
56.0% 
130 
Chickens 68.4% 
195 
61.6% 
1226 
58.6% 
1231 
52.2% 
713 
50.3% 
853 
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Multidrug Resistance
Table 47. Resistance Patterns among E. coli Isolates from Retail Meats and Chickens, 
by Year, 2000-2004
 Year 2000 2001 2002 2003 2004
 Number of Isolates Tested  Chicken Breasts 282 396 400
 Ground Turkey 
Ground Beef 
304 
295 
333 
311 
376
338
 Pork Chops 184 218 232
 Chickens 285 1989 2100 1365 1697
 Resistance Pattern  Isolate Source 
1. No Resistance Detected 
Chicken Breasts
27.0% 
76 
20.5% 
81 
20.8%
83 
Ground Turkey 16.8% 
51 
14.7% 
49 
19.1% 
72 
Ground Beef 63.1% 
186 
66.9% 
208 
73.1% 
247 
Pork Chops 41.3% 
76 
44.5% 
97 
37.9% 
88 
Chickens 9.8% 
28 
12.6% 
251 
15.1% 
317 
15.6% 
213 
17.0% 
288 
2. At Least ACSSuT1 Resistant 
Chicken Breasts
0.4% 
1 
0.0% 
0 
1.3%
5 
Ground Turkey 0.0% 
0 
2.7% 
9 
0.5% 
2 
Ground Beef 0.3% 
1 
1.0% 
3 
1.5% 
5 
Pork Chops 0.5% 
1 
1.4% 
3 
1.3% 
3 
Chickens 3.5% 
10 
2.0% 
40 
1.3% 
27 
1.0% 
14 
0.8% 
14 
3. At Least ACT/S2 Resistant 
Chicken Breasts
0.0% 
0 
0.0% 
0 
0.3%
1 
Ground Turkey 0.0% 
0 
0.9% 
3 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.5% 
1 
0.0% 
0 
0.4% 
1 
Chickens 1.4% 
4 
0.6% 
11  
0.3% 
7 
0.2% 
3 
0.3% 
5 
4. At Least ACSSuTAuCf 3 
Chicken Breasts
0.4% 
1 
0.0% 
0 
1.0%
4
 Resistant Ground Turkey 0.0% 
0 
0.3% 
1 
0.0% 
0 
Ground Beef 0.0% 
0 
0.0% 
0 
0.9% 
3 
Pork Chops 0.0% 
0 
0.5% 
1 
0.4% 
1 
Chickens 2.8% 
8 
1.1% 
22  
0.8% 
17  
0.8% 
11  
0.6% 
10 
5. At Least Ceftiofur and 
Chicken Breasts 0.4% 
1 
0.5% 
2 
0.8%
3
 Nalidixic Acid Resistant 
Ground Turkey 0.3% 
1 
0.3% 
1 
0.3% 
1 
Ground Beef 0.0% 
0 
0.0% 
0 
0.0% 
0 
Pork Chops 0.5% 
1 
0.0% 
0 
0.0% 
0 
Chickens 1.4% 
4 
0.3% 
5 
0.4% 
9 
0.9% 
12  
0.4% 
7
 1 ACSSuT = ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole, and tetracycline
 2 ACT/S = ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole
 3 ACSSuTAuCf = ACSSuT, amoxicillin-clavulanic acid, and ceftiofur 
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Appendix 
Table A1. Concentration Ranges Used for Susceptibility Testing of Salmonella 
and E. coli , 2004 
Antimicrobial Class  Antimicrobial Agent Concentration Range (µg/ml)
 Aminoglycosides  Amikacin 0.5 - 64 
Gentamicin 0.25 - 16 
Kanamycin 8 - 64 
Streptomycin 32 - 64 
Aminopenicillins  Ampicillin 1 - 32 
β-Lactam/β-Lactamase
 Inhibitor Combinations  Amoxicillin–Clavulanic Acid
1 / 0.5 - 32 / 16 
Cephalosporins Ceftiofur 0.12 - 8 
Ceftriaxone 0.25 - 64 
Cephamycins  Cefoxitin 0.5 - 32 
Folate Pathway Inhibitors  Sulfisoxazole 16 - 256 
Trimethoprim–Sulfamethoxazole 0.12 / 2.4 - 4 / 76 
Phenicols  Chloramphenicol 2 - 32 
Quinolones  Ciprofloxacin 0.015 - 4 
Nalidixic acid 0.5 - 32 
Tetracyclines  Tetracycline 4 - 32 
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Table A2. Concentration Ranges Used for Susceptibility Testing1 of 
Campylobacter , 2004 
Antimicrobial Class  Antimicrobial Agent 
Concentration Range (µg/ml) 
Etest® 
Broth 
Microdilution
 Aminoglycosides  Gentamicin 0.016 - 256 0.12 - 32
 Ketolides  Telithromycin N/A 0.015 - 8
 Lincosamides  Clindamycin 0.016 - 256 0.03 - 16
 Macrolides  Azithromycin 0.016 - 256 0.015 - 64
 Erythromycin 0.016 - 256 0.03 - 64
 Phenicols  Chloramphenicol 0.016 - 256 N/A
 Florfenicol N/A 0.03 - 64
 Quinolones  Ciprofloxacin 0.002 - 32 0.015 - 64
 Nalidixic acid 0.016 - 256 4 - 64
 Tetracyclines  Tetracycline 0.016 - 256 0.06 - 64 
1 Etest® was used to test human and food animal isolates while a broth microdilution method was used to 
test retail meat isolates 
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